{"BGC0001102.1|Malleilactone_1 # 1 # 8379 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.739": {"gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 1, "orf_end": 8379, "orf_from": "BGC0001102.1|Malleilactone_1 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.20572e-14, "max_identities": 120, "bit_score": 77.0258, "cvterm_id": "36789", "query": "HSVLAAIREHVARTPDALALKDGERTWTYRQLASHAGELADAFRAAGVGRQDVVGVFLPHGAEYVLTIVAAWSIGASVCLLEKSWPDSLVGEFVASCRVAQFATTPELLARAAK------------HLPDARCTLVGARPPLADRAWASVAPRPDDI---------------AFVSLTSGSTGKPKAVLTTHIGTSYCFHAR-DALYPYADGEREGLNVFLAWECLRPLMFGRPAVVIGDDVIFDPPRLVAL-----LRRERITRLVVTPSLLESVLDFPGVAAQLRDALAHMSAWFLMGEVMPPRVVDKARAAFPPSVRLVNAYSTWE-SLDVCYADLLPSRASDGSRRVPIGRPLPGCALAVLDDAG-----RAVPAGETGELHIASPGLGPGYLDDAARTAEKFLPSAPALAERGHDAPV-YRTGDRARLLPDGQISILGRIDNTVKIRGFKVLLHAVENVLDAVEGVSKSLVVPIDDPHTRQPSALAAYVVGSDGAPSETTLARLRQQ", "match": "HS+LAAI+ +  R   AL +K  ++T+TY+++   A  L+D +   GV R  ++ V     A Y   I A++  G +   L        + E + + +        + L+R +              LPD     +  + P     + +V     D+               A++  TSGSTGKPK +  ++    +C+ ++ D L+P    +R G    L ++     +F     +I    ++  P L  L     +R  ++T  +  P+++E  L    +      +L  +   F  G+ +   + ++ + A    V  +N Y   E ++ + Y   +   A  G   VPIGR      LA++++ G      + P G  GEL ++   L  GYL+D   T   F           H+  + YR+GD      +G +  LGR D+ VKI G +V L  +E V+  V       +VP     +   S   A+V        +  L++ +QQ", "sequence_from_db": "HSILAAIQAN--RHAPALWVK--QKTYTYQEMTDMALSLSDYWHLQGVQRVAILSV--RDLAAYS-AIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYP--QHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSY-SNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIF---YSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPH---SLPSLRLSFFCGQALLHDLAEQWQQATQQPV--INLYGPTECTIAITYHRFV---AHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQ---------HEGRIWYRSGDIVT-KSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQ", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 859, "query_end": 2274, "hit_start": 99, "hit_end": 1542, "orf_dna_sequence": "ATGAGGCAAATAGTTTCAACGAGCAACGGATCTCTCGATAGTCGAGCCCGGATCGTCGCATTCCCGTTCGCGGGCGGCAGCGACGCGAGCTACGCGGACATGGCCCGCGCACTTGGCGGCGCGTTCGCTTTCACGACGCTCAGCCTGCCCGGTCGCGGCGCGACCCAGCACATTCCGTTCTACGACGACTGGCCGTCTCTCGTCGACGATCTCGCCGCCGAGGTCGCGCGGCTCGACGACGGCACGCCCTTCTTCCTGTTCGGCCACAGCCTCGGCGCGCTGCTCGCCTACGAAGTCGCGCGCGCGCTCGAGCAACGCGGCGGCGCGCAGCCGGCCGGCGTCTTTCTGTCGGGCCATCCCGCGCCCTCGCGCGAGCGCGCAACCGACGCATGGCGTCAACCGACGCATGCGCTGCCCGACACCGCGTTCATCGAAGCCGTGCGACGCTGGGGCTTCTTCCCGGACGGCGCGCTCGACGATGCCGACGTCGCCCGCTACGTTCTTCCGCCGCTGCGGGCGGACCTCCGGCTCGCCGAAACCTACCGGCACGCCCCCGGCGACGCGCTGCGCGCGCCGTGCGCGATCTACGGCGGCGCGGCCGATCCGAGCACGACCATCGACGATCTGCGCGCGTGGCGCGCGCACGTCGGCTCACAGCATGCGTGCCCGGTCGAGACGTTCGACGGCCATCATTTCTATTTTCTGGAGCCGACATCGCGCGCGGCGCTGTGCGCGAGCGTCGCCGGCCATATCGAGCGACGGCTCGCGGAGCGCCCCGCGTCGATCGTCGCGGCGACGCCCGATCCGGGCTCGCGCGTCGCCGCGTGCCTGCGCGCGGCCGACGATTGGGGCGATGCGCATTCGGTGCTCGCCGCGATCCGCGAGCACGTCGCGCGCACCCCCGATGCGCTCGCGCTGAAGGACGGCGAACGCACGTGGACGTACCGGCAACTCGCATCGCATGCGGGCGAGCTCGCCGACGCGTTTCGCGCGGCGGGCGTCGGCCGGCAGGATGTGGTCGGCGTCTTTCTGCCGCACGGCGCCGAGTATGTGCTGACGATCGTCGCCGCATGGTCGATCGGCGCGTCGGTATGCCTGCTCGAAAAGAGCTGGCCCGATTCGCTCGTCGGCGAATTCGTCGCGAGCTGCCGCGTCGCGCAGTTCGCGACGACGCCCGAGTTGCTCGCGCGCGCGGCCAAACATCTGCCCGATGCGCGCTGCACGCTCGTCGGCGCGCGCCCGCCGCTCGCGGACCGCGCATGGGCGAGCGTCGCGCCGCGCCCCGACGACATCGCGTTCGTCTCGTTGACGAGCGGCTCGACGGGCAAGCCGAAGGCCGTCCTCACGACGCACATCGGCACGAGCTACTGCTTCCACGCGCGCGACGCGCTGTACCCGTACGCCGACGGCGAGCGCGAAGGGCTCAACGTGTTTCTCGCGTGGGAATGCCTGCGCCCGCTGATGTTCGGCCGCCCGGCCGTCGTGATCGGCGACGACGTGATCTTCGATCCGCCCCGGCTCGTCGCGCTGCTGCGTCGCGAGCGGATCACGCGGCTCGTCGTCACGCCGTCGCTGCTCGAAAGCGTGCTCGATTTCCCCGGCGTCGCCGCGCAACTGCGCGACGCGCTCGCGCACATGTCCGCGTGGTTCCTGATGGGCGAAGTCATGCCGCCGCGCGTCGTCGACAAGGCGCGCGCCGCGTTCCCGCCATCGGTGCGGCTCGTCAACGCGTACAGCACGTGGGAAAGCCTCGACGTCTGCTACGCCGATCTGCTGCCGTCGCGCGCGAGCGACGGCAGCAGGCGCGTGCCGATCGGCCGGCCGCTGCCCGGCTGCGCGCTCGCGGTGCTCGACGATGCGGGACGCGCCGTGCCGGCGGGCGAGACGGGCGAACTGCACATCGCGTCACCCGGCCTCGGTCCCGGCTATCTCGACGATGCGGCGCGCACCGCCGAGAAATTCCTGCCGTCCGCGCCCGCGCTCGCCGAACGCGGGCACGACGCGCCCGTCTACCGGACGGGCGACCGCGCGCGGCTGCTGCCGGACGGCCAGATCTCGATCCTCGGCCGCATCGACAACACGGTGAAGATCCGCGGCTTCAAGGTGCTGCTGCACGCGGTCGAGAACGTGCTCGACGCGGTCGAAGGCGTCAGCAAATCGCTCGTCGTGCCGATCGACGATCCGCACACGCGGCAGCCGTCGGCGCTCGCCGCGTACGTCGTCGGCAGCGACGGCGCGCCGTCGGAGACGACGCTCGCGCGGCTGCGCCAGCAAGCGCGCGCGAAGCTGCCCGAATACGCGGTGCCCGCGCATTTCATCGGCCTCGATGCGTTTGCGCTGCGCGCGGGCACGTCGCGCAAGCTCGACAAGCAGGCGCTGCCGCCCGTGCCGAGCGACGCGCGAACCGCCCCTCGCGACGCCGCCGCCCCAAGCGCGGGCGACGGGCTCGAAGCGCGGCTCGCGCAAGTGTGGCGCGACGTGCTCGGCGTCGCGTCGGTCGCGCGCGACGATCACTTCTTCGAGCTCGGCGGCAACTCGCTGAGCGCCGCGAAGGCGGTCGGCCTGCTCGGCGAGCGGCTCGGGCTCTCGCTCGCGGTCGTCGATCTGTATCAGCACAGCCGGCTGCGGGATCTCGCCGATCACTGCCGCCGCTCGCGGGAGGACGCCGCGCGCCCGCGCGCGGACGAAGCGCGCGACGTTCGCGCGCCGCGCGCGGCATCGGCCGCCGATGCGCCGAAGGTCGCGATCGTCGGCATGGCCGGCCGCTTCCCGGGCGCGGACTCGGTCGACGCGTTCTGGCGCAACCTGACGCAAGGCGTCGACAGCCTGTCGCGCTTCGCGCGCGAGCAGTTGCTCGCGAAGGGCGTCGACGCCGCGACGCTCGATCATCCGGACTGGGTGCCGGCCGCGCAGGCCGTCAGCGACGCGGACAAGTTCGACGCGCTCTTCTTCGGCATCGGCCCGCGCGAAGCGGCGCTGATGGACCCGCAGCACCGGCTCTTCATGCAAGTCGCGTGGAGCGCGCTCGAGCAGGCGGGCTACGCGCGCGCCGACAACCGCTACCGCACGCGCACCGGCGTGTTCGCGAGCTGCGGAATCGACGGCTATCTCGTCCATCATCTGCAAGGCGGCGGGCTGCTCACGCCGCTCGATCCGGGCCGGCTGATGCTCACCGAGATCGGCAACGAGAAGGACTACATCGCGACGCGCGTCGCGTATCAGCTCGATCTCGGCGGGCCCGCGGTGTCGGTCGGCGCCGCATGCAGCAGCGCGCTCGTCGCGGTCGTGCAGGCGGTGCAGGCGATTCGCGCCGGCCAGTGCGAGATGGCGATCGCGGGCGCGTCCGCGCTGTCGTTCCCGAACTTCGGCTTCTGCTATGAGGACGGCCTCGTCGGCAGCGCCGACGGCCACGTGCGCCCGTTCGACGCGCGCGCGAGCGGCACGCTGTTCGGCGACGCGGTCGGCGCGGTCGCGCTCAAGCGGCTCGACCTCGCCGAAGCCGACGGCGATCCGATCCTCGCGGTGATCTCGGGCGTCGGGCTGTCGAACGACGGCCGGATGAAGGCGGGCTACACCGCGCCGAACGCGGACGCGCAGCGGCGCTGCATCGTCGACGCGCTCGACATGGCGGGCGTGCGCTCCGAGCAGATCTCGTACGTCGAGTGCCACGCAACCGCGACGCTGATCGGCGACGCGATCGAGCTGAAGGGGCTCTCCGACGCATTCGCGCAAACGCGCGGCGCCGGTGCCGACATCGCCGCCGTCGCGGGCGGCTGTGCGATCGGCAGCGTGAAAGGCAACATCGGTCATGCGAATTGCGCGGCCGGCATCACGGGGCTCATCAAGACCGTGCTGCAGCTCCAGCACCGGCAGCGCGTGCCGACCGTGCATTTCGACACGCTCAATCCGAAGCTCGTGCCGTTCGTCGAGCACGATGCGTCGCCGTTCGTCGTGCAGCGCCGGATCGACGACTGGAGCGTCGCCGATCCGGCGACGCAATTGCCGCGGCGCGCCGGCGTATCGAGCTTCGGGATCGGCGGCACGAACGCGCACGTGATCGTCGAGGAAGCGCCCGCGCGCGCCGCCGCACCCGCCGAAGGCGTGCCGCGCGCGCATCACCTGATGACCGTGTCCGCACGCACGCCCGGCGCGCTCGCGCGCAACCTGCGAGCGCTCGCCGAGCAAGTCGCGACGATGGATGCGGCCGATCTCGGATGCGCGGCCCATACGCTGCACGTCGCGCGCGACGCGCATCCGCTGCGGGTCGCGCTCGCCGTGCCCGCGCGGCCCGCCGAAGCGGCCGCCGCGCTGCGCGAGCGCGCCGGCGCGCTCGATGAAGCGCCCGACGCAGGCGACGCGCCCGGCGCGCCCGTTCGCGCCAAACCCGGCGCGACCGTCGCGTTCTGCTTCTCCGGCCAAGGCTCGCAGCATCCGGGCATGGCGCGCGAGCTGTATCGGTCGAACGCGGAGGCCGGCCGCTTCCGCCATCACTTCGACGCCGCGTGCGCGGCGCTCGAGCGCGCGCTCGGCGCGCCGATCGCGGACACGATCCTGAACGCCGGCGACGATGCGATGCGCCGCCCGCTCGTCACGCAATGCGGGCTGTTCGCGCTCGAGCACGCGCTCGCGTCGGTGCTCGGCGAATACGGCGTGCGGCCCGTCGCGGTCGCGGGGCACAGTATCGGCCAGTATGCGGCCGCCGTCGCCGCCGAGGCGCTCACGCTCGAGCAGGCGGCCGCGCTCGTCGCGGCCCGCGCGCGCGCGACCGAGGCGCTGACGGCGCTCGCGGCCGGCGACGGCGCGCATGTGCGCGGCGGCATGCTCGCCGTGACGGGCGACGACGCGCGCATCGAGCAGTGGGCGGCCGGGCGCGCCGACATGTGGATCGCCGTGCGCAACGCGCCGCGCACGCTCGTGCTCGCGGGCACGGAACCCGCGCTCGCCGACGCCGCGCGCGCGCTCGCCGCGCTCGGTTGCCGGTGCCGGCCGGTGCCGGTGTCACATCCGTTCCATACGCCGCTGATGCAGCCCGTCGCCGACGCGATCGCCGCGCAGCGCATCGAGGGCGCCGCGCCGCGGATTCCGATGACGTGCAATGTGACGGGCGGCTGGCTCGGCGCCGACGCCGCATCGGCCGACTATTGGGCGCGCCATCTGCGCGAGCCGGTACGCTGGTCGGACAACGTGGCCGCGCTGCTGCGCTGGCAGCCCGACATCGTGCTCGAAATCGGTCCGGGCGCCGTGCTGTGCGGCCTGATCGGCAGGCATCTCGCGGCCGGGGCGAGTGCCGATGCATCGGCGCACGCGAACGCGCCGCGCGTGCTGCCGTCGCTGCCCGCCGCGCGCGACGGCGCGGGCGACGCCGATCACTTCAGCAACGTGATCGGCCAATTGTGGTGCGCGGGCGTGGCGATCGACTGGCGCGCGTATCACGCGCACGAAGCGGCGTCGCCCGGCCGCGCGCTCGCGCGCGTGCCGCTGCCCGGCTATGCGTTCGAGCGCGACAGCTACTGGACGCGGCCCGAGGCGTCGATCTATGTCGATGCGGCGCCGGCTGCGGCCGAATCCGAGATCTCGGCAAACCGTGCGGAAAACCACGCAGCAAACCGCGCGAGCGTCCCCGCCGACGCCGCCGGCATCACGCCAAACGACGCGCCGGCAACGCCCCGCGCGCACGCGGCGTCGACGCTCGCGTGTTCCGGCGGATGCTCGTGCGCCGCCGGATCGCGGTCATGCAACGGCGGACATGACGCCACGGCCGCCGCCCGCATCGCCGCGCCGCCGCCTCCCGCGTCGCGCTGGCTCGCGCGGCTCAGGCCGCGCCGCCGGCCGCGCATGAAGCTGTACTGCTTCCCGTATGCGGGCGGCAGTAGCCGCAGCTTCGACGGCTGGGCGCGCACCGCGCCTGACTGGCTCGACCTCGTCGCGATCGAATGGCCCGGCCGCAACGCGCGCGCCGAGGAATCGCCCGCGCGCGACGACGCCGACGACCTCGCCGCGCGCGACGCGATCGCCGCCGCGATCGTCGCGGATGCGGGCGAACTGCCCGTCGCGTTCTGCGGGCTGAGCTACGGCGGCGCGGCCGCGACCGAACTGCTGGCCGGACCGCTGCGCGCATGGGCGGCGAGCGGCCGCGTGAAGGGGCTCGCCGTCGTCGGGCGCGCGCCTCTCCTCGAGCAGCCGGCAATCGACGCGCCCGCCGACAGCTTCCTGCTCGTCCCCGACGCGCTGCGCGACGATCCGCTGTGGCAGGAAATCTTCCGGCCGGTGCTCGAAGCCGATCTCGACGCCGACACGCGCACCGCGCACCGGATCGCGCGGCGCTGGCGCGACGGCGAGCGGCGGCCGCTGCTGGCGACGCCGCTGCAGATTCACGGCGGCGACGACGATCCGGCGTTCGACTGGCGGCTCGCCGGAGACTGGGCGCGGATCTCGTCCGCGCCGCTCGCGGGCCTGCACGCGTACCCGGGCGGCCATGACTTCATGATGCGATGCGAGGCCGAGATCGTCGCGCGCGTGGCCGCGTGGCTGCGGCCGCAGCGCGCCGCGCGAACGGTGGCGCCCGCGCCGATGTTCGCGCTGCATTGGCAGCCGCGTGCGATCGCGCCGGACTCGGCCATCGCCGCCGTTGCTTCGCGGCTCGATGCTCCAGGCGCGGCTGCCGGCGAAGCGCCGTCGCCCGAATGCGCGGTGTACGCGACGGGCGGCGAGGCCGGCGCGCTCGAATGGCTCGCGCCGCGCCTGCGCGCGAGCGACGGCCATGCGGCGCTGCTCTGCATCGGCGCGGCCGACGATCCGCTCGGCGTCGCGCAATGCGCGGGCTTCGTCAGGCTATGGCAGGCGCTCGCCGCGCGCGAGTGCACCGGCACGCTGACGCTCGTGCTGCCGGCCGGCGCGGCAAGCGGCCCGCTCGTCGGCGCGGCGCGCGTCGCGAGCGCCGAGCACGCGGCGCTGCGCGTGCGGCTCGTGCTCGCCGACGATCACCCGGACCTTGCGCCGCGCGAAGCAGATCCGCGTTGGGCCGCCGGGCTCGCACGCGACGCCGCGCGCTGCGGCGGCGAGCCGTGGCTGCTGCACCGCGCCGGCCGGATGTTCGCGCCGCGCCTGATGCCGCACGCGGCGCCCGCGTTGCCCGAAGGCGCGCTCGGCGCGGCGGGCGGCCCGTATCTCGTCACCGGCGCGGCGGGCGGCGTCGGCCGCGCGCTCATCGACTGGCTGATCGACGAGCAGCAGGTGCCGCCGGAGAAGATCGTCGCGCTGTGTCGCGACGCCGCATCCGCGCCGCGCGGCGTGCGCGCCGTCGCCGTCGATCTCGCCGATGAACGCGCGCTCGACGCCGCGCTCGAATCGATCGACGAAGTCGAAGGCATATTCCATCTCGCGGGCACGCTCGACGACGGCGTCATCGCGAATCTCGACGACGCGCGGCTGCGCCGCGTGCTCGCGCCGAAGCAAAGCCTCGCCGCGCTGCTCGCGCACGCGCCGCGCTGGCGCACGCGCTGGGCGGTGGCGTTCTCGTCGACGAGCGCGCTGCTCGGCGTGCCCGGCCAGGCGAATTACGCGGCCGCGAACGCGTGGCTCGATCAGCTCGCGTGCTGGCCCGCGCGGCCCGGCGAGCCGCCCGTACTGAGCATCCAGTGGGGCAGTTGGGCCGATGTCGGCATGAGCGCGCGCAACGGCCGGGCGCTGCGTCGCGCGATGCAGGACGGCGAACGCCCGCTCGCGCCCGATGCCGCGTTCGCCGCGCTCGGCGCGCTGCTCGCCGGCGTGCTCGGCGGCGCGACGGCGGGACGCCAGTTCGCGGTCTGCGACGTCGACTGGCCGCGCTCGCCGTGGCGCGACGCACCGATTGCCGCCGACATCGCGCGCGGCGATGCGGCGGGCGCCGCGACGGCGCACGACACGGCGGCGGCGCACGACGCGCCGAACGCGCCGAACGCGGCAAACACGGCACGCGCGGCAACTGCGGCGAACGGAGCGGGCCGCGCGAACGGCACGACCGCGATGTCGCACACATCCGCATCCGGCAACGAGGCCGTCATCCGCGCCGACGATGGCTCGGACTCCGCACGATCGATACAACCCGAACCCGCGCGACCCGCCGCGGCTGGCCCCGAGGCGCCCGCCGCGCAGGCGGCGCGCCCCGCCAGCATGCGCGACCCCGTCCGCGCGTTTCTCGAAGACTACGTGAGCCGCTGGGACGAGCGGCTCGATCTCGCGACGCTCGGGCTCGATTCGCTCGATCTCGCGCAGATGCGCAACGGCTTTTTCAAGAAATTCGGCGTGCAGATCCCGCTTTCGACGCTCGCGTCGCCGACGCTGAAGATCGGCGAGCTGGCCCGCCGAATGCGGAACGTCGCCGGCATCGCGGACGAGTAG", "orf_prot_sequence": "MRQIVSTSNGSLDSRARIVAFPFAGGSDASYADMARALGGAFAFTTLSLPGRGATQHIPFYDDWPSLVDDLAAEVARLDDGTPFFLFGHSLGALLAYEVARALEQRGGAQPAGVFLSGHPAPSRERATDAWRQPTHALPDTAFIEAVRRWGFFPDGALDDADVARYVLPPLRADLRLAETYRHAPGDALRAPCAIYGGAADPSTTIDDLRAWRAHVGSQHACPVETFDGHHFYFLEPTSRAALCASVAGHIERRLAERPASIVAATPDPGSRVAACLRAADDWGDAHSVLAAIREHVARTPDALALKDGERTWTYRQLASHAGELADAFRAAGVGRQDVVGVFLPHGAEYVLTIVAAWSIGASVCLLEKSWPDSLVGEFVASCRVAQFATTPELLARAAKHLPDARCTLVGARPPLADRAWASVAPRPDDIAFVSLTSGSTGKPKAVLTTHIGTSYCFHARDALYPYADGEREGLNVFLAWECLRPLMFGRPAVVIGDDVIFDPPRLVALLRRERITRLVVTPSLLESVLDFPGVAAQLRDALAHMSAWFLMGEVMPPRVVDKARAAFPPSVRLVNAYSTWESLDVCYADLLPSRASDGSRRVPIGRPLPGCALAVLDDAGRAVPAGETGELHIASPGLGPGYLDDAARTAEKFLPSAPALAERGHDAPVYRTGDRARLLPDGQISILGRIDNTVKIRGFKVLLHAVENVLDAVEGVSKSLVVPIDDPHTRQPSALAAYVVGSDGAPSETTLARLRQQARAKLPEYAVPAHFIGLDAFALRAGTSRKLDKQALPPVPSDARTAPRDAAAPSAGDGLEARLAQVWRDVLGVASVARDDHFFELGGNSLSAAKAVGLLGERLGLSLAVVDLYQHSRLRDLADHCRRSREDAARPRADEARDVRAPRAASAADAPKVAIVGMAGRFPGADSVDAFWRNLTQGVDSLSRFAREQLLAKGVDAATLDHPDWVPAAQAVSDADKFDALFFGIGPREAALMDPQHRLFMQVAWSALEQAGYARADNRYRTRTGVFASCGIDGYLVHHLQGGGLLTPLDPGRLMLTEIGNEKDYIATRVAYQLDLGGPAVSVGAACSSALVAVVQAVQAIRAGQCEMAIAGASALSFPNFGFCYEDGLVGSADGHVRPFDARASGTLFGDAVGAVALKRLDLAEADGDPILAVISGVGLSNDGRMKAGYTAPNADAQRRCIVDALDMAGVRSEQISYVECHATATLIGDAIELKGLSDAFAQTRGAGADIAAVAGGCAIGSVKGNIGHANCAAGITGLIKTVLQLQHRQRVPTVHFDTLNPKLVPFVEHDASPFVVQRRIDDWSVADPATQLPRRAGVSSFGIGGTNAHVIVEEAPARAAAPAEGVPRAHHLMTVSARTPGALARNLRALAEQVATMDAADLGCAAHTLHVARDAHPLRVALAVPARPAEAAAALRERAGALDEAPDAGDAPGAPVRAKPGATVAFCFSGQGSQHPGMARELYRSNAEAGRFRHHFDAACAALERALGAPIADTILNAGDDAMRRPLVTQCGLFALEHALASVLGEYGVRPVAVAGHSIGQYAAAVAAEALTLEQAAALVAARARATEALTALAAGDGAHVRGGMLAVTGDDARIEQWAAGRADMWIAVRNAPRTLVLAGTEPALADAARALAALGCRCRPVPVSHPFHTPLMQPVADAIAAQRIEGAAPRIPMTCNVTGGWLGADAASADYWARHLREPVRWSDNVAALLRWQPDIVLEIGPGAVLCGLIGRHLAAGASADASAHANAPRVLPSLPAARDGAGDADHFSNVIGQLWCAGVAIDWRAYHAHEAASPGRALARVPLPGYAFERDSYWTRPEASIYVDAAPAAAESEISANRAENHAANRASVPADAAGITPNDAPATPRAHAASTLACSGGCSCAAGSRSCNGGHDATAAARIAAPPPPASRWLARLRPRRRPRMKLYCFPYAGGSSRSFDGWARTAPDWLDLVAIEWPGRNARAEESPARDDADDLAARDAIAAAIVADAGELPVAFCGLSYGGAAATELLAGPLRAWAASGRVKGLAVVGRAPLLEQPAIDAPADSFLLVPDALRDDPLWQEIFRPVLEADLDADTRTAHRIARRWRDGERRPLLATPLQIHGGDDDPAFDWRLAGDWARISSAPLAGLHAYPGGHDFMMRCEAEIVARVAAWLRPQRAARTVAPAPMFALHWQPRAIAPDSAIAAVASRLDAPGAAAGEAPSPECAVYATGGEAGALEWLAPRLRASDGHAALLCIGAADDPLGVAQCAGFVRLWQALAARECTGTLTLVLPAGAASGPLVGAARVASAEHAALRVRLVLADDHPDLAPREADPRWAAGLARDAARCGGEPWLLHRAGRMFAPRLMPHAAPALPEGALGAAGGPYLVTGAAGGVGRALIDWLIDEQQVPPEKIVALCRDAASAPRGVRAVAVDLADERALDAALESIDEVEGIFHLAGTLDDGVIANLDDARLRRVLAPKQSLAALLAHAPRWRTRWAVAFSSTSALLGVPGQANYAAANAWLDQLACWPARPGEPPVLSIQWGSWADVGMSARNGRALRRAMQDGERPLAPDAAFAALGALLAGVLGGATAGRQFAVCDVDWPRSPWRDAPIAADIARGDAAGAATAHDTAAAHDAPNAPNAANTARAATAANGAGRANGTTAMSHTSASGNEAVIRADDGSDSARSIQPEPARPAAAGPEAPAAQAARPASMRDPVRAFLEDYVSRWDERLDLATLGLDSLDLAQMRNGFFKKFGVQIPLSTLASPTLKIGELARRMRNVAGIADE", "perc_identity": 23.44}}, "BGC0001102.1|Malleilactone_2 # 8785 # 8997 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=CGA;rbs_spacer=14bp;gc_cont=0.695": {"gnl|BL_ORD_ID|890|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8785, "orf_end": 8997, "orf_from": "BGC0001102.1|Malleilactone_2 ", "model_name": "rphA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1500", "model_id": "910", "ARO_accession": "3000444", "ARO_name": "rphA", "ARO_category": {"41087": {"category_aro_accession": "3004040", "category_aro_cvterm_id": "41087", "category_aro_name": "rifampin phosphotransferase", "category_aro_description": "Enzymes, protein or other gene products that inactivate rifampin (rifamycin) antibiotics through phosphorylation of the antibiotic at the 21-OH position.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36669": {"category_aro_accession": "3000530", "category_aro_cvterm_id": "36669", "category_aro_name": "rifabutin", "category_aro_description": "Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.54861, "max_identities": 11, "bit_score": 22.7126, "cvterm_id": "39689", "query": "MLTMDYASTEDVLMRQFECHCGAPNCRRW", "match": "+LT D A     L R+ E H G+P    W", "sequence_from_db": "VLTDDQAVELVALGRRIEAHFGSPQDIEW", "sequence_from_broadstreet": "MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS", "dna_sequence_from_broadstreet": "ATGAGCGGGCGTCTGGTCGTGGATCTTCAGGACGTCGACGCGGCGGGGCTCGCCGAGGTCGGCGGCAAGGGCGCCCACCTGGGCGAGCTGTCCCGGATCGACGGGGTCCGGGTGCCGTCCGGGTTCTGTGTGACGACGCACGCCTTCCGGCGGATCATGGCGGAGGCACCCGAGAGCGGGGAACTCCTCGACCGGCTGTCCCGCGTGGACGAGGGCGACCAGGAGGCGGTCCGATCCCTCGCCGCCCGTCTACGGCAGGTCGTCGGGGCGACGCCCCTCCCGGACGAGGTGGCGGCGGCCGTCACCGGGGCGCTCGCCCGGCACGGTGAGCGGTCCGCGTACGCCGTACGGTCCAGCGCGACGGCCGAGGACCTGCCGACCGCGTCGTTCGCCGGCCAGCAGGACACGTACCTGAACGTCGTCGGCACCGAGGAGATCCTCCGGCACGTCAGCCGGTGCTGGGCCTCCCTGTTCACCGAGCGGGCGGTGACCTACCGCGGGCGTCAGGGCGTCGACCACCGTACGGTCCACATGGGCGTGGTCGTGCAGCGGATGGTCGTGCCGCGGGCGTCCGGCATCCTGTTCACCGCCGACCCGGTGACGGGAGACCGCCGCACGGCGACCGTGGACGCCGGTTTCGGTCTCGGCGAGGCCCTGGTGTCGGGGCTGGTCGACCCGGACGTCCTCACGGTGCGGCACGGCGAGGTCGTCGCGCGGACGATCGCCGCGAAGCGGCGCGCCCTGCACGCCGTGCAGGGCGGTGGGACGCGCGAGACCCCGATCGAGGAACGGCGGCAGCGCGAACCGGTACTGACGGACGATCAGGCCGTGGAGCTGGTCGCGCTCGGGCGGCGGATCGAGGCGCACTTCGGCAGCCCGCAGGACATCGAGTGGTGCCTGGACGACGACGGCTTCCACATCGTGCAGAGCCGGCCGATCACCACGCTGTTCCCCGTGCCCGAGCGGGACGACGACGTCTTCCGCGTCTATCTCTCGGTCGGCCACCAGCAGATGATGACCGACGCCATGAAGCCCCTGGGCCTCTCGATGTGGCGGCTGACGGCCCTGGCACCGATGTACGAGGCCGGCGGGCGGCTGTTCGTCGACGCCACCGCCCGGCTGGCGGTGCCCGGGAGCCGTGCCACTCTCCTGGACGTCGTCGGCCGTGGCGACCCGCTGACCCGGGACGCGCTCGAAACGGTCCTGGAGAACGGCGAGTTCGAGCCGACGCCGGCGGAGACGGACGGAGGCGCGCCGCCCGCCGGTGACGGGGCCGAACCGGACGAGGCCGATCCTTCCATCGTCACCGAGCTGATCGAGCGCAGCCGGCGCTCCCTCGCCGAGCTGGAGCGGGAGATCGGCACGAAGAGCGGTCCCGCCCTGTTCGCGTTCCTGCGGGAGGCGTTCGAGGAGCACAAGCGGGTGGTCGGCGATCCGCTGAACATCCGCGCGATCATGGCGGGCATGGAGGCCACCTGGTGGCTGAACGACCGGCTGGAGGAGTGGCTCGGCGAGAAGAACGCCGCCGACACGCTCACGCTGTCCGCCCCCGACAACGTGACCTCGGAGATGGGGCTGGAGCTGCTCGACGTCGCCGACGTGGTCCGCACGCACCCGGAGGTGGTGGCCTTCCTGGAGGGCGTCGAGGACGACGGCTTCCTGGACGAGCTGCCCAAGGTCCCCGGTGGCGCCGAGGCCCGGGACGCCTTCGAGGCATACCTGGACCGGTACGGCATGCGCTGCGTCGGCGAGATCGACATCACGNGGCCCCCGGTGCGGGAACGGCCCAGCGCGCTCGTGCCGGTCGTCCTCGACCACGTGCGCGCCTTCGGGCCCGGCGCCGCCGCGCGCCGCTTCGAGGACGGCCGGCGCAGGGCGCTCGCGAAGGAGCGTGAGGTGCTGGAGCGGCTGCGGGACCTGCCGGACGGGGAGCGCAGGGCCGACGCGGCGCGCCGGATGATCCGGCAGGTCCGCGCGTTCGCCGGCTACCGGGAGTACCCGAAGTACGCGATCGTCAGCCGCTCCTTCGTCTACCGTCAGGCCCTGCTGCGGGAGGCCGACGAGCTGGTGCGGGCCGGCGTCCTCGCCGACCGGGAGGACGTCCACTACCTGACGTTCGACGAGTTCGAGGAGGCCGTCCGCGTGCGCCGGGTGGACGAGCGGCTGGTGCGGCGCCGCAAGGACGCCTTCCGTTCGTACCAGGCGCTGACCCCGCCCCGCGTCCTCACCTCGGAGGGTGTGGCCCTCTCCGGGGCGTACCGGCGCGACGACGTGCCGGAAGGGGCGCTGGCGGGTCTCGCGGTGTCCGCGGGGACCGTGGAGGGCCGGGCCCGGGTGGTCCTCGACATGGCGGAGGCCGATCTGGAGGCGGGCGACATCCTGGTCACGCGGTTCACGGACCCCAGCTGGTCACCGCTGTTCGTCGGGATCGCGGGCCTGGTGACGGAGGTGGGCGGTCTGATGACCCATGGCGCGGTGATCGCCCGCGAGTACGGTCTGGCGGCCGTGGTCGGGGTGGAGCGGGCCACCCGGCTGATCCGGGACGGGCAGCGCATCCGGGTGCACGGGACGGAGGGCTATATCGAGCTTCTGTCCTGA", "partial": "0", "query_start": 8833, "query_end": 8919, "hit_start": 807, "hit_end": 894, "orf_dna_sequence": "ATGGCGGGCTTCGAGCTCTGGTCGCTGCGCGACATCGCGGCGGGCGAGATGCTGACGATGGACTACGCATCGACCGAGGACGTGCTGATGCGCCAGTTCGAATGCCACTGCGGCGCGCCGAACTGCCGGCGCTGGATCACGGGCGCGAAGGAGCTGCCGAACGATATCGGGCAGGCGCTCCTCGCCGGATTGCGGGCCGCCGCGCTCGCGTGA", "orf_prot_sequence": "MAGFELWSLRDIAAGEMLTMDYASTEDVLMRQFECHCGAPNCRRWITGAKELPNDIGQALLAGLRAAALA", "perc_identity": 37.93}}, "BGC0001102.1|Malleilactone_3 # 9406 # 10548 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=TCG;rbs_spacer=13bp;gc_cont=0.714": {"gnl|BL_ORD_ID|602|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9406, "orf_end": 10548, "orf_from": "BGC0001102.1|Malleilactone_3 ", "model_name": "vanY gene in vanB cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "50", "model_id": "556", "ARO_accession": "3002956", "ARO_name": "vanY gene in vanB cluster", "ARO_category": {"36216": {"category_aro_accession": "3000077", "category_aro_cvterm_id": "36216", "category_aro_name": "vanY", "category_aro_description": "VanY is a D,D-carboxypeptidase that cleaves removes the terminal D-Ala from peptidoglycan for the addition of D-Lactate. The D-Ala-D-Lac peptidoglycan subunits have reduced binding affinity with vancomycin compared to D-Ala-D-Ala.", "category_aro_class_name": "AMR Gene Family"}, "36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.73504, "max_identities": 29, "bit_score": 25.0238, "cvterm_id": "35918", "query": "FFCAAAADEGGEVPI--NDIRLTAAQ--IPDEILAKFERKRIGYHRYLPRDSTPTQIGWTDTFGVRERD-------AADALMRDKGYAHRWLDDDGLVYGYV", "match": " F AA AD  G  PI  +  R T  Q  I DE +A+++ K  GY     +    T   W    G  E          AD +       +RWLD++   +G++", "sequence_from_db": "LFDAARAD--GVYPIVASGYRTTEKQQEIMDEKVAEYKAK--GYTSAQAKAEAET---WVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFI", "sequence_from_broadstreet": "MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK", "dna_sequence_from_broadstreet": "ATGGAAAAAAGCAACTATCATTCCAATGTGAATCATCACAAACGGCATATGAAACAATCTGGGGAAAAACGGGCTTTTCTATGGGCGTTCATTATCTCGTTCACAGTCTGCACGCTGTTTTTGGGGTGGAGATTGGTTTCCGTATTGGAGGCAACACAGCTACCGCCCATCCCTGCAACTCATACAGGCAGCGGGACTGGTGTAGCGGAGAATCCAGAGGAAAACACTCTTGCCACCGCCAAAGAACAGGGAGATGAACAGGAATGGAGCCTGATTTTAGTGAACAGGCAGAACCCCATCCCCGCCCAGTACGATGTGGAACTTGAGCAGCTGTCAAATGGTGAGCGGATAGACATTCGGATTTCTCCCTACCTCCAGGATTTGTTTGATGCCGCAAGAGCTGATGGAGTTTACCCGATTGTCGCATCCGGATACCGGACAACAGAAAAACAGCAAGAAATCATGGATGAAAAAGTCGCCGAATACAAGGCGAAAGGCTACACCTCTGCACAGGCTAAAGCGGAAGCAGAAACTTGGGTGGCCGTGCCGGGAACAAGCGAGCATCAGCTTGGTCTTGCTGTGGATATCAATGCGGATGGAATTCATTCAACCGGCAACGAGGTTTACAGATGGCTGGATGAAAACAGCTATCGCTTTGGTTTTATTCGCCGCTACCCGCCAGACAAGACAGAGATAACCGGTGTGAGCAACGAGCCGTGGCATTACCGATATGTCGGCATCGAAGCTGCCACAAAGATATACCACCAAGGGCTTTGCCTTGAGGAATATTTAAACACAGAAAAATGA", "partial": "0", "query_start": 9952, "query_end": 10224, "hit_start": 381, "hit_end": 666, "orf_dna_sequence": "ATGCGCGACGCAACGCAATGCCGCCGCTCCGATCACGCGCGCCGACCACCGCAGGCCGCCGGCGCGCGCGATCGCGCATCGCCCCGCCCGCTTCATCAACGCATGGAGAAACGCGCTATGGATAGCTTCATCGAACTGCAAGAAAACGACCGGCGCCAGGTGCCCGTGCGCGGCCGCGCGTATCTCGCCGGCGCAGACAGCCCGCTCGTGCCGGTGACGATTCCGGTCGCGAACGATCTGGCGCTCAAGCTCGCGCACGCGGCCGACACGCCCGCCGAAGCCGCCGCGCGCTGCCGCGACGCGATCGACGCGCGCCTGCCCGACACCGGCGCGCTGCTGTTCCGCGGGCTGCCGATCGCGGATCGCGCGGGCTTCGACACGTTCATGCACGCGCTCGGCTACGCGCCGCACAGCTACGACGGCGGTATCGCGGTGCGCGCGCGCGACGCGGGCTACGCGCTCGTCGCGAGCCAGGAAGACCCGCGCATCACGATGGCGCCGCACAACGAGATGGCGTATCTGCCGAATCCGCCGCGCAAGGTGTTCTTCTTCTGCGCGGCGGCCGCCGACGAGGGCGGCGAGGTGCCGATCAACGACATCCGGCTCACGGCCGCGCAGATCCCCGACGAGATCCTCGCGAAGTTCGAGCGCAAGCGGATCGGCTATCACCGCTACCTGCCGCGCGACTCGACGCCGACGCAGATCGGCTGGACGGACACGTTCGGCGTGCGCGAGCGCGACGCGGCCGATGCGCTGATGCGCGACAAGGGCTACGCGCACCGCTGGCTCGACGACGACGGCCTCGTCTACGGCTACGTGCACGACGCGTTCCTCGACGATCCGGCGGGCGGCGCGCCGCTGTGGTTCAACCAGGTGACGGAGCTGCACGCGTCGTACTGGCGCAGCCATCCGCTCTTCCCGTCCGACTGGGACGACGCGCGCTACCCGGCGACGACGACCTACGGCGACGGCGAGCCGATCGACCCCGAACTCGTCACGAAGCTGCGCGCGGCGCTGTGGCGCACGTCGCGCGCGGTCGCGATGCGCCCGGGCGACGTGCTCGTGCTCGACAACGTCTACGTGCAGCACGGCCGCTTCGCGTTCTCCGGGCCGCGCCTGCATCTCGTCAGCCTGACCGACTGA", "orf_prot_sequence": "MRDATQCRRSDHARRPPQAAGARDRASPRPLHQRMEKRAMDSFIELQENDRRQVPVRGRAYLAGADSPLVPVTIPVANDLALKLAHAADTPAEAAARCRDAIDARLPDTGALLFRGLPIADRAGFDTFMHALGYAPHSYDGGIAVRARDAGYALVASQEDPRITMAPHNEMAYLPNPPRKVFFFCAAAADEGGEVPINDIRLTAAQIPDEILAKFERKRIGYHRYLPRDSTPTQIGWTDTFGVRERDAADALMRDKGYAHRWLDDDGLVYGYVHDAFLDDPAGGAPLWFNQVTELHASYWRSHPLFPSDWDDARYPATTTYGDGEPIDPELVTKLRAALWRTSRAVAMRPGDVLVLDNVYVQHGRFAFSGPRLHLVSLTD", "perc_identity": 28.43}}, "BGC0001102.1|Malleilactone_4 # 10557 # 11978 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.703": {"gnl|BL_ORD_ID|3415|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10557, "orf_end": 11978, "orf_from": "BGC0001102.1|Malleilactone_4 ", "model_name": "CRP-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "4484", "ARO_accession": "3006868", "ARO_name": "CRP-1", "ARO_category": {"43860": {"category_aro_accession": "3005400", "category_aro_cvterm_id": "43860", "category_aro_name": "CRP beta-lactamase", "category_aro_description": "CRP beta-lactamases are class A beta-lactamase found in Chromobacterium piscinae.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.37992, "max_identities": 30, "bit_score": 26.5646, "cvterm_id": "35506", "query": "AAALGARLAERAPGDLKRVHLTTCGSTAVESALRFAHYYFGATGRPHKRH-IVTRGDAYHGSTYLAASVSGKAWDRTCFHYDSTIVHHLSSPNPYRRPAGMSVAAFCASLVDEFDALIAKL", "match": "+AA+ A LA++    L+RV     G  A+++    A  Y     R  +R  + +    +  ++ LA S S   +     HY    +   S  +   + +GM+VA  CA+ V   D   A +", "sequence_from_db": "SAAMPANLADQKIARLERVFGGQIGVYALDTGSGAAVSY-----RADERFPLCSSFKGFLAASALAHSQSKPGFLDQILHYGKEELIAWSPISEKHQSSGMTVAGLCAATVQYSDNAAANV", "sequence_from_broadstreet": "MRLSRRLVLLSCLLLPQAGFSAAMPANLADQKIARLERVFGGQIGVYALDTGSGAAVSYRADERFPLCSSFKGFLAASALAHSQSKPGFLDQILHYGKEELIAWSPISEKHQSSGMTVAGLCAATVQYSDNAAANVLMKQLDGPAGLTAFMRAIGDSTFRLDRWEPELNTAIPGDARDTSTPRAVAESLQKLTLGTALAAHQRQQLVDWLKGNTTGNQRIRAAVPAGWLVGDKTGTCGVYGTANDYAVIWPTGRAPIVMAVYTRASKKDIKHSDAVIADAAKAALEALGVMTR", "dna_sequence_from_broadstreet": "ATGAGACTGTCCCGCCGCCTCGTTTTGCTGTCTTGCCTGCTATTGCCGCAGGCAGGCTTTTCCGCAGCCATGCCTGCCAATCTTGCCGACCAGAAAATAGCCAGGCTGGAGCGCGTTTTTGGCGGCCAGATCGGGGTGTATGCGCTGGATACCGGCTCAGGCGCCGCCGTGAGTTACCGCGCGGATGAGCGCTTCCCGCTGTGCAGCTCGTTCAAGGGTTTTCTGGCCGCCTCCGCGCTGGCGCATAGCCAGAGCAAACCGGGCTTTCTGGATCAAATCCTCCATTACGGCAAGGAAGAGCTGATAGCCTGGTCCCCCATCTCGGAGAAGCACCAGTCCAGCGGCATGACGGTAGCCGGCCTGTGCGCGGCCACTGTGCAGTACAGCGATAATGCAGCCGCCAATGTCTTGATGAAGCAGCTGGATGGCCCGGCCGGCCTGACGGCCTTCATGCGCGCCATCGGCGACAGCACCTTCCGCCTTGACCGCTGGGAGCCGGAGTTGAACACGGCCATACCCGGCGACGCGCGCGATACCTCCACCCCGCGCGCCGTGGCGGAAAGCCTGCAAAAACTGACCCTTGGCACGGCACTGGCGGCGCATCAGCGCCAGCAGCTGGTGGATTGGCTCAAAGGGAACACTACCGGCAACCAGCGCATTCGCGCCGCCGTGCCGGCCGGCTGGTTGGTGGGCGACAAAACCGGCACTTGCGGCGTGTACGGCACGGCCAATGATTACGCGGTGATCTGGCCCACTGGCCGCGCGCCCATCGTGATGGCGGTTTATACCCGCGCGTCCAAGAAAGACATCAAGCACAGCGATGCCGTCATTGCCGATGCGGCCAAGGCCGCGCTGGAAGCGCTAGGGGTGATGACGCGGTAA", "partial": "0", "query_start": 10845, "query_end": 11204, "hit_start": 60, "hit_end": 408, "orf_dna_sequence": "ATGGCACACCGAAACGATTCCCTTCTGACGAGCGCGCAGCAGGACGCGCGGCATCTGCTGCACCCGTGGGCCGACCTGACCGCGCTCGGCCGCGAGACGCCGACCGTCATCGTCGACGCGCAAGGCACGCGCGTGACCGACGCCGAAGGCCGCACGTATCTCGACGCGATCGGCGGCATGTGGTGCGTGACCGTCGGCTACGGCCGGCGCGAGATCGCGGACGCGATCCGCGACCAGGCGCTGCGCATGCCGTTCTACACGCCGTTCGGCGCGATGACGAACGCGCCCGCCGCCGCGCTCGGCGCGCGGCTCGCCGAGCGCGCGCCCGGCGATCTGAAGCGCGTGCATCTGACCACCTGCGGCTCGACCGCGGTCGAATCGGCGCTGCGTTTCGCGCACTACTACTTCGGCGCGACGGGCCGCCCGCACAAGCGCCACATCGTCACGCGCGGCGACGCGTACCACGGCAGCACGTATCTCGCCGCGTCGGTGTCCGGCAAGGCGTGGGACCGCACGTGCTTTCACTACGACAGCACGATCGTCCATCACCTGTCGTCGCCGAACCCGTACCGGCGGCCGGCCGGCATGAGCGTCGCCGCGTTCTGCGCGTCGCTCGTCGACGAATTCGACGCGCTGATCGCAAAGCTCGGCGCGGACCGGATCGCCTGCTTCATCGCCGAGCCGATCCTCGCGTCGGGCGGCGTGATCGTGCCGCCGCCCGGTTATCTCGCCGCGATGCGCGAGCGCTGCCGCCGGCACGACATCCTGTACATCTCCGACGAAGTCGTCACGGGCTTCGGCCGCGTCGGCCATTTCTTCGCGTCGCAGGCGCACTTCGGCATCGAGCCCGACATGATCGTCGTCGCGAAGGGACTCACGTCCGGCTACCAGCCGCTCGGCGCGGTGCTGATCTCGGAGCGGCTCGTCGAGGCGGTGTCCGGCGAGCGCGCGTACGGCAACGGCGTGTTCACGAACGGCTTCACCTATTCGGGCCATCCGGTCGCGTGCGCGGCGGCGCTCGCGAACATCGAGCTGATGGAGCGCGAGCGGATCTGCGAGCACGTGCGCGACGTCGGCCCGTACTTCATTCGCCGGCTCGACGCGCTGCGGCGCTTTCCCATCGTCGGCGACGTGCGCGGCGACCACCTGATGGCGTGCATCGAATGCACGAGCGGCGCGGGCGCGACGGGCGCGCTACCGACGCCCGCGGACATCGCGATCGCGCAGCGCGTCGATCGCCATTGCGAGGAGATGGGCCTGCTCGTGCGGCCCTACGAGAGCATGTGCATCCTGTCGCCGCCCCTCACCGTGACCCGCGCCGACATCGATGAAATCTGCGAGATTCTCGCGGCCGCGCTCGAGCGCACGCAGCGCGAGCTCGCGGAACGCGCCCCCGTTCGCGAGGAAAACGAAACATGCTGA", "orf_prot_sequence": "MAHRNDSLLTSAQQDARHLLHPWADLTALGRETPTVIVDAQGTRVTDAEGRTYLDAIGGMWCVTVGYGRREIADAIRDQALRMPFYTPFGAMTNAPAAALGARLAERAPGDLKRVHLTTCGSTAVESALRFAHYYFGATGRPHKRHIVTRGDAYHGSTYLAASVSGKAWDRTCFHYDSTIVHHLSSPNPYRRPAGMSVAAFCASLVDEFDALIAKLGADRIACFIAEPILASGGVIVPPPGYLAAMRERCRRHDILYISDEVVTGFGRVGHFFASQAHFGIEPDMIVVAKGLTSGYQPLGAVLISERLVEAVSGERAYGNGVFTNGFTYSGHPVACAAALANIELMERERICEHVRDVGPYFIRRLDALRRFPIVGDVRGDHLMACIECTSGAGATGALPTPADIAIAQRVDRHCEEMGLLVRPYESMCILSPPLTVTRADIDEICEILAAALERTQRELAERAPVREENETC", "perc_identity": 24.79}, "gnl|BL_ORD_ID|2309|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10557, "orf_end": 11978, "orf_from": "BGC0001102.1|Malleilactone_4 ", "model_name": "tetB(46)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1150", "model_id": "2644", "ARO_accession": "3004033", "ARO_name": "tetB(46)", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.32961, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "41065", "query": "IVDAQGTRVTDAEGRTYLDAIGGMWCVTVGYGR--------------REIADAIRDQALRMPFYTPFGAMTNAPAAALGARLAE", "match": "++D   T +T   G+  L  +GG + + +  G+               ++  ++RDQA ++    P     + PA  +  R+  ", "sequence_from_db": "MIDGPLTALTHGGGQGDLLQMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIATRIVN", "sequence_from_broadstreet": "MKVLKRLLSRITLYPTVFLAGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLLQMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIATRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLYKVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRILLADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLSRQFPNIRRSLETGSRVLAFLDQPLEADGALELKIEKAEVVFDDVQFAYEEGKPVLKDISIQAHPGQTLALVGHTGSGKSSIMNLLYRFYDPQEGEIRIDGQNIRHFSRESLRSHMGIVLQDPYLFTGTIASNVAMSQEHIDRNAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGERQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVLQKGRTTFIIAHRLSTIQDADQILVLSEGRIVERGQHADLVAHGGIYAQMQAIQQTVE", "dna_sequence_from_broadstreet": "ATGAAAGTATTGAAACGATTATTATCTAGGATCACGCTTTATCCAACTGTCTTTCTTGCTGGCTTCATTTGCCTCTTACTAGCCACCATTTTTTCTGAATTGTCTCCCTTTCTTCTCCAAAAGATGATCGATGGGCCTTTGACTGCATTGACCCACGGTGGAGGACAAGGGGACTTGCTTCAGATGGGAGGATTCTATCTCTTGGTCTTGAGCCTGGGGCAGCTGATTAGCTACATGGGCAATCGGATCTTGCTACATGGAAGTAATCAAGTAACCGCTAGTCTGAGAGACCAAGCCTTTCAAGTCATGCAAGGGCTGCCTATTTCTTATTTTGATGATAAGCCGGCTGGGAAGATCGCGACAAGAATTGTCAATGATACGGAGACCTTGAGGACCCAGTTTTATAACTCTTGTATGATTTTAGTCATCTATTTGGTACGCTTTCTCTTTATCCTAGGGATTCTCTTTTACCTGAGTCCTATGATGGGCCTTCTCTTGTGTTTGGTCTTTCCGATTTTCTATGGGATCCAGTATCTCTACAAGGTCATGACGGACCAGCCTATGAAGGATTTCTTTGATGCGCGAAGCGAGGTCAATACCCAGGTCAATGAACTCTTGCACGGTGCTAGTATGATTCAGCTCTATCATCAAGAGCCTGGTGTGGTGGAGGAGTTTGAAGCCACTACCCAGAAGATGTTAGGAGCAAATGATCGAATCCTCTTAGCCGATTCTATCGCTTCTTGGACCTTGACGGAATTGCTCAAGTTTTTAGTGATTGCAGGCATTTTGACTATCGCTGGGATTTCTTTCCTACAGGGTAATATCGGTGTGACGGCTGGTTTCTTATTTATCAATATTAACTATGTGATTAATCTATTTGATCTCATGGCCAATCTTAGTCGTCAATTCCCAAATATTCGGCGATCCTTAGAAACGGGGAGCCGCGTCCTTGCCTTCTTAGACCAACCGTTAGAGGCCGATGGTGCATTGGAACTGAAGATAGAAAAGGCAGAGGTCGTGTTTGACGACGTTCAATTTGCCTATGAAGAAGGTAAGCCAGTTCTGAAGGATATTTCCATCCAAGCCCATCCAGGTCAAACCCTTGCCTTGGTTGGCCATACTGGTTCGGGTAAATCCTCCATTATGAACTTGCTCTATCGTTTCTATGATCCGCAGGAGGGAGAAATTCGGATCGACGGCCAGAATATTCGCCATTTCTCTAGAGAGAGTCTTCGCTCCCACATGGGCATTGTTCTACAAGATCCTTATCTATTTACAGGAACCATTGCTAGTAATGTGGCCATGAGTCAGGAACACATTGATCGGAATGCGGTCAAAGATGCCTTGAAAAAAGTCGGAGCATGGCCCTTTGTAGAGCGTCTTGAAAAGGGAATCGACCATCCAGTTGTAGAAAAAGGATCGGCCTTTTCAAGTGGCGAACGCCAGTTGATTTCCTTTGCGAGGACGCTCTATATGAATCCGCAAATTCTGATTTTGGATGAGGCAACCTCTCACATCGATACGGAAACAGAAGAAATCATCCAGAAAGCTATGGCTGTCCTGCAAAAGGGCCGGACCACCTTTATCATTGCCCATCGCTTGTCGACTATCCAAGATGCGGATCAGATCTTGGTTCTATCAGAAGGGCGCATTGTCGAACGTGGGCAACATGCAGACTTAGTTGCCCATGGTGGCATCTACGCCCAGATGCAAGCTATCCAACAGACGGTTGAATAA", "partial": "0", "query_start": 10665, "query_end": 10874, "hit_start": 123, "hit_end": 375, "orf_dna_sequence": "ATGGCACACCGAAACGATTCCCTTCTGACGAGCGCGCAGCAGGACGCGCGGCATCTGCTGCACCCGTGGGCCGACCTGACCGCGCTCGGCCGCGAGACGCCGACCGTCATCGTCGACGCGCAAGGCACGCGCGTGACCGACGCCGAAGGCCGCACGTATCTCGACGCGATCGGCGGCATGTGGTGCGTGACCGTCGGCTACGGCCGGCGCGAGATCGCGGACGCGATCCGCGACCAGGCGCTGCGCATGCCGTTCTACACGCCGTTCGGCGCGATGACGAACGCGCCCGCCGCCGCGCTCGGCGCGCGGCTCGCCGAGCGCGCGCCCGGCGATCTGAAGCGCGTGCATCTGACCACCTGCGGCTCGACCGCGGTCGAATCGGCGCTGCGTTTCGCGCACTACTACTTCGGCGCGACGGGCCGCCCGCACAAGCGCCACATCGTCACGCGCGGCGACGCGTACCACGGCAGCACGTATCTCGCCGCGTCGGTGTCCGGCAAGGCGTGGGACCGCACGTGCTTTCACTACGACAGCACGATCGTCCATCACCTGTCGTCGCCGAACCCGTACCGGCGGCCGGCCGGCATGAGCGTCGCCGCGTTCTGCGCGTCGCTCGTCGACGAATTCGACGCGCTGATCGCAAAGCTCGGCGCGGACCGGATCGCCTGCTTCATCGCCGAGCCGATCCTCGCGTCGGGCGGCGTGATCGTGCCGCCGCCCGGTTATCTCGCCGCGATGCGCGAGCGCTGCCGCCGGCACGACATCCTGTACATCTCCGACGAAGTCGTCACGGGCTTCGGCCGCGTCGGCCATTTCTTCGCGTCGCAGGCGCACTTCGGCATCGAGCCCGACATGATCGTCGTCGCGAAGGGACTCACGTCCGGCTACCAGCCGCTCGGCGCGGTGCTGATCTCGGAGCGGCTCGTCGAGGCGGTGTCCGGCGAGCGCGCGTACGGCAACGGCGTGTTCACGAACGGCTTCACCTATTCGGGCCATCCGGTCGCGTGCGCGGCGGCGCTCGCGAACATCGAGCTGATGGAGCGCGAGCGGATCTGCGAGCACGTGCGCGACGTCGGCCCGTACTTCATTCGCCGGCTCGACGCGCTGCGGCGCTTTCCCATCGTCGGCGACGTGCGCGGCGACCACCTGATGGCGTGCATCGAATGCACGAGCGGCGCGGGCGCGACGGGCGCGCTACCGACGCCCGCGGACATCGCGATCGCGCAGCGCGTCGATCGCCATTGCGAGGAGATGGGCCTGCTCGTGCGGCCCTACGAGAGCATGTGCATCCTGTCGCCGCCCCTCACCGTGACCCGCGCCGACATCGATGAAATCTGCGAGATTCTCGCGGCCGCGCTCGAGCGCACGCAGCGCGAGCTCGCGGAACGCGCCCCCGTTCGCGAGGAAAACGAAACATGCTGA", "orf_prot_sequence": "MAHRNDSLLTSAQQDARHLLHPWADLTALGRETPTVIVDAQGTRVTDAEGRTYLDAIGGMWCVTVGYGRREIADAIRDQALRMPFYTPFGAMTNAPAAALGARLAERAPGDLKRVHLTTCGSTAVESALRFAHYYFGATGRPHKRHIVTRGDAYHGSTYLAASVSGKAWDRTCFHYDSTIVHHLSSPNPYRRPAGMSVAAFCASLVDEFDALIAKLGADRIACFIAEPILASGGVIVPPPGYLAAMRERCRRHDILYISDEVVTGFGRVGHFFASQAHFGIEPDMIVVAKGLTSGYQPLGAVLISERLVEAVSGERAYGNGVFTNGFTYSGHPVACAAALANIELMERERICEHVRDVGPYFIRRLDALRRFPIVGDVRGDHLMACIECTSGAGATGALPTPADIAIAQRVDRHCEEMGLLVRPYESMCILSPPLTVTRADIDEICEILAAALERTQRELAERAPVREENETC", "perc_identity": 19.05}}, "BGC0001102.1|Malleilactone_7 # 25593 # 26654 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.703": {"gnl|BL_ORD_ID|4748|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 25593, "orf_end": 26654, "orf_from": "BGC0001102.1|Malleilactone_7 ", "model_name": "Erm(52)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5742", "ARO_accession": "3007041", "ARO_name": "Erm(52)", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.24316, "max_identities": 15, "bit_score": 26.9498, "cvterm_id": "36807", "query": "HSLVQGDVRPLPGRDLAMLAPRMYGDPIRRYYLAGQGAPAYFDIVA", "match": "HS  + D  P P  D  ML  +++ D      L+G     Y D+VA", "sequence_from_db": "HSFKRSDFFPSPNVDTVMLHMQLWDDR-----LSGDDLQNYKDLVA", "sequence_from_broadstreet": "MKNLGYSQNFLVNKKLVERLISKSNIDVTDYVIEIGPGKGIITDVLSQHAGEVVAVEYDQELYNNLVRYHSHDNVTYIFGDFLKYKLPLNRRYKIFSNIPFQITADIIRKLTDDVNPPSDINIIIQREAAKKNCGIPLQKYEGFRAAIIKAQYKVEITHSFKRSDFFPSPNVDTVMLHMQLWDDRLSGDDLQNYKDLVAFFYTNIKGETAKERLSILFSNEQIKRLGKANRISLSNSYTLITAEQWMNIYYYSKIGLTDEKKKKFQDAYKKLQKMNKKLKKQNRTSLRKSSSNKKCRTRIDTSNGTKNR", "dna_sequence_from_broadstreet": "ATGAAAAATCTTGGATATTCACAAAATTTTTTGGTTAATAAAAAGTTGGTAGAACGTTTAATAAGCAAGTCAAATATTGATGTAACAGATTATGTTATTGAAATTGGTCCTGGAAAAGGGATAATAACAGATGTACTTTCTCAGCATGCTGGAGAGGTTGTTGCAGTTGAATATGATCAAGAATTATATAATAATTTAGTAAGATATCACAGTCATGATAATGTTACATATATATTTGGTGATTTTTTAAAATATAAGTTGCCTTTAAATCGCAGATATAAAATATTCTCCAATATTCCTTTTCAGATAACAGCGGATATTATTAGGAAATTAACAGACGATGTAAATCCACCATCAGATATAAATATCATAATTCAAAGAGAGGCAGCTAAAAAGAATTGCGGTATTCCATTACAAAAATATGAAGGTTTTCGTGCTGCTATAATAAAGGCACAATATAAGGTAGAAATTACACATAGTTTTAAAAGGAGCGATTTTTTTCCTTCGCCTAATGTTGATACAGTTATGCTTCATATGCAGTTATGGGATGATAGATTGAGTGGTGATGATCTTCAAAATTATAAAGATTTAGTGGCTTTTTTTTACACTAATATTAAAGGAGAGACTGCTAAAGAGAGACTTTCTATTTTATTTTCTAATGAGCAAATCAAAAGATTGGGAAAAGCCAATAGAATTAGTCTTTCAAATTCATATACGTTAATCACGGCCGAGCAGTGGATGAATATTTATTATTACTCCAAAATTGGATTGACAGATGAAAAGAAAAAAAAGTTTCAAGATGCATATAAAAAACTTCAAAAAATGAATAAAAAATTGAAAAAGCAAAACAGAACATCTTTACGAAAGTCTAGTAGCAATAAGAAATGTAGAACAAGGATTGATACTTCTAATGGTACAAAAAATAGATAG", "partial": "0", "query_start": 25920, "query_end": 26057, "hit_start": 474, "hit_end": 597, "orf_dna_sequence": "ATGAACGATCTCATCTATCAGGACGAACACGCTTCGCTGCAACCGCTCGAAGGGCGCACCGTCGCCGTGATCGGCTACGGCATCCAGGGCCGCGCGTTCGCCGCGAATCTGCGCGACAGCGGCGTCGCGGTGCGCGTCGGCAACATCGACGACCGCTACTTCGAGCTCGCGCGCGCGGAAGGCCATCGCGTGACGAACATCGCCGAGGCGGTCGCGCACGCGGACATCGTGCTGCTGCTGATTCCGGACGAAGCGCACGGCGCGGTGTTCGACGTCGACATCGCGCCGAACCTGCGCGACGGCGCGCTGCTGTGCGTCGCGCACGGGCACTCGCTCGTGCAGGGCGACGTGCGCCCGCTCCCGGGGCGCGACCTCGCGATGCTCGCGCCGCGCATGTATGGCGATCCGATTCGCCGCTACTACCTTGCCGGGCAAGGCGCGCCCGCGTACTTCGACATCGTCGCGGACCACACCGGCCGCGCGCGCGACAGGGTGCTCGCGATCGCGCGCGCGGTCGGCTTCACGCGCGCGGGCGTGATGGCGCTCGGCTACCGGCAGGAAACGTTCCTCGATCTGTTCCAGGAGCAGTTCCTCGCGCCCGCGCTCGTCGATCTCGTCGAAACGGGCTTTCAGGTGCTCGTCGAACGCGGCTTCAATCCGAAGGCCGCGCTGCTGGAGGTCTACGGCTCGGGCGAGATGGGCAAGATGATGCTCGACGGCGCGGACATCGGGCTCGACGAAGTCGTCGCGCTGCAAGGCTCGCCCACCTGCCAGGTCGGCTATCACCGCTGGCGCGGCCGCACGCTGCCCACGGCCGTGCGCGAGCTCGCCGCGCGCGTGCTCGACCAGATCGAAGGCGGCGACTTCTCCGCGTATCTGAAGGAGCAGGCATCGAACGACTACGCGTCGCTCGACGACGCGCGCCGCGCGGCGCTGAAACGGCCGCTCAACGTCGCGCATGCGCAGGTGCGCGCGGCGTTCCGGTTCCCGACCGAGGCGGCGGGCGGGCTCTATCAGGCGGCGCAAGCACCCGCCGACGTCGAACCTGAGGCCGCGCGATGA", "orf_prot_sequence": "MNDLIYQDEHASLQPLEGRTVAVIGYGIQGRAFAANLRDSGVAVRVGNIDDRYFELARAEGHRVTNIAEAVAHADIVLLLIPDEAHGAVFDVDIAPNLRDGALLCVAHGHSLVQGDVRPLPGRDLAMLAPRMYGDPIRRYYLAGQGAPAYFDIVADHTGRARDRVLAIARAVGFTRAGVMALGYRQETFLDLFQEQFLAPALVDLVETGFQVLVERGFNPKAALLEVYGSGEMGKMMLDGADIGLDEVVALQGSPTCQVGYHRWRGRTLPTAVRELAARVLDQIEGGDFSAYLKEQASNDYASLDDARRAALKRPLNVAHAQVRAAFRFPTEAAGGLYQAAQAPADVEPEAAR", "perc_identity": 32.61}, "gnl|BL_ORD_ID|2587|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 25593, "orf_end": 26654, "orf_from": "BGC0001102.1|Malleilactone_7 ", "model_name": "vmlR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2907", "ARO_accession": "3004476", "ARO_name": "vmlR", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37021": {"category_aro_accession": "3000677", "category_aro_cvterm_id": "37021", "category_aro_name": "virginiamycin S2", "category_aro_description": "Virginiamycin S2 is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.73988, "max_identities": 21, "bit_score": 26.5646, "cvterm_id": "39579", "query": "ALLCVAHGHSLVQGDVRPLPGRDLAMLAPRMYGDPIRRYYLAGQGAPAYFDIVADHTGRARDRVLAIARAVGFTRAGV------MALGYR", "match": " LL +  G    +G V   P  ++  L   ++  P+ +        P   ++  + T +AR  V  + R +GFT A        M++G R", "sequence_from_db": "TLLNIILGQETAEGSVWVSPSANIGYLTQEVFDLPLEQ-------TPE--ELFENETFKARGHVQNLMRHLGFTAAQWTEPIKHMSMGER", "sequence_from_broadstreet": "MKEIVTLTNVSYEVKDQTVFKHVNASVQQGDIIGIIGKNGAGKSTLLHLIHNDLAPAQGQILRKDIKLALVEQETAAYSFADQTPAEKKLLEKWHVPLRDFHQLSGGEKLKARLAKGLSEDADLLLLDEPTNHLDEKSLQFLIQQLKHYNGTVILVSHDRYFLDEAATKIWSLEDQTLIEFKGNYSGYMKFREKKRLTQQREYEKQQKMVERIEAQMNGLASWSEKAHAQSTKKEGFKEYHRVKAKRTDAQIKSKQKRLEKELEKAKAEPVTPEYTVRFSIDTTHKTGKRFLEVQNVTKAFGERTLFKNANFTIQHGEKVAIIGPNGSGKTTLLNIILGQETAEGSVWVSPSANIGYLTQEVFDLPLEQTPEELFENETFKARGHVQNLMRHLGFTAAQWTEPIKHMSMGERVKIKLMAYILEEKDVLILDEPTNHLDLPSREQLEETLSQYSGTLLAVSHDRYFLEKTTNSKLVISNNGIEKQLNDVPSERNEREELRLKLETERQEVLGKLSFMTPNDKGYKELDQAFNELTKRIKELDHQDKKD", "dna_sequence_from_broadstreet": "ATGAAAGAGATCGTAACATTAACAAACGTTAGCTATGAAGTAAAGGATCAAACTGTTTTTAAACATGTAAACGCCAGTGTTCAGCAAGGAGATATCATTGGGATTATCGGCAAAAACGGCGCTGGGAAATCTACGTTGCTGCACCTCATTCACAATGACTTAGCCCCTGCACAGGGTCAAATCCTTCGGAAGGATATAAAACTGGCTTTGGTTGAACAGGAAACCGCGGCGTATTCCTTTGCGGATCAGACACCTGCCGAAAAGAAGTTACTGGAGAAATGGCATGTGCCTCTTCGTGATTTTCATCAGTTAAGCGGCGGTGAAAAACTGAAAGCGCGGCTGGCGAAAGGACTATCAGAGGATGCAGATCTGCTGCTGTTAGATGAACCGACAAACCACCTTGATGAAAAAAGCTTGCAATTTCTCATCCAACAGCTGAAACATTATAACGGCACTGTGATTCTCGTTTCTCACGATCGATATTTTTTAGACGAAGCCGCAACAAAAATATGGTCGCTTGAGGATCAGACGCTGATTGAATTCAAAGGGAATTACTCCGGGTATATGAAGTTCCGGGAGAAGAAAAGACTCACCCAGCAGCGTGAATATGAAAAGCAGCAAAAAATGGTTGAACGGATTGAAGCACAAATGAATGGGCTCGCTTCTTGGTCGGAAAAAGCCCATGCTCAATCGACGAAAAAGGAAGGGTTTAAAGAATATCACCGGGTAAAAGCGAAGCGTACGGATGCCCAGATAAAATCCAAGCAGAAGCGGCTTGAAAAAGAGCTTGAAAAAGCAAAGGCGGAACCCGTTACCCCAGAATATACAGTCCGCTTTTCAATCGATACAACCCACAAAACAGGAAAACGTTTTTTAGAAGTTCAGAATGTAACAAAAGCGTTTGGAGAAAGGACTCTCTTTAAAAACGCAAACTTTACAATTCAGCACGGCGAAAAGGTTGCGATCATAGGCCCCAATGGCAGCGGAAAAACGACATTACTGAACATCATTCTGGGACAGGAAACAGCAGAAGGAAGTGTATGGGTGTCGCCGTCCGCAAACATCGGCTATTTAACGCAGGAGGTGTTTGATTTGCCTTTAGAACAAACACCGGAAGAGTTATTTGAGAATGAAACATTCAAAGCAAGGGGGCACGTTCAAAATCTGATGAGGCACTTAGGTTTTACAGCCGCCCAATGGACTGAACCGATCAAGCATATGAGTATGGGTGAGCGTGTAAAGATCAAGCTGATGGCATATATTCTGGAGGAAAAAGACGTGCTGATTTTAGATGAGCCGACAAACCATCTCGACCTGCCGTCACGCGAACAGCTGGAAGAAACACTGTCACAATACAGCGGCACATTGCTGGCGGTTTCACATGACCGATACTTTCTCGAAAAAACAACAAACAGTAAACTCGTCATCTCAAACAACGGCATCGAAAAGCAGTTAAACGACGTTCCTTCAGAAAGAAATGAGCGGGAGGAGCTTCGGTTAAAGCTTGAGACAGAAAGACAAGAAGTGCTGGGAAAGCTCAGTTTTATGACGCCAAATGATAAAGGGTATAAGGAGCTTGATCAGGCTTTCAATGAGCTTACGAAACGAATAAAAGAGCTGGATCATCAAGACAAAAAAGACTGA", "partial": "0", "query_start": 25896, "query_end": 26147, "hit_start": 993, "hit_end": 1236, "orf_dna_sequence": "ATGAACGATCTCATCTATCAGGACGAACACGCTTCGCTGCAACCGCTCGAAGGGCGCACCGTCGCCGTGATCGGCTACGGCATCCAGGGCCGCGCGTTCGCCGCGAATCTGCGCGACAGCGGCGTCGCGGTGCGCGTCGGCAACATCGACGACCGCTACTTCGAGCTCGCGCGCGCGGAAGGCCATCGCGTGACGAACATCGCCGAGGCGGTCGCGCACGCGGACATCGTGCTGCTGCTGATTCCGGACGAAGCGCACGGCGCGGTGTTCGACGTCGACATCGCGCCGAACCTGCGCGACGGCGCGCTGCTGTGCGTCGCGCACGGGCACTCGCTCGTGCAGGGCGACGTGCGCCCGCTCCCGGGGCGCGACCTCGCGATGCTCGCGCCGCGCATGTATGGCGATCCGATTCGCCGCTACTACCTTGCCGGGCAAGGCGCGCCCGCGTACTTCGACATCGTCGCGGACCACACCGGCCGCGCGCGCGACAGGGTGCTCGCGATCGCGCGCGCGGTCGGCTTCACGCGCGCGGGCGTGATGGCGCTCGGCTACCGGCAGGAAACGTTCCTCGATCTGTTCCAGGAGCAGTTCCTCGCGCCCGCGCTCGTCGATCTCGTCGAAACGGGCTTTCAGGTGCTCGTCGAACGCGGCTTCAATCCGAAGGCCGCGCTGCTGGAGGTCTACGGCTCGGGCGAGATGGGCAAGATGATGCTCGACGGCGCGGACATCGGGCTCGACGAAGTCGTCGCGCTGCAAGGCTCGCCCACCTGCCAGGTCGGCTATCACCGCTGGCGCGGCCGCACGCTGCCCACGGCCGTGCGCGAGCTCGCCGCGCGCGTGCTCGACCAGATCGAAGGCGGCGACTTCTCCGCGTATCTGAAGGAGCAGGCATCGAACGACTACGCGTCGCTCGACGACGCGCGCCGCGCGGCGCTGAAACGGCCGCTCAACGTCGCGCATGCGCAGGTGCGCGCGGCGTTCCGGTTCCCGACCGAGGCGGCGGGCGGGCTCTATCAGGCGGCGCAAGCACCCGCCGACGTCGAACCTGAGGCCGCGCGATGA", "orf_prot_sequence": "MNDLIYQDEHASLQPLEGRTVAVIGYGIQGRAFAANLRDSGVAVRVGNIDDRYFELARAEGHRVTNIAEAVAHADIVLLLIPDEAHGAVFDVDIAPNLRDGALLCVAHGHSLVQGDVRPLPGRDLAMLAPRMYGDPIRRYYLAGQGAPAYFDIVADHTGRARDRVLAIARAVGFTRAGVMALGYRQETFLDLFQEQFLAPALVDLVETGFQVLVERGFNPKAALLEVYGSGEMGKMMLDGADIGLDEVVALQGSPTCQVGYHRWRGRTLPTAVRELAARVLDQIEGGDFSAYLKEQASNDYASLDDARRAALKRPLNVAHAQVRAAFRFPTEAAGGLYQAAQAPADVEPEAAR", "perc_identity": 23.33}}, "BGC0001102.1|Malleilactone_8 # 26651 # 28015 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=CGA;rbs_spacer=15bp;gc_cont=0.744": {"gnl|BL_ORD_ID|2722|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 26651, "orf_end": 28015, "orf_from": "BGC0001102.1|Malleilactone_8 ", "model_name": "tet(50)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3287", "ARO_accession": "3004584", "ARO_name": "tet(50)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.48342, "max_identities": 16, "bit_score": 26.5646, "cvterm_id": "36791", "query": "YVGATFTASPLEPLLRAQGFDDVAFTRYNQLLQALLAPDPQ", "match": "+VGA   A  L+   +A G    AFTRYN+LL   +  + Q", "sequence_from_db": "FVGAYILAGELK---KADGDYIQAFTRYNELLHPFVEANQQ", "sequence_from_broadstreet": "MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE", "dna_sequence_from_broadstreet": "ATGACTAAACATATAAAAATTCTTGTAATAGGGGTTGGGGTTGCGGGCCCTGCAGTCGCTTATTGGTTAAAAAGATTTGGGTTTTCTCCGGTCTTAATTGAAAAATCAGCTGCCGTTAGAAAAGGGGGCCAGGCACTTGATATTCGCGGCATAGCCACACATATCGCTAAAGAAATGGGCATTTACGACCAGATATGTAACATGCGGACTCAAATAAAGTGTGGACGTTATGTGGATGTAAAGGGTAATGTTTTGCATGAAGAACAAGGTGAAACCTTTGGTTTCCGGCAAGATGACGAAGTTGAGATTCTTCGTGGAGACCTAGTTGAAATTCTAATGAAAGCAATTGCAGATATACCTTGTGAATTCAAACAATCCGTCATAAAAATTGAACAAAACGAAGATAGTGTAACTGTCACCTACAAAGATGGCAGAGTTGAAAATTATGACCTTGTGATCGCTGCCGATGGTATTCATTCTGCTACCAGGGGAATGGTTTTTAGTAAAAATGAATATCAGTTGATTAATCTCGGCTCCTACGTCAGCGCATTTACCATCCCAAATTATCTCGGTTTGGATCACATGGAACTCCTATGTGAATCAAATCATAAACTGGTTACTCTACAAAGCGACAGCCAAGCTGACAAAGCCATGGCGGGATTTATGTTCCGTTCAAAACATGTATTAGAAGATATTCGTGATGAGCAAGAACAAAAACATTTCTTACACGCCAGTTTTCAAAATTTCGGTTGGGAAACACAAAATATTTTAAATCGAATGCCAGAAAGCGATGACTTTTATTTTGACGCGATTACTCAAATCAAAATGAAAAGCTGGACTAAAGGCCGTATAGCCTTAATCGGCGATGCCGCTTATTGCCCCTCACCTTTATCAGGTCAGGGGAATAATTTAGCTTTTGTTGGCGCTTATATTTTGGCGGGTGAATTGAAAAAGGCTGATGGTGATTATATACAAGCATTTACCCGATATAACGAATTGCTACATCCCTTTGTTGAGGCTAACCAACAATTTGGTGTGTGGGTAAGCGAATCCTTTCTCCTAAAAGATGATGAAGTCTCTAAAGAGATTGCGGAAGCCCGTTCTAATAAAATTTTGGCAATGATAAAGTCAGTCTCTAATTCAATAAACTTGCCACAATACGAATAA", "partial": "0", "query_start": 26669, "query_end": 26791, "hit_start": 915, "hit_end": 1029, "orf_dna_sequence": "ATGAGCGCCGGGCGTCTCTACGTCGGCGCGACGTTCACCGCATCGCCGCTCGAACCGCTGCTGCGCGCGCAGGGCTTCGACGACGTCGCGTTCACGCGCTACAACCAGTTGCTGCAAGCGCTGCTCGCGCCCGATCCGCAACACGCGGGCGACGCGACGCTGCTGCTCGTGCGGCTCGCCGACTTCGTGCGGCACGAAGCGCACGACCGCGCGCAATCGACGGACGCGCTCGCCGCGCTGCTCGCGCAACGCGCGGATGCGTGGCTCGACGCGCTCGCTTCGTTCGCCGCCGGGCGCGCGACGCCGCCGTGCGTCGTCGTGCTGCCGTCGCCCGCGCTCGACGCGCGCGGCGGGGCGCTCGCCGAAGCATGCGGGCGGCTCGAGCGCGCGCTGCTCGACGTGCCCGGCTTGCGCGCGCTCGATTGGGCCGACTTCACCGCGTCGGGCGCGATCGCGCAGCCGTTCGATTCCGTCGCGGACAAGCTCGGCCACGTGCCGCTGACGATCGAGGGCTTCGCGGCGTTCGCGCGATGGCTCGCCGAGCGCTTGCGCGGCGAAGCGGGCGACGCCGCACACGCCGGCGCGAGCGCGAACTCGCCCGCTCGCGCCGAAGCCGACGCACATGCGAAGGTCGATCCGCACGCCGCCACTGCCGCCGCTGCCGCCGCTGCGGCCGCGCATCCGAGCGCCGAAGCCGCCGGCGCGGCCGATGCGGCGACCACGCACGCCGCCGCATCGCCGCCCGCGCCGTCGCTCGCCCGCTTCTTCGAGCGCCTGCAACTGCGCATCGCGAGCGTCCCCTTCGACGACGAAACCGCGCTCGCGAAAAGCGCGCGCCTGAGCCACACGGCCGCGACGTTCCATCTGAGCGCTCGCCCGTATCTCGAAGCCGATCTGCTCGACGCGACTTCGCGCGACGCGGCGGGACTCGCGCTGACCGTCGCCGACCGCTTCGGCCAATACGGCTGCAGCGGCTTCGCACTCGTGCGCGTCGACGCCGGCCTGCCCGTGCTCGCCGAGTTCGTGCTGAGCTGCACGGTGCTCGGCAAGCAGGTCGAGCACGGCGTGCTGCTCGCGCTCGCGCATGCCGCGCAGCGCGCCGCGTTGCCGGCCGTCGCGCTCGATTACGTGCGCACCGGCGGCAACCAGCCGGCTGTCGACTTCGTCGACGCAATCGCCGCGCAAGCGGGCGTCGTCATCGACCGAAGCGGCCCGCGCGCGCGGCTACGCATCGCGCCGGCCGCGCTCGCCGAGGCCGTGCTCGCCTGCGCGAACGCGCCGCAAGCGCTTGCGGCGGCCGCGCAGGCGCTCGATCTCGCGCCGCTCTTCCTCCACTCAACCGCTCACCTGGCCGCCCATCGATGA", "orf_prot_sequence": "MSAGRLYVGATFTASPLEPLLRAQGFDDVAFTRYNQLLQALLAPDPQHAGDATLLLVRLADFVRHEAHDRAQSTDALAALLAQRADAWLDALASFAAGRATPPCVVVLPSPALDARGGALAEACGRLERALLDVPGLRALDWADFTASGAIAQPFDSVADKLGHVPLTIEGFAAFARWLAERLRGEAGDAAHAGASANSPARAEADAHAKVDPHAATAAAAAAAAAHPSAEAAGAADAATTHAAASPPAPSLARFFERLQLRIASVPFDDETALAKSARLSHTAATFHLSARPYLEADLLDATSRDAAGLALTVADRFGQYGCSGFALVRVDAGLPVLAEFVLSCTVLGKQVEHGVLLALAHAAQRAALPAVALDYVRTGGNQPAVDFVDAIAAQAGVVIDRSGPRARLRIAPAALAEAVLACANAPQALAAAAQALDLAPLFLHSTAHLAAHR", "perc_identity": 39.02}, "gnl|BL_ORD_ID|2723|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 26651, "orf_end": 28015, "orf_from": "BGC0001102.1|Malleilactone_8 ", "model_name": "tet(51)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3288", "ARO_accession": "3004586", "ARO_name": "tet(51)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.01458, "max_identities": 20, "bit_score": 25.7942, "cvterm_id": "36791", "query": "VGATFTASPLEPLLRAQGFDDVAFTRYNQLLQALLAPDPQHAGDATLLLVRLADFVRHEA", "match": "VGA   A  L+   +A+G    AF RYN+LLQ  +  + +       +LV  +  VR E ", "sequence_from_db": "VGAYIFAGELK---QAEGNYHRAFNRYNELLQPFVEANQKFG-----VLVNESFLVRDEV", "sequence_from_broadstreet": "MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE", "dna_sequence_from_broadstreet": "ATGCCTATCATAAATAAAATTCTGGTAATAGGAGCCGGCATTGCTGGACCCGCGGTTTGTTATTGGTTAAGAAGATTTGGCTTTTCTCCCATTTTAGTTGAAAGGTGTGCCAATTTACGAAAAGGAGGGCATGCTGTGGATATTCGAGGTGTTGCTATCGATCTTGCTAAAAGCATGGGTATTTATAAAAAAATATGCAATATGCGCACCCAGGTGGAATTAGGAAGGTATGTTGACGCCGAAGGTAATATCTTGCATGAAGAAAAAGGCGAAAGATTTGGCTTTAGGGAGGGTGATGATATTGAAATTCTCCGCGGTGATTTAGTTCAAATACTGATAGATGCCATGGGAGATGTTCCCTGTCATTTCAATCAATGGGTTGAGAGCATTAAGCAGAGGGATAATGATGTAGAGGTTCAATTTAAAGATGGTAGAACGGAACTTTACGATTTGGTTATCGGTGCTGATGGCTTGCATTCAACCACCAGAAGGATGGTTTTTGATAAGGATGAATATAAATTAACTAACCTTGGTGCATACTTTAGTGCTTTTAGTATTCCAAATTATCTTAATTTGAATCACACCGATGTGCAATTCGAGGCTAATCAAAAACTTATATCTATGGCTAGCGATAAGAACCCTAAAATTGCTATAACAGGATTCTGTTTCCGTGCACAGAATGTCTTGAATAATTTGCGCGATGAAAACGAGCAACGGAGATTTCTACGCGATACTTTTCAAGATTTTGGCTGGGAGACATCCAAAATACTTGAACTGATGTCAGATAGTAATGATTTTTATTTTGATTCATTCACTCAAGTGAAAATGAAGTCATGGACAAAAGGACGAGTTGCTTTGGTGGGCGATGCAGGTTACTGCGCATCCCCATTCCCTGGTCAAGGTAGTAATCAGGCACTGGTAGGTGCTTATATTTTTGCAGGAGAACTAAAACAGGCAGAAGGCAATTATCATCGAGCATTTAACCGTTATAATGAATTATTACAACCATTTGTTGAAGCCAATCAAAAATTTGGCGTCTTGGTTAACGAATCGTTTCTCGTTCGTGATGAAGTCTCTAAGGAGGTGGCAGAAGAAAGATCGAATAAGATTATGCAAGAGATAAAAATTGTATCGAATATGATTTCGTTGCCGAATTATGAATGA", "partial": "0", "query_start": 26672, "query_end": 26851, "hit_start": 918, "hit_end": 1074, "orf_dna_sequence": "ATGAGCGCCGGGCGTCTCTACGTCGGCGCGACGTTCACCGCATCGCCGCTCGAACCGCTGCTGCGCGCGCAGGGCTTCGACGACGTCGCGTTCACGCGCTACAACCAGTTGCTGCAAGCGCTGCTCGCGCCCGATCCGCAACACGCGGGCGACGCGACGCTGCTGCTCGTGCGGCTCGCCGACTTCGTGCGGCACGAAGCGCACGACCGCGCGCAATCGACGGACGCGCTCGCCGCGCTGCTCGCGCAACGCGCGGATGCGTGGCTCGACGCGCTCGCTTCGTTCGCCGCCGGGCGCGCGACGCCGCCGTGCGTCGTCGTGCTGCCGTCGCCCGCGCTCGACGCGCGCGGCGGGGCGCTCGCCGAAGCATGCGGGCGGCTCGAGCGCGCGCTGCTCGACGTGCCCGGCTTGCGCGCGCTCGATTGGGCCGACTTCACCGCGTCGGGCGCGATCGCGCAGCCGTTCGATTCCGTCGCGGACAAGCTCGGCCACGTGCCGCTGACGATCGAGGGCTTCGCGGCGTTCGCGCGATGGCTCGCCGAGCGCTTGCGCGGCGAAGCGGGCGACGCCGCACACGCCGGCGCGAGCGCGAACTCGCCCGCTCGCGCCGAAGCCGACGCACATGCGAAGGTCGATCCGCACGCCGCCACTGCCGCCGCTGCCGCCGCTGCGGCCGCGCATCCGAGCGCCGAAGCCGCCGGCGCGGCCGATGCGGCGACCACGCACGCCGCCGCATCGCCGCCCGCGCCGTCGCTCGCCCGCTTCTTCGAGCGCCTGCAACTGCGCATCGCGAGCGTCCCCTTCGACGACGAAACCGCGCTCGCGAAAAGCGCGCGCCTGAGCCACACGGCCGCGACGTTCCATCTGAGCGCTCGCCCGTATCTCGAAGCCGATCTGCTCGACGCGACTTCGCGCGACGCGGCGGGACTCGCGCTGACCGTCGCCGACCGCTTCGGCCAATACGGCTGCAGCGGCTTCGCACTCGTGCGCGTCGACGCCGGCCTGCCCGTGCTCGCCGAGTTCGTGCTGAGCTGCACGGTGCTCGGCAAGCAGGTCGAGCACGGCGTGCTGCTCGCGCTCGCGCATGCCGCGCAGCGCGCCGCGTTGCCGGCCGTCGCGCTCGATTACGTGCGCACCGGCGGCAACCAGCCGGCTGTCGACTTCGTCGACGCAATCGCCGCGCAAGCGGGCGTCGTCATCGACCGAAGCGGCCCGCGCGCGCGGCTACGCATCGCGCCGGCCGCGCTCGCCGAGGCCGTGCTCGCCTGCGCGAACGCGCCGCAAGCGCTTGCGGCGGCCGCGCAGGCGCTCGATCTCGCGCCGCTCTTCCTCCACTCAACCGCTCACCTGGCCGCCCATCGATGA", "orf_prot_sequence": "MSAGRLYVGATFTASPLEPLLRAQGFDDVAFTRYNQLLQALLAPDPQHAGDATLLLVRLADFVRHEAHDRAQSTDALAALLAQRADAWLDALASFAAGRATPPCVVVLPSPALDARGGALAEACGRLERALLDVPGLRALDWADFTASGAIAQPFDSVADKLGHVPLTIEGFAAFARWLAERLRGEAGDAAHAGASANSPARAEADAHAKVDPHAATAAAAAAAAAHPSAEAAGAADAATTHAAASPPAPSLARFFERLQLRIASVPFDDETALAKSARLSHTAATFHLSARPYLEADLLDATSRDAAGLALTVADRFGQYGCSGFALVRVDAGLPVLAEFVLSCTVLGKQVEHGVLLALAHAAQRAALPAVALDYVRTGGNQPAVDFVDAIAAQAGVVIDRSGPRARLRIAPAALAEAVLACANAPQALAAAAQALDLAPLFLHSTAHLAAHR", "perc_identity": 33.33}}, "BGC0001102.1|Malleilactone_9 # 28012 # 29274 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712": {"gnl|BL_ORD_ID|670|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 28012, "orf_end": 29274, "orf_from": "BGC0001102.1|Malleilactone_9 ", "model_name": "PC1 beta-lactamase (blaZ)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "726", "ARO_accession": "3000621", "ARO_name": "PC1 beta-lactamase (blaZ)", "ARO_category": {"41361": {"category_aro_accession": "3004197", "category_aro_cvterm_id": "41361", "category_aro_name": "BlaZ beta-lactamase", "category_aro_description": "BlaZ beta-lactamases are Class A beta-lactamases. These beta-lactamases are responsible for penicillin resistance in Staphylococcus aureus.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.64291, "max_identities": 18, "bit_score": 27.335, "cvterm_id": "35526", "query": "IFGIDACSPEELREALACGFAPERISYTAHGMMPDEAALLAALP------DVHVNCDTLSAIALLGSRSPGREIGIRVNPGVGIGYGDS", "match": "++ +D  S +E++       + +R +Y +     + A LL  +P       VH+N D + A + +  +  G++I ++      + Y D+", "sequence_from_db": "VYALDTKSGKEVKFN-----SDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDN", "sequence_from_broadstreet": "MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF", "dna_sequence_from_broadstreet": "TTGAAAAAGTTAATATTTTTAATTGTAATTGCTTTAGTTTTAAGTGCATGTAATTCAAACAGTTCACATGCCAAAGAGTTAAATGATTTAGAAAAAAAATATAATGCTCATATTGGTGTTTATGCTTTAGATACTAAAAGTGGTAAGGAAGTAAAATTTAATTCAGATAAGAGATTTGCCTATGCTTCGACTTCAAAAGCGATAAATAGTGCTATTTTGTTAGAACAAGTACCTTATAATAAGTTAAATAAAAAAGTACATATTAACAAAGATGATATAGTTGCTTATTCTCCTATTTTAGAAAAATATGTAGGAAAAGATATCGCTTTAAAAGAACTTATTGAGGCTTCAATGAAGTACAGTGATAATACAGCAAACAATAAAATTATAAACGAAATCGGTGGAATCAAAAAAATTAAAAAACGTTTAAAAAAATTGGGAGATAAAGTAACAAATCCAGTTAGATATGAAATAGAATTAAATTACTATTCACCAAAGAGCAAAAAAGATACTTCAACGCCTGCTGCTTTCGGCAAGACTTTAAATAAACTTATCGCAAATGGAAAATTAAGCAAAAAAAATAAAAATTTCTTACTTGATTTAATGTTAAATAATAAAAACGGAGACACTTTAATTAAAGATGGTATTCCAAAAGACTATAAAGTTGCTGATAAAAGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTTGCTTTTGTTTATCCTAAGGGCCAATCTGAACCTATTGTTTTAGTCATTTTTACGAATAAAGACAATAAAAGTGATAAGCCAAATGATAAGTTGATAAGTGAAACCGCCAAGAGTGTAATGAAGGAATTTTAA", "partial": "0", "query_start": 28315, "query_end": 28563, "hit_start": 117, "hit_end": 369, "orf_dna_sequence": "ATGAACGCGAATCCCGACGCACTCAAGCTCACGCGCGCGCACGCCGCGCCGCCCGCCGACTGGTGGGCGCGCGAGCGGCTGCACTACCGCGACAACTCACTGCACTTCTGCGGCCGCCGCGTCGCCGAACTCGCGGCCGCGTTCGCCGAACCGGTGTTCCTGTACGACCCGCAGCGCGCGGTCGACAACGTCGCGCGCCTGCAACGCGCGCTGGGCGACCTGCAACGCGGCGACTTTCACGTCTACTACGCGATGAAGGCGAATCGCTTCCGCCCGCTGCTGTCCGAGCTGCGGCGCTCGCCGATCTTCGGCATCGACGCGTGCTCGCCCGAGGAGTTGCGCGAAGCGCTCGCGTGCGGCTTCGCGCCGGAGCGCATCTCGTACACCGCGCACGGCATGATGCCCGACGAAGCCGCGCTCCTCGCCGCGCTGCCCGACGTGCACGTGAACTGCGACACGCTGAGCGCGATCGCGCTGCTCGGCAGCCGTTCGCCGGGGCGCGAGATCGGCATTCGCGTGAACCCCGGCGTCGGCATCGGCTACGGCGACAGCGAGCGCCTGAGCTACGCGGGCGCGACCATCACGAAGTTCGGCATCTATGCGGAACAGTTCGGCGCGGCGCTCGAGCTCGCCGCGCGGCACGGCCTCACCGTGACGTGGCTGCATTGCCACGCGGGCTGCGGCTATCTCGACGCGCAGCTCGACTCGTTCGAGCGCGTGCTCGATGCGCTCGATGCGTTCGTCGCGCGCGCGCCGGGGCTGCGCGGCATCAACCTCGGCGGCGGGCTCGGCCTGCCGCATCGCGCGACCGACCGCCCGCTCGATCTCGAACGCTGGCGCGCGGCCGTGCACGCGCGCTTCGGCGGCCGGCCGCTCGCGCTCGCGATCGAGCCAGGCGACTTCATCGCGAAGGACGCCGGCATGCTCGTGCTGCGCGTCGCATACGTCGAGCTCAAGCGCAACCGCCGTTTCGTCGGATTGAACGGCGGCTTCAATCTCGCGATAGAACCCGCGTTCTACGATCTGCCGTGCGAGCCCGTGCCGTGCGTGCGCCGGCCGGGCCCCACGCAATCGGTGTGCCTCGCGGGCAACATCAACGAAGCGCTCGACGTGTGGGGCGACGACGTGAGCCTGCCGCCCGTCGAGCCGGGCGATTTCGTCGCGCTGCTGAACGCGGGCGGCTACGCGTCATCGATGAGCTCGAACCACTGCCTGCGCGGGCAGTTCCGCGAGCTCGCGCTGTTCGACGCCGCGCCGCACTGA", "orf_prot_sequence": "MNANPDALKLTRAHAAPPADWWARERLHYRDNSLHFCGRRVAELAAAFAEPVFLYDPQRAVDNVARLQRALGDLQRGDFHVYYAMKANRFRPLLSELRRSPIFGIDACSPEELREALACGFAPERISYTAHGMMPDEAALLAALPDVHVNCDTLSAIALLGSRSPGREIGIRVNPGVGIGYGDSERLSYAGATITKFGIYAEQFGAALELAARHGLTVTWLHCHAGCGYLDAQLDSFERVLDALDAFVARAPGLRGINLGGGLGLPHRATDRPLDLERWRAAVHARFGGRPLALAIEPGDFIAKDAGMLVLRVAYVELKRNRRFVGLNGGFNLAIEPAFYDLPCEPVPCVRRPGPTQSVCLAGNINEALDVWGDDVSLPPVEPGDFVALLNAGGYASSMSSNHCLRGQFRELALFDAAPH", "perc_identity": 20.22}}, "BGC0001102.1|Malleilactone_10 # 29382 # 31172 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=TCG;rbs_spacer=14bp;gc_cont=0.692": {"gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 29382, "orf_end": 31172, "orf_from": "BGC0001102.1|Malleilactone_10 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.431e-05, "max_identities": 69, "bit_score": 43.8986, "cvterm_id": "36789", "query": "ASILYTSGTTGHPKGVVLSHRNLLSDARALVRWFAFEPGTRTMCILPLFHNNGQVITLLSPLIAGGSSVILEGKSALPSFWKLIDTYRVN-WTSVMPAFLSAFLEYGLKRTDDT------LRGIVCGGQVLLDEVRNRFESEYRVPVFEGFGLTETTSFATMNRHPAERRRFG-SIGVALPCNALRIVDADG-----REVAAGETGEILIRGENVATRYHGLAELTAERF--RDG--WLHTGDYGYRDDEGHFFFATRVDDLIIKGGENIYPAEIENAL", "match": "A I+ TSG+TG PK + +S+ NL      + + F      R      L  +   V  +   LI+G    ++   + L S  + I  +++  W SV        +E  L+R   T      LR     GQ LL ++  +++   + PV   +G TE T   T +R  A        IG A     L I++  G          G  GE+L+ G+ +   Y      T   F   +G  W  +GD   + + G      R D  +   G+ +   EIE  +", "sequence_from_db": "AYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLS-VHDIFYSLISGACLYVVPELAKL-SPAEFIRHHQLTVWLSV-----PTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSN-GVLIHLGRRDHQVKIAGQRVELEEIETVV", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 30099, "query_end": 30884, "hit_start": 588, "hit_end": 1401, "orf_dna_sequence": "ATGCAGAATCTCGCCGAATGGTCGTCGCTCGCGCACGTCCAGTTGCTCGGCAAGGTCGCCGCCGAATTCGGCGTCGATATCGATATCGAAGAAGCCTATCGGCTCGACAGTTTCGAGCGGCTGCTGCAGTACATCGAGCGGCGGTGCGAACCGGGCGGCGACACGCCGCCCGCGTCCTCGACGCCGGACGCGGCGTCGGACGCCGCCGTCGGGCCGCCCGATACGATCGGCGCGCTGCTTCGCGCGCGCGCCGACGCGCTGCCCGACGAGCCGTTCCTGTTTTTCCCCGCCGACGATCTCAGCTACACCTATCGCGCGTTCCACGGGCTCGCGTGCGCGGCGGCCGATACGCTGCGCGCGCACGGACTCGCGCGCGGCGACCGTCTGTCGGTCGTGCTGCCGAACGGCCCCGAGTTCCTCGCGTACTACTTCGGCGCGCATCTGCTCGGCGCCGTGTCGGTGCCGATCAACCCGGCGCTCACCGCGGCCGAGTGCGCGTACATCGTCCGCAACAGCGGCGCGAAGCTCGTCGTGTTCGACCGGCGCATGACGTACCTGCGCGACGCGGTGCGCGCCGAGCTCGGCGACGATGGCGGCGCGCGCCTCGCGAGCGCCGACGCCGCATCCGGCTTCGGCCTGGAAGCGCTGGCCGCGCTCGCGGCAACGGGCGAGCGCGCGGCGATCGCCCCCGATCCCGATCTCGCCGCCGGCGACGACGCGAGCATTCTCTACACGTCCGGCACGACGGGGCACCCGAAGGGCGTCGTGCTGTCGCACCGCAATCTCCTGTCGGATGCGCGCGCGCTCGTCCGCTGGTTCGCGTTCGAGCCCGGCACGCGCACGATGTGCATCCTGCCGCTGTTCCACAACAACGGGCAGGTGATCACGCTGCTGTCGCCGCTGATCGCGGGCGGCAGCTCGGTGATCCTGGAAGGCAAGTCGGCGCTGCCGTCGTTCTGGAAGCTGATCGACACATATCGCGTGAACTGGACGAGCGTGATGCCGGCGTTCCTGTCCGCGTTCCTCGAATACGGCCTGAAGCGCACCGACGACACGCTGCGCGGCATCGTCTGCGGCGGCCAGGTGCTGCTCGACGAAGTGCGCAACCGCTTCGAGAGCGAATACCGCGTGCCGGTGTTCGAGGGCTTCGGGCTCACCGAGACGACGTCGTTCGCGACGATGAACCGCCATCCCGCCGAGCGCCGACGCTTCGGCTCGATCGGCGTCGCGCTGCCGTGCAATGCGTTGCGCATCGTCGATGCCGACGGCCGCGAGGTGGCCGCGGGCGAGACGGGCGAAATCCTGATCCGCGGCGAGAACGTCGCGACGCGCTACCACGGGCTCGCCGAACTCACCGCCGAGCGCTTTCGCGACGGCTGGCTGCATACCGGCGACTATGGCTATCGCGACGACGAAGGCCACTTTTTCTTCGCGACGCGCGTCGACGATCTCATCATCAAGGGCGGCGAGAACATCTACCCGGCCGAAATCGAGAACGCGCTGCACGGCTGCGACGACGTGATCGAATGCGCGGCGCTCGGCGTGCCCGATCCGATTCTCGGCCAGGACGTGTGCGTGTACGTGAAGCTGCGGCCGTCGTCGACGCTCGGCAAGGACGGCGTTCGCCGCTTGTGCGAGGGCCGCATCGCGCATTACAAGTGCCCGCGCCACGTCGTGCTGCTCAACGAGCTCGACGATCTGCCCGAGCTGCCGAAGGGCCCGACGCGCAAGATCCTGCGCCGCAAGCTGCTCGCGCATTTCGCGACGCTGCGCGAGCGGGAATCCGCATGA", "orf_prot_sequence": "MQNLAEWSSLAHVQLLGKVAAEFGVDIDIEEAYRLDSFERLLQYIERRCEPGGDTPPASSTPDAASDAAVGPPDTIGALLRARADALPDEPFLFFPADDLSYTYRAFHGLACAAADTLRAHGLARGDRLSVVLPNGPEFLAYYFGAHLLGAVSVPINPALTAAECAYIVRNSGAKLVVFDRRMTYLRDAVRAELGDDGGARLASADAASGFGLEALAALAATGERAAIAPDPDLAAGDDASILYTSGTTGHPKGVVLSHRNLLSDARALVRWFAFEPGTRTMCILPLFHNNGQVITLLSPLIAGGSSVILEGKSALPSFWKLIDTYRVNWTSVMPAFLSAFLEYGLKRTDDTLRGIVCGGQVLLDEVRNRFESEYRVPVFEGFGLTETTSFATMNRHPAERRRFGSIGVALPCNALRIVDADGREVAAGETGEILIRGENVATRYHGLAELTAERFRDGWLHTGDYGYRDDEGHFFFATRVDDLIIKGGENIYPAEIENALHGCDDVIECAALGVPDPILGQDVCVYVKLRPSSTLGKDGVRRLCEGRIAHYKCPRHVVLLNELDDLPELPKGPTRKILRRKLLAHFATLRERESA", "perc_identity": 24.73}}, "BGC0001102.1|Malleilactone_11 # 31245 # 31676 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.641": {"gnl|BL_ORD_ID|1272|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "oleB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "1388", "ARO_accession": "3003036", "ARO_name": "oleB", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.59683, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "36823", "query": "YAARNDYAAWERIDRLQHKLG", "match": "+ AR+ YAA  R+D   H LG", "sequence_from_db": "FEARDGYAADARVDAAMHGLG", "sequence_from_broadstreet": "MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE", "dna_sequence_from_broadstreet": "ATGCAGAACGCACACCGTTCCGATACCGGCGCCGCGGCGCTCACCGGCACGCCGGAAAAGCTCCTTCCCACGCAACCTGAGACCGGTTCCTTCCAGGTCGTCCTCGACGACGTCGTCCGGGCACCCGGCGGACGGCCGCTGTTGGACGGCGTCAACCAGTCGGTGGCACTCGGCGAGCGCGTCGGCATCATCGGTGAGAACGGATCGGGCAAGTCGACCCTGCTCCGCATGCTCGCCGGCGTGGACCGCCCGGACGGTGGCCAGGTCCTCGTCCGGGCTCCCGGCGGCTGCGGCTACCTCCCCCAGACACCGGACCTGCCCCCGGAGGACACCGTTCAGGACGCCATCGACCACGCCCTCGCCGAACTGCGCTCCCTGGAGCGGGGGTTGCGTGAGGCGGAGCAGGCGCTGGCCGGGGCGGAGCCCGAGGAGCTGGAGGGCCTGCTCGGCGCCTACGGCGACCTGCTGGAGGCGTTCGAGGCCCGCGACGGCTACGCGGCGGACGCCCGTGTCGACGCGGCGATGCACGGCCTCGGTCTGGCGGGCATCACGGGCGACCGGCGGCTCGGCAGCCTCTCCGGAGGTGAGCAGGCGCGTCTCAACCTGGCCTGCCTGCTGGCCGCGTCCCCGCAGCTGATGCTGCTCGACGAACCCACCAACCACCTCGACGTCGGGGCGCTGGAGTGGCTGGAGGAGCGCCTGCGGGCCCACCGCGGCAGCGTGCTGGTCGTCTCGCACGACCGGGTCTTCCTGGAGCGCGTGGCCACCGCCCTGTGGGAGGTGGACGGCGAGCGGCGCACCGTCAACCGGCACGGCGGCGGTTACGCGGGATACCTGCAAGCCAAGGCGGCCGCGCGGCGCCGCTGGGAGCAGGCTTACCAGGACTGGCTGGAGGACCTGGCACGCCAGCGGGAACTGGCCCGCAGCGCCGCCGACCACCTGGCCACCGGCCCGCGGCGCAACACCGAGCGGTCGAACCAGCGCCACCAGCGCAACGTGGAGAAGCAGATCTCCGCGCGGGTCCGCAACGCCAAGGAGCGGGTCCGCCGGCTGGAGGAGAACCCGGTGCCGCGGCCCCCTCAACCCATGCGTTTCCGGGCCCGGGTGGAGGGTGGCGGCACGGTCGGGCGCGGCGGGGCACTCGCCGAGCTGTACAAGGTCACCGTCGGCACGCGGCTCGACGTCCCGTCCTTCACCGTCGACCCCGGTGAGCGCATCCTGATCACGGGGCACAACGGCGCGGGCAAGAGCACCCTGCTGCGCGTGCTGGCCGGTGACCTGGCGCCCGATCAGGGCGAGTGCGAGCGCCCGGAGCGCATCGGCTGGCTGCCGCAGGAGACGGAGATCACCGACCGGCAGCAGAGCCTGCTGGCGGCCTTCGCGGCGGGGCTGCCCGGCATCGCGGAGGAACACCGGGGCGCGCTCCTGGGATTCGGGCTCTTCCGGCCCTCGGCGCTGGGCACCGCGGTGGGAGACCTGTCCACCGGGCAGTTGAGGCGGCTGGCCCTGGCCCGTCTGCTGCGCGACCCGGCGGACCTGCTGCTGCTCGACGAGCCGACGAACCACCTGTCGCCCGCGCTCGTGGAGGACCTGGAGGAGGCGCTGGCGCACTACCGGGGCGCACTGGTCGTGGTCTCCCACGACCGCATGTTCGCGCAGCGGTTCACCGGTCGCCGCATGCACATGGAGGGTGGCCGCTTCGTGGAGTGA", "partial": "0", "query_start": 31548, "query_end": 31610, "hit_start": 474, "hit_end": 537, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 47.62}, "gnl|BL_ORD_ID|2573|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "OXA-417", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "530", "model_id": "3500", "ARO_accession": "3001608", "ARO_name": "OXA-417", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.6248, "max_identities": 16, "bit_score": 23.8682, "cvterm_id": "39094", "query": "VEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTP", "match": " EG+    I R   +  + + L  S+ +YV  PA T  ++   I L H   TP", "sequence_from_db": "TEGVL--VIKRGQTEEIYGNDLKRSSTEYV--PASTFKMLNALIGLEHHKATP", "sequence_from_broadstreet": "MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSNEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQFAYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGKIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGATCAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATTGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGGATGGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAATGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGCCCAGTTTGCTTATGAACTAGCCCATAAAACTCTTCCTTTTAGCAAGAATGTGCAAGAACAAGTTCAATCTATGCTGTTCATAGAAGAAAAAAATGGACGGAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGAGCCTCAAGTGGGCTGGTTAACAGGCTGGGTCGTTCAACCTCAAGGAAAAATTGTAGCGTTCTCACTCAATTTAGAAATGAAAAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAGGGATTAGAGCAGCTAGGTATTTTATAA", "partial": "0", "query_start": 31305, "query_end": 31463, "hit_start": 144, "hit_end": 291, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 30.19}, "gnl|BL_ORD_ID|3787|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "OXA-522", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4857", "ARO_accession": "3005752", "ARO_name": "OXA-522", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.68633, "max_identities": 16, "bit_score": 23.8682, "cvterm_id": "35506", "query": "VEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTP", "match": " EG+    I R   +  + + L  S+ +YV  PA T  ++   I L H   TP", "sequence_from_db": "TEGVL--VIKRGQTEEIYGNDLKRSSTEYV--PASTFKMLNALIGLEHHKATP", "sequence_from_broadstreet": "MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQKAQFAYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGKIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGATCAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATTGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGGATGGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAAAAGCCCAGTTTGCTTATGAACTAGCCCATAAAACTCTTCCTTTTAGCAAGAATGTGCAAGAACAAGTTCAATCTATGCTGTTCATAGAAGAAAAAAATGGACGGAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGAGCCTCAAGTGGGCTGGTTAACAGGCTGGGTCGTTCAACCTCAAGGAAAAATTGTAGCGTTCTCACTCAATTTAGAAATGAAAAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAGGGATTAGAGCAGCTAGGTATTTTATAA", "partial": "0", "query_start": 31305, "query_end": 31463, "hit_start": 144, "hit_end": 291, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 30.19}, "gnl|BL_ORD_ID|3767|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "OXA-502", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4837", "ARO_accession": "3005732", "ARO_name": "OXA-502", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.74844, "max_identities": 16, "bit_score": 23.8682, "cvterm_id": "40550", "query": "VEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTP", "match": " EG+    I R   +  + + L  S+ +YV  PA T  ++   I L H   TP", "sequence_from_db": "TEGVL--VIKRGQTEEIYGNDLKRSSTEYV--PASTFKMLNALIGLEHHKATP", "sequence_from_broadstreet": "MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQFAYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGATCAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATTGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGGATGGGCAAAAGCGTTTATTTCCCGATTGGGAAAAAGACATGACATTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTCTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGCCCAGTTTGCTTATGAACTAGCCCATAAAACTCTTCCTTTTAGCAAGAATGTGCAAGAACAAGTTCAATCTATGCTGTTCATAGAAGAAAAAAATGGACGGAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGAGCCTCAAGTGGGCTGGTTAACAGGCTGGGTCGTTCAACCTCAAGGAGAAATTGTAGCGTTCTCACTCAATTTAGAAATGAAAAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAGGGATTAGAGCAGCTAGGTATTTTATAA", "partial": "0", "query_start": 31305, "query_end": 31463, "hit_start": 144, "hit_end": 291, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 30.19}, "gnl|BL_ORD_ID|3823|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "OXA-564", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4893", "ARO_accession": "3005788", "ARO_name": "OXA-564", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.87437, "max_identities": 16, "bit_score": 23.8682, "cvterm_id": "36787", "query": "VEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTP", "match": " EG+    I R   +  + + L  S+ +YV  PA T  ++   I L H   TP", "sequence_from_db": "TEGVL--VIKRGQTEEIYGNDLKRSSTEYV--PASTFKMLNALIGLEHHKATP", "sequence_from_broadstreet": "MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQFAYELAHKTLPFSKNVQEQVQSMLFIEEKNGQKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGATCAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATTGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGGATGGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGCCCAGTTTGCTTATGAACTAGCCCATAAAACTCTTCCTTTTAGCAAGAATGTGCAAGAACAAGTTCAATCTATGCTGTTCATAGAAGAAAAAAATGGACAGAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGAGCCTCAAGTGGGCTGGTTAACAGGCTGGGTCGTTCAACCTCAAGGAGAAATTGTAGCGTTCTCACTCAATTTAGAAATGAAAAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAGGGATTAGAGCAGCTAGGTATTTTATAA", "partial": "0", "query_start": 31305, "query_end": 31463, "hit_start": 144, "hit_end": 291, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 30.19}, "gnl|BL_ORD_ID|3771|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "OXA-506", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4841", "ARO_accession": "3005736", "ARO_name": "OXA-506", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.87437, "max_identities": 16, "bit_score": 23.8682, "cvterm_id": "37046", "query": "VEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTP", "match": " EG+    I R   +  + + L  S+ +YV  PA T  ++   I L H   TP", "sequence_from_db": "TEGVL--VIKRGQTEEIYGNDLKRSSTEYV--PASTFKMLNALIGLEHHKATP", "sequence_from_broadstreet": "MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQFAYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGKIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGATCAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATTGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGGATGGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGCCCAGTTTGCTTATGAACTAGCCCATAAAACTCTTCCTTTTAGCAAGAATGTGCAAGAACAAGTTCAATCTATGCTGTTCATAGAAGAAAAAAATGGACGGAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGAGCCTCAAGTGGGCTGGTTAACAGGCTGGGTCGTTCAACCTCAAGGAAAAATTGTAGCGTTCTCACTCAATTTAGAAATGAAAAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAGGGATTAGAGCAGCTAGGTATTTTATAA", "partial": "0", "query_start": 31305, "query_end": 31463, "hit_start": 144, "hit_end": 291, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 30.19}, "gnl|BL_ORD_ID|4054|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "OXA-821", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5124", "ARO_accession": "3006019", "ARO_name": "OXA-821", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.13331, "max_identities": 16, "bit_score": 23.8682, "cvterm_id": "36787", "query": "VEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTP", "match": " EG+    I R   +  + + L  S+ +YV  PA T  ++   I L H   TP", "sequence_from_db": "TEGVL--VIKRGQTEEIYGNDLKRSSTEYV--PASTFKMLNALIGLEHHKATP", "sequence_from_broadstreet": "MTKKALFFAISTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQFAYELAHKTLPFSKNVQEEVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTAGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGATCAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCATTGATTGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGGATGGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGCCCAGTTTGCTTATGAACTAGCCCATAAAACTCTTCCTTTTAGCAAGAATGTGCAAGAAGAAGTTCAATCTATGCTGTTCATAGAAGAAAAAAATGGACGGAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGAGCCTCAAGTGGGCTGGTTAACAGGCTGGGTCGTTCAACCTCAAGGAGAAATTGTAGCGTTCTCACTCAATTTAGAAATGAAAAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAGGGATTAGAGCAGCTAGGTATTTTATAA", "partial": "0", "query_start": 31305, "query_end": 31463, "hit_start": 144, "hit_end": 291, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 30.19}, "gnl|BL_ORD_ID|3768|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "OXA-503", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4838", "ARO_accession": "3005733", "ARO_name": "OXA-503", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.47069, "max_identities": 14, "bit_score": 23.8682, "cvterm_id": "36787", "query": "IDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTP", "match": "I R   +  + + L  S+ +YV  PA T  ++   I L H   TP", "sequence_from_db": "IKRGQTEEIYGNDLKRSSTEYV--PASTFKMLNALIGLEHHKATP", "sequence_from_broadstreet": "MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQNEGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQFAYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGKIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGATCAAGCACAAAATGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATTGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGGATGGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGCCCAGTTTGCTTATGAACTAGCCCATAAAACTCTTCCTTTTAGCAAGAATGTGCAAGAACAAGTTCAATCTATGCTGTTCATAGAAGAAAAAAATGGACGGAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGAGCCTCAAGTGGGCTGGTTAACAGGCTGGGTCGTTCAACCTCAAGGAAAAATTGTAGCGTTCTCACTCAATTTAGAAATGAAAAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAGGGATTAGAGCAGCTAGGTATTTTATAA", "partial": "0", "query_start": 31329, "query_end": 31463, "hit_start": 162, "hit_end": 291, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 31.11}, "gnl|BL_ORD_ID|2543|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "OXA-272", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3439", "ARO_accession": "3001728", "ARO_name": "OXA-272", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.47069, "max_identities": 16, "bit_score": 23.8682, "cvterm_id": "42802", "query": "VEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTP", "match": " EG+    I R   +  + + L  S+ +YV  PA T  ++   I L H   TP", "sequence_from_db": "TEGVL--VIKRGQTEEIYGNDLKRSSTEYV--PASTFKMLNALIGLEHHKATP", "sequence_from_broadstreet": "MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWYGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEVRFAYKLANKTLPFSKNVQEQVQSMVFIEEKNGRKIYAKSGWGWDVDPQVGWFTGWVVQPQGEIIAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGATCAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGTAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATAGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGTATGGGCAAAAGCGTTTATTTCCCGATTGGGAAAAAGACATGACCTTAGGTGATGCTATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGTACGGTTTGCTTACAAATTAGCCAACAAAACTCTTCCCTTTAGTAAAAATGTACAAGAACAAGTTCAATCTATGGTGTTCATTGAAGAAAAAAATGGACGAAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTTGACCCTCAAGTGGGTTGGTTTACAGGCTGGGTAGTTCAACCTCAGGGAGAAATTATAGCTTTCTCACTTAATTTAGAAATGAAGAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAGCAGCTAGGTATTTTATAG", "partial": "0", "query_start": 31305, "query_end": 31463, "hit_start": 144, "hit_end": 291, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 30.19}, "gnl|BL_ORD_ID|4039|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "OXA-804", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5109", "ARO_accession": "3006004", "ARO_name": "OXA-804", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.54004, "max_identities": 16, "bit_score": 23.8682, "cvterm_id": "36787", "query": "VEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTP", "match": " EG+    I R   +  + + L  S+ +YV  PA T  ++   I L H   TP", "sequence_from_db": "TEGVL--VIKRGQTEEIYGNDLKRSSTEYV--PASTFKMLNALIGLEHHKATP", "sequence_from_broadstreet": "MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEVRFAYKLANKTLPFSKNVQEQVQSMVFIEEKNGRKIYAKSGWGWDVDPEVGWFTGWVVQPQGEIIAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL", "dna_sequence_from_broadstreet": "ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGATCAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATTGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGGATGGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGTACGGTTTGCTTATAAATTAGCCAACAAAACTCTTCCCTTTAGCAAAAATGTACAAGAACAAGTTCAATCTATGGTGTTCATTGAAGAAAAAAATGGACGAAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTTGACCCAGAAGTTGGTTGGTTTACAGGCTGGGTAGTTCAACCTCAGGGAGAAATTATAGCTTTCTCACTTAATTTAGAAATGAAGAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAGGGATTAGAGCAGCTAGGTATTTTATAA", "partial": "0", "query_start": 31305, "query_end": 31463, "hit_start": 144, "hit_end": 291, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 30.19}, "gnl|BL_ORD_ID|2778|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31245, "orf_end": 31676, "orf_from": "BGC0001102.1|Malleilactone_11 ", "model_name": "eptB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3791", "ARO_accession": "3005047", "ARO_name": "eptB", "ARO_category": {"41433": {"category_aro_accession": "3004269", "category_aro_cvterm_id": "41433", "category_aro_name": "pmr phosphoethanolamine transferase", "category_aro_description": "This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36593": {"category_aro_accession": "3000454", "category_aro_cvterm_id": "36593", "category_aro_name": "polymyxin B", "category_aro_description": "Polymyxin B is mixture of mostly polymyxins B1 and B2, mainly used for resistant gram-negative infections. They are polypeptides with cationic detergent action on cell membranes.", "category_aro_class_name": "Antibiotic"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.97863, "max_identities": 14, "bit_score": 23.483, "cvterm_id": "43247", "query": "LIFVAAWMSCVIVEGIFEHAIDR--SPEQRAFISKLHWSTDKYVEIP", "match": "++F AA     I E    H   R  +P ++  +  + W +DKY+E P", "sequence_from_db": "IVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENP", "sequence_from_broadstreet": "MPQRQAVFYSSFSRFACMKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVVVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK", "dna_sequence_from_broadstreet": "GTGCCACAGCGTCAGGCGGTGTTTTATTCTTCTTTTTCCAGGTTTGCTTGCATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTCCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTTTCTGGAAAGGGCTTTCCGGTGTTGTTGAACTGGTTGCCACGGTATTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGCCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTCCTGTTTTCCGCCGCGGCGAGTTACTACATGACGTTCCTCAATGTGGTGATTGGCTACGGGATTATCGCTTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCACCTGATCCTCTGGCTGGTGGTGGTGAGCGCGCCGCCGTTGCTGTTCATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAGCTGCGCACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGCTGGCCGGACTGATTGTCTGGGGACCCATCCGCCTGCTAGAGCTGCGCCAGCATGATGTGGAGCGCCATTCGGAAGTGGATATGCCGAGCTATGGCGGGGTGATCGCCAACTCTTACCTGCCGTCGAACTGGTTGTCGGCGCTGGGACTGTACGCCTGGGCGCAGGTGGATGAATCCTCAGACAACAAATCGCTGATTAACCCGGCGAAGAAGTTCACCTACGTCGCGCCGGAAGGTCTGGATGATACCTACGTGGTGTTTATCATTGGCGAAACGACCCGCTGGGACCATATGGGCATCCTCGACTATAGCCGCAATACCACGCCAGAGCTGGAGAAAGAGAAGAATCTCGTCGCCTTCCGCGGTTACTTGTGCGATACCGCTACCAAACTGTCGTTACGCTGCATGTTTGTGCGCGAGGGCGGGGCGGAAGATAACCCCCAGCGGACGCTCAAAGAGCAGAATGTCTTTGCCGTGCTGCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGCGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTACCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGTAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGCGCAGGGCAACGCCTCCGGTAAGCATCTGATCATTCTCCACACCAAAGGCTCCCACTTTAACTACACCCAACGCTACCCGCGCAGCTTCGCCCAGTGGAAACCGGAGTGCGTCGGCGTCGACAACAAGTGCTCGAAAGCGGAACTGATCAATTCCTACGACAATAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGGGAGTCGATTAACGAGCGTGAACACCTGCACGGTACGCCGCGCAAGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTGTGGATGTCGGATAAGTACCTGGAAAATCCCGATCACGCCGCCGCGTTTGCCCATCTGCAGCAGCAGGCTGCGATGAAGGTGCCGCGCCGTCACGTCGAGCTGTACGACACCATTATGGGCTGCCTCGGCTATACCTCGCCGGATGGCGGGATCAATGAGAACAACAACTGGTGCCGGTGGAAAAAGTAA", "partial": "0", "query_start": 31269, "query_end": 31403, "hit_start": 1425, "hit_end": 1566, "orf_dna_sequence": "ATGAAGCTTGTGCTGTTCCTGCATCTGATTTTCGTCGCCGCGTGGATGAGCTGCGTGATCGTCGAGGGCATCTTCGAGCACGCGATCGATCGGAGTCCCGAGCAACGCGCGTTCATCTCGAAGCTGCACTGGAGCACCGACAAGTACGTCGAGATCCCGGCGTTCACGATCGTGCTGATCACGGGTGCAATCCTGCTCGCGCACCGCGCGCCGACGCCGCTGTTGCTGACCAAGGTCGCGTTCGGCACGCTCGCGATCGCGCTGAACGCGGTGTGCGTGTGGATCGTGATCCGCCGCACCCGCTATGCGGCGCGAAACGACTACGCGGCGTGGGAGCGCATCGACCGCCTGCAGCACAAGCTCGGCGGTGTCGTCGCGATCTCGATGCTCGTCGCGCTTGGCATCGGCGGCTACCTGTTCGCAGGAGGATGA", "orf_prot_sequence": "MKLVLFLHLIFVAAWMSCVIVEGIFEHAIDRSPEQRAFISKLHWSTDKYVEIPAFTIVLITGAILLAHRAPTPLLLTKVAFGTLAIALNAVCVWIVIRRTRYAARNDYAAWERIDRLQHKLGGVVAISMLVALGIGGYLFAGG", "perc_identity": 29.79}}, "BGC0001102.1|Malleilactone_12 # 31677 # 32576 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.708": {"gnl|BL_ORD_ID|2009|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 31677, "orf_end": 32576, "orf_from": "BGC0001102.1|Malleilactone_12 ", "model_name": "mexP", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "650", "model_id": "2211", "ARO_accession": "3003698", "ARO_name": "mexP", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36309": {"category_aro_accession": "3000170", "category_aro_cvterm_id": "36309", "category_aro_name": "imipenem", "category_aro_description": "Imipenem is a broad-spectrum antibiotic and is usually taken with cilastatin, which prevents hydrolysis of imipenem by renal dehydropeptidase-I. It is resistant to hydrolysis by most other beta-lactamases. Notable exceptions are the KPC beta-lactamases and Ambler Class B enzymes.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36595": {"category_aro_accession": "3000456", "category_aro_cvterm_id": "36595", "category_aro_name": "thiamphenicol", "category_aro_description": "Derivative of Chloramphenicol. The nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3).", "category_aro_class_name": "Antibiotic"}, "37626": {"category_aro_accession": "3001227", "category_aro_cvterm_id": "37626", "category_aro_name": "kitasamycin", "category_aro_description": "Kitasamycin is a macrolide antibiotic and is produced by Streptoverticillium kitasatoense. The drug has antimicrobial activity against a wide spectrum of pathogens.", "category_aro_class_name": "Antibiotic"}, "40353": {"category_aro_accession": "3003701", "category_aro_cvterm_id": "40353", "category_aro_name": "rokitamycin", "category_aro_description": "Rokitamycin is a macrolide antibiotic. Synthesized from strains of Streptomyces kitasatoensis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.61429, "max_identities": 21, "bit_score": 25.7942, "cvterm_id": "36752", "query": "IVEAADDAMGLSVERLCVDDPDGLLADTRYAQPAIFVVNALHLAAWRDAHGAHDDASVWFAGHSLG", "match": "+  AAD   G    R  VD+PDG L       P +F    L     R        A V  A HS+G", "sequence_from_db": "LANAADRGTGTVRVRAVVDNPDGQLT------PGLFAKVRLETGKPR--------AQVLVADHSIG", "sequence_from_broadstreet": "MNLRHFIRITATLGVAALIAGCGESAPPGAASAPPSVPVAEVVVRPVTPYAEFTGSLTAVEQVELRPRVAGYIQDVTVPEGRLVEKGQQLFLIDPRVFKAAQDAARARLREAEAAALLARTEHERAELLYARKVVARERLDSAIASRNASKAQVDAARAALDAAQLDLGFTRVTAPIGGRVGHIQVTEGNYVTNGVTALTSIVSVDPLYVYFDVDERTYLQALAPTRGREGEQAPRVKVALLTDESYGRSSRLDFLANAADRGTGTVRVRAVVDNPDGQLTPGLFAKVRLETGKPRAQVLVADHSIGTDQGRRYVLVVDEGNKTQYRPVELGPMVDGLRVVRQGLQPGERIVVKGLVRPDMQITPRLAEIDGTPVDLSKTVGAAQ", "dna_sequence_from_broadstreet": "ATGAATCTCAGACACTTCATCCGCATCACCGCGACGCTAGGTGTCGCGGCCCTTATCGCTGGCTGCGGGGAATCGGCGCCGCCGGGGGCGGCGAGCGCCCCGCCAAGCGTTCCCGTCGCCGAGGTGGTGGTTCGCCCGGTGACACCCTACGCCGAGTTCACCGGCTCGCTGACCGCTGTCGAGCAGGTAGAACTGCGGCCGCGCGTCGCCGGCTACATCCAGGACGTTACGGTGCCGGAAGGCCGCCTGGTAGAGAAGGGCCAGCAACTGTTCCTCATCGACCCGCGCGTGTTCAAGGCGGCGCAGGATGCCGCCAGGGCACGCCTGCGCGAGGCCGAGGCCGCGGCGTTGCTGGCGCGCACCGAACACGAGCGAGCCGAGCTGCTGTATGCGCGGAAGGTCGTCGCCCGGGAGCGGCTCGACAGCGCCATCGCCTCGCGCAATGCCAGCAAGGCCCAGGTCGATGCGGCCAGGGCCGCCCTCGACGCGGCGCAACTGGATCTCGGCTTCACGCGGGTGACGGCACCGATCGGCGGGCGTGTCGGGCATATCCAGGTCACCGAGGGCAACTACGTCACCAATGGCGTCACCGCGCTGACCAGCATCGTTTCGGTCGATCCGCTGTACGTGTACTTCGATGTCGACGAGCGCACCTACCTGCAGGCCCTGGCGCCGACCCGCGGCAGGGAAGGCGAGCAGGCCCCCAGGGTCAAGGTGGCGCTGCTCACCGACGAGTCCTATGGACGAAGCAGTCGCCTCGATTTCCTCGCCAACGCCGCCGACCGCGGGACCGGCACGGTCCGGGTTCGGGCGGTGGTGGACAACCCGGACGGGCAACTGACGCCGGGGCTGTTCGCCAAGGTCAGGCTGGAGACCGGCAAGCCTCGCGCGCAGGTGCTGGTCGCCGACCATTCCATCGGCACCGACCAGGGCAGGCGCTATGTGCTGGTCGTCGACGAAGGCAACAAGACCCAGTACCGGCCGGTGGAACTCGGCCCGATGGTCGACGGCCTGCGGGTCGTCCGCCAGGGCCTGCAGCCGGGCGAGCGCATCGTCGTCAAGGGCCTGGTCCGGCCGGACATGCAGATCACACCGCGCCTTGCGGAAATCGATGGCACGCCCGTCGACCTGTCGAAGACCGTGGGGGCCGCACAATGA", "partial": "0", "query_start": 31755, "query_end": 31952, "hit_start": 765, "hit_end": 921, "orf_dna_sequence": "ATGAAAGCACTGATTTTCCCCGGGCAGGGCGCGCAGGCGGCCGGCATGGGCGACGGTCTCTTCGAACGGTATCCTGAGATCGTCGAGGCGGCGGACGACGCGATGGGCCTGTCTGTCGAGCGGCTTTGCGTCGACGATCCGGACGGCCTGCTCGCCGACACCCGCTATGCACAGCCCGCGATCTTCGTCGTCAACGCGCTCCACCTCGCCGCATGGCGCGACGCGCACGGCGCACACGACGACGCAAGCGTCTGGTTCGCCGGGCACAGCCTCGGCGAATACAGCGCGCTCCTCGCCGCGGGCGCGTTCGACTTCCGCACCGGGCTCGAGATCGTCAAGCGGCGCGGCGAGCTGTTCGCCTCGGCGAACGGCGGCGCGATGGCGGCCGTCGTCGGCGTCGCCTCCGCCGAGCTCGGCCGCCGGCTGCGCGCCGCCGGCCTCGCCGACGTCGATCTCGCGAACTTCAACAGCGCCGAGCAGACCGTGATCGCCGGCCCAGCCGCGTCGGTCGACGCCGCCGCGCGCATGCTCGACGCATGTGGCGACGTCACCGTTCATCCGCTGAAGGTCAGCGGCGCGTTCCATTCGCGTTGCATGACGCCGCTCAAATCCGAGTTCGACGCGTTTCTCGCACGCTTCGCGCTCACGCTGCCCGCACGGCCTGTCGTGTCGAACGTGACCGCACGCCCGTATCAGCCGCCCGGCACGCCCGCCGACTATCTCGTCGAGCAGCTCGACCAGCCCGTGCGCTGGCGCGACAGCGTCCGCCACATGCTGCGCGCGGGCGTCGACGAATGGATCGAGCTCGGCCCCGGCCGCCGGATTCTCACGCGTCTCGTCGACGCGATCCGGCGCGAGCAGTCCGAGCGGCTCGTCGCGCCGCAACCCGCACAACTTTGA", "orf_prot_sequence": "MKALIFPGQGAQAAGMGDGLFERYPEIVEAADDAMGLSVERLCVDDPDGLLADTRYAQPAIFVVNALHLAAWRDAHGAHDDASVWFAGHSLGEYSALLAAGAFDFRTGLEIVKRRGELFASANGGAMAAVVGVASAELGRRLRAAGLADVDLANFNSAEQTVIAGPAASVDAAARMLDACGDVTVHPLKVSGAFHSRCMTPLKSEFDAFLARFALTLPARPVVSNVTARPYQPPGTPADYLVEQLDQPVRWRDSVRHMLRAGVDEWIELGPGRRILTRLVDAIRREQSERLVAPQPAQL", "perc_identity": 31.82}}, "BGC0001102.1|Malleilactone_13 # 32593 # 34461 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.701": {"gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 32593, "orf_end": 34461, "orf_from": "BGC0001102.1|Malleilactone_13 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.27813, "max_identities": 22, "bit_score": 29.261, "cvterm_id": "36789", "query": "EPQPTGAIGEICIASDSVCHGYFGRPDATDATFRAYRSSAFPNGMLRTGDLGFIDDDGHLFVSGRIKDLIILNGVNYYPQDIEGAVLNVSD", "match": "E  P G  GE+ ++   + +GY   P  T + F  +    +     R+GD+     +G L   GR    + + G     ++IE  V  V+ ", "sequence_from_db": "ESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIW----YRSGDI-VTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQ", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 33823, "query_end": 34095, "hit_start": 1158, "hit_end": 1416, "orf_dna_sequence": "ATGTCATCCATCCAATCCGCCCTCGCCGCCTGCCGCTCGCTCACCGCGCCGCCGCCGCTCGCGCCCGCGGCCAATTTCGCCGACGTACTGCGCTTTCGCGCCGACACGACGCCCGACGAGTTCGCTTACGGCTACCTCGGCTTCGGCCGCACGCCGGACCGCGTGATGCGCTACGGCGACATTCACCGCCGCGCGCTCGCGATCGCGCGCGAGATTGCCGCGCACGGCCGCACGGGAAACCCCGTGCTGCTGATCTTTCCGTCGGCCGCCGATTTCATCGAGGCGTTCTTCGGCTGCCTGTACGCGGGCCGCATGGCCGTGCCGGCGCTGCCGCCGCGCACGGAGAAGGAACGCCGCCGGCTGATCTCGATCGCGCGCGACTGCGCGCCGTCGCTCGCGATCTGCGGCGACGGCGAAATGGACACCGTGCTCGCCGAGCTGCGCACGGCGGGTGTCGTCGCGCCGCCGTGCCGCGAAGTCGGCGCGATTCCCGACTGCGGCGGCGGCAACGGCGGCGGCCCGAGCGAGCTGCCCGCCGTCGCGCCGGACAGCATCGCGTTCCTCCAGTACACGTCCGGCTCGACGTCCGATCCGAAGGGCGTGATGGTCGGCCACGACAACCTGCTCGCGAACGAGCGGCTGCTGCGCCGGCACTGGGGCAGCGACCGCGAGCGCTGGCTGATCGTGTCGTGGCTGCCGCATTATCACGACATGGGGTTGATCGGCGGCATCCTGCAGCCGATCTATGCGGGACGGCCCGCGGTGTTCATGTCGCCGCAGGATTTTCTTCAGCATCCGGCGCGCTGGCTGCATGCGGTGTCCGACTACGGCGCGACCTGCAGCGGCGCGCCGAACTTCGGCTACGAGCTGTGCCGGCGGCGCGCGAGCCGGATGGACCTCACGCGGCTCGATCTGTCGACGTGGGAGCAGGCGTTCAACGGCGCGGAGCCGGTGCGGCCGCGCACGATGCGCGAATTCGCCGATGCGTTCTCGTCCACCGGCTTTCGCCACGACGCGTTCGCGCCGTGCTACGGGCTCGCGGAGCTCACGCTCGTCGCGACGTCGAAGCAGATCGGCGCGCCCGTCGTGATCCGGCGCGCGGACTGCGCGGCGCTCGCGGACGGACGCTTCGAGCCGCCGCAAGGCGACGGCCGATCGATCGACGCCGTGTCGGTCGGCGCGCTCGAGCACGCGCATCAAGCGTTTTGCATCGTCGATCCGTCGACGGGCGAGCCGCAGCCGACGGGCGCGATCGGCGAGATCTGCATCGCGAGCGACAGCGTGTGCCACGGTTATTTCGGCCGGCCGGACGCGACCGACGCGACGTTCCGCGCGTACCGCTCCAGCGCGTTTCCGAACGGCATGCTGCGCACGGGCGACCTCGGCTTCATCGACGACGACGGCCATCTGTTCGTCTCCGGGCGAATCAAGGATCTGATCATCCTGAATGGCGTCAACTACTATCCGCAGGACATCGAAGGCGCCGTGCTGAACGTGTCCGACCAGATCCGCGCGAACCGGCTCGCCGCGATCGCGGTCGAGCGCGGCGAGCAGGCGGGCGTCGTCGTCGTGCTCGAGGCGATCGGCCGGTTCGATCTTGCGGCGCTCGCGCCGGAAATCAGCCGCGAAGTATGGGACGCGTGCCAACTGACGCTGAGCGGCGTGATTCGCGTGAAGAAGGGCGAGATACACACGACGTCGAGCGGCAAGATCCAGCGCGCGACCTGCGCGAAGATGCTCGCCGACGGCGCGTTCACGATCGAGGACGCCTATCTGCACGACGCTGCGCAAGCATGGCTCGCACCGGTGGTCGAGCGGTGCGGGAGCGCTCGCCGCGAATCGTCGGGGCAGGCTCGGGCGGTTGCCTGA", "orf_prot_sequence": "MSSIQSALAACRSLTAPPPLAPAANFADVLRFRADTTPDEFAYGYLGFGRTPDRVMRYGDIHRRALAIAREIAAHGRTGNPVLLIFPSAADFIEAFFGCLYAGRMAVPALPPRTEKERRRLISIARDCAPSLAICGDGEMDTVLAELRTAGVVAPPCREVGAIPDCGGGNGGGPSELPAVAPDSIAFLQYTSGSTSDPKGVMVGHDNLLANERLLRRHWGSDRERWLIVSWLPHYHDMGLIGGILQPIYAGRPAVFMSPQDFLQHPARWLHAVSDYGATCSGAPNFGYELCRRRASRMDLTRLDLSTWEQAFNGAEPVRPRTMREFADAFSSTGFRHDAFAPCYGLAELTLVATSKQIGAPVVIRRADCAALADGRFEPPQGDGRSIDAVSVGALEHAHQAFCIVDPSTGEPQPTGAIGEICIASDSVCHGYFGRPDATDATFRAYRSSAFPNGMLRTGDLGFIDDDGHLFVSGRIKDLIILNGVNYYPQDIEGAVLNVSDQIRANRLAAIAVERGEQAGVVVVLEAIGRFDLAALAPEISREVWDACQLTLSGVIRVKKGEIHTTSSGKIQRATCAKMLADGAFTIEDAYLHDAAQAWLAPVVERCGSARRESSGQARAVA", "perc_identity": 24.18}, "gnl|BL_ORD_ID|4935|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 32593, "orf_end": 34461, "orf_from": "BGC0001102.1|Malleilactone_13 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.16283, "max_identities": 11, "bit_score": 26.5646, "cvterm_id": "36789", "query": "AFLQYTSGSTSDPKGVMVGHDNL", "match": "A++  TSGST  PK + V + NL", "sequence_from_db": "AYIMQTSGSTGKPKRIAVSYSNL", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 33148, "query_end": 33216, "hit_start": 588, "hit_end": 657, "orf_dna_sequence": "ATGTCATCCATCCAATCCGCCCTCGCCGCCTGCCGCTCGCTCACCGCGCCGCCGCCGCTCGCGCCCGCGGCCAATTTCGCCGACGTACTGCGCTTTCGCGCCGACACGACGCCCGACGAGTTCGCTTACGGCTACCTCGGCTTCGGCCGCACGCCGGACCGCGTGATGCGCTACGGCGACATTCACCGCCGCGCGCTCGCGATCGCGCGCGAGATTGCCGCGCACGGCCGCACGGGAAACCCCGTGCTGCTGATCTTTCCGTCGGCCGCCGATTTCATCGAGGCGTTCTTCGGCTGCCTGTACGCGGGCCGCATGGCCGTGCCGGCGCTGCCGCCGCGCACGGAGAAGGAACGCCGCCGGCTGATCTCGATCGCGCGCGACTGCGCGCCGTCGCTCGCGATCTGCGGCGACGGCGAAATGGACACCGTGCTCGCCGAGCTGCGCACGGCGGGTGTCGTCGCGCCGCCGTGCCGCGAAGTCGGCGCGATTCCCGACTGCGGCGGCGGCAACGGCGGCGGCCCGAGCGAGCTGCCCGCCGTCGCGCCGGACAGCATCGCGTTCCTCCAGTACACGTCCGGCTCGACGTCCGATCCGAAGGGCGTGATGGTCGGCCACGACAACCTGCTCGCGAACGAGCGGCTGCTGCGCCGGCACTGGGGCAGCGACCGCGAGCGCTGGCTGATCGTGTCGTGGCTGCCGCATTATCACGACATGGGGTTGATCGGCGGCATCCTGCAGCCGATCTATGCGGGACGGCCCGCGGTGTTCATGTCGCCGCAGGATTTTCTTCAGCATCCGGCGCGCTGGCTGCATGCGGTGTCCGACTACGGCGCGACCTGCAGCGGCGCGCCGAACTTCGGCTACGAGCTGTGCCGGCGGCGCGCGAGCCGGATGGACCTCACGCGGCTCGATCTGTCGACGTGGGAGCAGGCGTTCAACGGCGCGGAGCCGGTGCGGCCGCGCACGATGCGCGAATTCGCCGATGCGTTCTCGTCCACCGGCTTTCGCCACGACGCGTTCGCGCCGTGCTACGGGCTCGCGGAGCTCACGCTCGTCGCGACGTCGAAGCAGATCGGCGCGCCCGTCGTGATCCGGCGCGCGGACTGCGCGGCGCTCGCGGACGGACGCTTCGAGCCGCCGCAAGGCGACGGCCGATCGATCGACGCCGTGTCGGTCGGCGCGCTCGAGCACGCGCATCAAGCGTTTTGCATCGTCGATCCGTCGACGGGCGAGCCGCAGCCGACGGGCGCGATCGGCGAGATCTGCATCGCGAGCGACAGCGTGTGCCACGGTTATTTCGGCCGGCCGGACGCGACCGACGCGACGTTCCGCGCGTACCGCTCCAGCGCGTTTCCGAACGGCATGCTGCGCACGGGCGACCTCGGCTTCATCGACGACGACGGCCATCTGTTCGTCTCCGGGCGAATCAAGGATCTGATCATCCTGAATGGCGTCAACTACTATCCGCAGGACATCGAAGGCGCCGTGCTGAACGTGTCCGACCAGATCCGCGCGAACCGGCTCGCCGCGATCGCGGTCGAGCGCGGCGAGCAGGCGGGCGTCGTCGTCGTGCTCGAGGCGATCGGCCGGTTCGATCTTGCGGCGCTCGCGCCGGAAATCAGCCGCGAAGTATGGGACGCGTGCCAACTGACGCTGAGCGGCGTGATTCGCGTGAAGAAGGGCGAGATACACACGACGTCGAGCGGCAAGATCCAGCGCGCGACCTGCGCGAAGATGCTCGCCGACGGCGCGTTCACGATCGAGGACGCCTATCTGCACGACGCTGCGCAAGCATGGCTCGCACCGGTGGTCGAGCGGTGCGGGAGCGCTCGCCGCGAATCGTCGGGGCAGGCTCGGGCGGTTGCCTGA", "orf_prot_sequence": "MSSIQSALAACRSLTAPPPLAPAANFADVLRFRADTTPDEFAYGYLGFGRTPDRVMRYGDIHRRALAIAREIAAHGRTGNPVLLIFPSAADFIEAFFGCLYAGRMAVPALPPRTEKERRRLISIARDCAPSLAICGDGEMDTVLAELRTAGVVAPPCREVGAIPDCGGGNGGGPSELPAVAPDSIAFLQYTSGSTSDPKGVMVGHDNLLANERLLRRHWGSDRERWLIVSWLPHYHDMGLIGGILQPIYAGRPAVFMSPQDFLQHPARWLHAVSDYGATCSGAPNFGYELCRRRASRMDLTRLDLSTWEQAFNGAEPVRPRTMREFADAFSSTGFRHDAFAPCYGLAELTLVATSKQIGAPVVIRRADCAALADGRFEPPQGDGRSIDAVSVGALEHAHQAFCIVDPSTGEPQPTGAIGEICIASDSVCHGYFGRPDATDATFRAYRSSAFPNGMLRTGDLGFIDDDGHLFVSGRIKDLIILNGVNYYPQDIEGAVLNVSDQIRANRLAAIAVERGEQAGVVVVLEAIGRFDLAALAPEISREVWDACQLTLSGVIRVKKGEIHTTSSGKIQRATCAKMLADGAFTIEDAYLHDAAQAWLAPVVERCGSARRESSGQARAVA", "perc_identity": 47.83}, "gnl|BL_ORD_ID|4653|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 32593, "orf_end": 34461, "orf_from": "BGC0001102.1|Malleilactone_13 ", "model_name": "ZOG-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "475", "model_id": "5724", "ARO_accession": "3007006", "ARO_name": "ZOG-1", "ARO_category": {"43918": {"category_aro_accession": "3005458", "category_aro_cvterm_id": "43918", "category_aro_name": "ZOG beta-lactamase", "category_aro_description": "ZOG beta-lactamases are class B1 beta-lactamases found in Zobellia galactanivorans.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.78221, "max_identities": 17, "bit_score": 27.7202, "cvterm_id": "35506", "query": "DCGGG-NGGGPSELPAVAPDSIAFLQYTSGSTSDPKGVMVGHDNLLANERLLRRHWGSDRERWLIVSWLPHYH", "match": "DC GG        +P+ A ++   L    G+     G    ++  +  ++++ RH+G    +  IVS++P  H", "sequence_from_db": "DCLGGIEAFHELSIPSYASNTTIELAKKEGNPVPQIGFDTTNELTIGKQKIINRHFGEAHTKDNIVSYIPSEH", "sequence_from_broadstreet": "MTYKSTVLLLFLITAFFSCKSQQPTLTYSSEDLKIIPLSKNSFVHISYLSTGDFGKVACNGLIYINQGQAVVFDTPTDNETSEELIHWITETKKQQIKAVVINHFHDDCLGGIEAFHELSIPSYASNTTIELAKKEGNPVPQIGFDTTNELTIGKQKIINRHFGEAHTKDNIVSYIPSEHLLFGGCALKSLNAAKGYLGDANTNEWGNTIKKIKAAYPDLKTAIPGHGEYGGSELLDYTISLFSTKQ", "dna_sequence_from_broadstreet": "ATGACCTATAAATCAACCGTATTACTTTTGTTCTTGATTACGGCTTTCTTTTCCTGTAAGTCACAACAACCGACCTTAACTTACAGTAGCGAGGACTTAAAAATCATCCCGCTCTCCAAAAACAGCTTCGTCCATATCTCTTACCTATCGACCGGAGACTTTGGAAAAGTGGCCTGTAACGGACTTATCTACATAAACCAAGGCCAGGCCGTTGTTTTCGATACGCCCACCGACAACGAAACTTCCGAAGAGCTCATCCATTGGATAACCGAAACTAAAAAACAACAGATCAAGGCCGTGGTCATCAACCACTTTCACGACGACTGCCTTGGCGGGATCGAGGCCTTTCACGAACTAAGCATTCCCTCTTACGCTAGCAATACGACCATAGAACTTGCTAAAAAAGAAGGAAACCCGGTTCCACAAATTGGTTTTGACACCACCAACGAACTGACCATTGGGAAGCAAAAAATAATCAACCGTCATTTTGGCGAGGCCCATACCAAAGACAACATTGTAAGTTACATCCCTAGCGAGCACCTCCTTTTTGGCGGATGCGCCCTTAAATCGCTCAATGCCGCCAAAGGATACCTAGGCGATGCGAACACCAACGAATGGGGCAACACCATCAAAAAGATAAAAGCAGCCTATCCCGACCTTAAAACGGCCATTCCCGGACACGGGGAATACGGAGGCTCAGAATTACTGGATTATACCATTTCCCTTTTTAGCACGAAACAATAA", "partial": "0", "query_start": 33085, "query_end": 33300, "hit_start": 321, "hit_end": 540, "orf_dna_sequence": "ATGTCATCCATCCAATCCGCCCTCGCCGCCTGCCGCTCGCTCACCGCGCCGCCGCCGCTCGCGCCCGCGGCCAATTTCGCCGACGTACTGCGCTTTCGCGCCGACACGACGCCCGACGAGTTCGCTTACGGCTACCTCGGCTTCGGCCGCACGCCGGACCGCGTGATGCGCTACGGCGACATTCACCGCCGCGCGCTCGCGATCGCGCGCGAGATTGCCGCGCACGGCCGCACGGGAAACCCCGTGCTGCTGATCTTTCCGTCGGCCGCCGATTTCATCGAGGCGTTCTTCGGCTGCCTGTACGCGGGCCGCATGGCCGTGCCGGCGCTGCCGCCGCGCACGGAGAAGGAACGCCGCCGGCTGATCTCGATCGCGCGCGACTGCGCGCCGTCGCTCGCGATCTGCGGCGACGGCGAAATGGACACCGTGCTCGCCGAGCTGCGCACGGCGGGTGTCGTCGCGCCGCCGTGCCGCGAAGTCGGCGCGATTCCCGACTGCGGCGGCGGCAACGGCGGCGGCCCGAGCGAGCTGCCCGCCGTCGCGCCGGACAGCATCGCGTTCCTCCAGTACACGTCCGGCTCGACGTCCGATCCGAAGGGCGTGATGGTCGGCCACGACAACCTGCTCGCGAACGAGCGGCTGCTGCGCCGGCACTGGGGCAGCGACCGCGAGCGCTGGCTGATCGTGTCGTGGCTGCCGCATTATCACGACATGGGGTTGATCGGCGGCATCCTGCAGCCGATCTATGCGGGACGGCCCGCGGTGTTCATGTCGCCGCAGGATTTTCTTCAGCATCCGGCGCGCTGGCTGCATGCGGTGTCCGACTACGGCGCGACCTGCAGCGGCGCGCCGAACTTCGGCTACGAGCTGTGCCGGCGGCGCGCGAGCCGGATGGACCTCACGCGGCTCGATCTGTCGACGTGGGAGCAGGCGTTCAACGGCGCGGAGCCGGTGCGGCCGCGCACGATGCGCGAATTCGCCGATGCGTTCTCGTCCACCGGCTTTCGCCACGACGCGTTCGCGCCGTGCTACGGGCTCGCGGAGCTCACGCTCGTCGCGACGTCGAAGCAGATCGGCGCGCCCGTCGTGATCCGGCGCGCGGACTGCGCGGCGCTCGCGGACGGACGCTTCGAGCCGCCGCAAGGCGACGGCCGATCGATCGACGCCGTGTCGGTCGGCGCGCTCGAGCACGCGCATCAAGCGTTTTGCATCGTCGATCCGTCGACGGGCGAGCCGCAGCCGACGGGCGCGATCGGCGAGATCTGCATCGCGAGCGACAGCGTGTGCCACGGTTATTTCGGCCGGCCGGACGCGACCGACGCGACGTTCCGCGCGTACCGCTCCAGCGCGTTTCCGAACGGCATGCTGCGCACGGGCGACCTCGGCTTCATCGACGACGACGGCCATCTGTTCGTCTCCGGGCGAATCAAGGATCTGATCATCCTGAATGGCGTCAACTACTATCCGCAGGACATCGAAGGCGCCGTGCTGAACGTGTCCGACCAGATCCGCGCGAACCGGCTCGCCGCGATCGCGGTCGAGCGCGGCGAGCAGGCGGGCGTCGTCGTCGTGCTCGAGGCGATCGGCCGGTTCGATCTTGCGGCGCTCGCGCCGGAAATCAGCCGCGAAGTATGGGACGCGTGCCAACTGACGCTGAGCGGCGTGATTCGCGTGAAGAAGGGCGAGATACACACGACGTCGAGCGGCAAGATCCAGCGCGCGACCTGCGCGAAGATGCTCGCCGACGGCGCGTTCACGATCGAGGACGCCTATCTGCACGACGCTGCGCAAGCATGGCTCGCACCGGTGGTCGAGCGGTGCGGGAGCGCTCGCCGCGAATCGTCGGGGCAGGCTCGGGCGGTTGCCTGA", "orf_prot_sequence": "MSSIQSALAACRSLTAPPPLAPAANFADVLRFRADTTPDEFAYGYLGFGRTPDRVMRYGDIHRRALAIAREIAAHGRTGNPVLLIFPSAADFIEAFFGCLYAGRMAVPALPPRTEKERRRLISIARDCAPSLAICGDGEMDTVLAELRTAGVVAPPCREVGAIPDCGGGNGGGPSELPAVAPDSIAFLQYTSGSTSDPKGVMVGHDNLLANERLLRRHWGSDRERWLIVSWLPHYHDMGLIGGILQPIYAGRPAVFMSPQDFLQHPARWLHAVSDYGATCSGAPNFGYELCRRRASRMDLTRLDLSTWEQAFNGAEPVRPRTMREFADAFSSTGFRHDAFAPCYGLAELTLVATSKQIGAPVVIRRADCAALADGRFEPPQGDGRSIDAVSVGALEHAHQAFCIVDPSTGEPQPTGAIGEICIASDSVCHGYFGRPDATDATFRAYRSSAFPNGMLRTGDLGFIDDDGHLFVSGRIKDLIILNGVNYYPQDIEGAVLNVSDQIRANRLAAIAVERGEQAGVVVVLEAIGRFDLAALAPEISREVWDACQLTLSGVIRVKKGEIHTTSSGKIQRATCAKMLADGAFTIEDAYLHDAAQAWLAPVVERCGSARRESSGQARAVA", "perc_identity": 23.29}, "gnl|BL_ORD_ID|1490|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 32593, "orf_end": 34461, "orf_from": "BGC0001102.1|Malleilactone_13 ", "model_name": "vgaE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1020", "model_id": "1626", "ARO_accession": "3002833", "ARO_name": "vgaE", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.92096, "max_identities": 16, "bit_score": 26.9498, "cvterm_id": "35536", "query": "RGEQAGVVVVLEAIGRFDLAALAPEISREVWDACQLTLSGVIRVK--KGEI", "match": "RG    +   LE + R D     PEI  ++ +   LT   V+R +  KGE+", "sequence_from_db": "RGSAKALETRLEQLDRIDKVKELPEIKMDILNKESLTNQSVLRAENIKGEV", "sequence_from_broadstreet": "MLLFEGTSLKKHIQDRLLFDIDLIQVHEHQRIGLVGRNGTGKTSLLKIITGEELVDGGNVNHFTSVKLVPQFKETRSEKSGGEITQQYLQLAFNEKPGLLILDEPTTHLDTQRIDWLEKKLANYQGAFVVVSHDRTFLNNVCTEIWEIEDGSLNAFKGDYNAYAEQKELIKTQQQIAFEKYEREKKQLEKAIRQKEERAQRATKKPKNLSSSEARITGAKTHYANIQKKLRGSAKALETRLEQLDRIDKVKELPEIKMDILNKESLTNQSVLRAENIKGEVDGRKLWNPFSLYLYGGDKVAIIGKNGTGKTTLLKKIVERDERIAIPEKVRIGYFSQHLTILDDDKTIIENIQLTSSQDETLIRTVLARMHFWDEDVYKKVGILSGGEKVKVALAKLFLSDVNMLVLDEPTNFLDIESLEALETLMKSYHGTILFVTHDRTLVTNIATKIIDIKDGKITVFDGSYEAYEEWLENQTKSNNDDQLLLIETKISDVLGRLSLEPSRELEDEFQRLLKEKKELTKKL", "dna_sequence_from_broadstreet": "ATGTTATTATTTGAAGGTACATCATTGAAAAAACACATACAAGACAGATTATTATTTGATATAGATTTAATACAAGTACATGAACATCAGCGAATAGGATTAGTAGGTAGGAATGGAACGGGGAAAACAAGTCTATTAAAAATTATTACAGGTGAAGAACTAGTTGATGGAGGGAATGTTAATCATTTTACCTCTGTAAAATTAGTACCACAATTTAAAGAAACAAGATCGGAGAAAAGTGGTGGAGAAATAACGCAACAATATTTGCAATTAGCATTTAATGAAAAGCCAGGATTATTAATTTTAGATGAACCAACGACTCATTTAGATACACAAAGAATTGATTGGTTAGAAAAGAAATTAGCAAACTATCAAGGAGCATTTGTTGTCGTATCACATGATCGGACATTTCTAAATAATGTGTGTACTGAAATATGGGAAATAGAAGATGGTAGTCTAAACGCGTTTAAAGGGGATTATAATGCTTATGCGGAACAAAAGGAATTAATAAAAACACAGCAGCAGATTGCATTTGAAAAGTACGAACGAGAGAAAAAGCAATTAGAAAAAGCAATACGACAAAAAGAGGAAAGAGCACAGCGAGCAACAAAGAAACCTAAAAATCTGAGTTCTTCAGAGGCAAGAATAACAGGAGCTAAAACCCATTATGCCAATATACAGAAAAAGTTGAGGGGTTCTGCAAAAGCATTAGAAACAAGGTTGGAACAACTGGATAGGATTGACAAGGTGAAAGAACTACCTGAAATTAAGATGGATATATTAAATAAAGAAAGTCTAACAAACCAGTCTGTGTTACGCGCTGAAAACATTAAGGGAGAGGTTGACGGACGTAAGCTTTGGAATCCCTTTAGTTTATATTTATATGGCGGCGATAAAGTTGCTATCATTGGGAAAAATGGCACGGGTAAAACAACCTTACTTAAAAAAATAGTTGAGCGAGATGAAAGAATAGCAATCCCAGAAAAGGTGAGGATAGGTTATTTTTCCCAACACCTCACAATTCTCGATGATGATAAAACAATCATAGAAAATATACAATTGACCTCTAGTCAGGATGAAACATTAATTAGAACAGTTTTAGCAAGAATGCATTTTTGGGATGAAGATGTCTATAAAAAGGTCGGCATATTAAGTGGTGGTGAAAAAGTAAAAGTAGCACTAGCTAAACTATTCTTAAGTGACGTGAATATGCTGGTGTTAGATGAACCTACAAATTTTTTAGATATTGAATCTTTAGAAGCGCTAGAAACATTAATGAAAAGTTATCATGGAACGATTCTATTTGTTACTCACGACCGAACGTTAGTAACAAATATAGCTACAAAAATAATTGATATAAAAGATGGTAAGATAACAGTATTCGATGGATCATACGAAGCATATGAAGAGTGGTTAGAGAATCAAACAAAGTCCAACAATGATGATCAACTTTTACTAATCGAAACTAAAATATCTGACGTTCTGGGTAGGTTGAGTTTGGAGCCTTCACGAGAGTTAGAAGATGAATTTCAAAGATTATTGAAAGAAAAGAAAGAACTGACTAAAAAACTATAA", "partial": "0", "query_start": 34135, "query_end": 34281, "hit_start": 690, "hit_end": 843, "orf_dna_sequence": "ATGTCATCCATCCAATCCGCCCTCGCCGCCTGCCGCTCGCTCACCGCGCCGCCGCCGCTCGCGCCCGCGGCCAATTTCGCCGACGTACTGCGCTTTCGCGCCGACACGACGCCCGACGAGTTCGCTTACGGCTACCTCGGCTTCGGCCGCACGCCGGACCGCGTGATGCGCTACGGCGACATTCACCGCCGCGCGCTCGCGATCGCGCGCGAGATTGCCGCGCACGGCCGCACGGGAAACCCCGTGCTGCTGATCTTTCCGTCGGCCGCCGATTTCATCGAGGCGTTCTTCGGCTGCCTGTACGCGGGCCGCATGGCCGTGCCGGCGCTGCCGCCGCGCACGGAGAAGGAACGCCGCCGGCTGATCTCGATCGCGCGCGACTGCGCGCCGTCGCTCGCGATCTGCGGCGACGGCGAAATGGACACCGTGCTCGCCGAGCTGCGCACGGCGGGTGTCGTCGCGCCGCCGTGCCGCGAAGTCGGCGCGATTCCCGACTGCGGCGGCGGCAACGGCGGCGGCCCGAGCGAGCTGCCCGCCGTCGCGCCGGACAGCATCGCGTTCCTCCAGTACACGTCCGGCTCGACGTCCGATCCGAAGGGCGTGATGGTCGGCCACGACAACCTGCTCGCGAACGAGCGGCTGCTGCGCCGGCACTGGGGCAGCGACCGCGAGCGCTGGCTGATCGTGTCGTGGCTGCCGCATTATCACGACATGGGGTTGATCGGCGGCATCCTGCAGCCGATCTATGCGGGACGGCCCGCGGTGTTCATGTCGCCGCAGGATTTTCTTCAGCATCCGGCGCGCTGGCTGCATGCGGTGTCCGACTACGGCGCGACCTGCAGCGGCGCGCCGAACTTCGGCTACGAGCTGTGCCGGCGGCGCGCGAGCCGGATGGACCTCACGCGGCTCGATCTGTCGACGTGGGAGCAGGCGTTCAACGGCGCGGAGCCGGTGCGGCCGCGCACGATGCGCGAATTCGCCGATGCGTTCTCGTCCACCGGCTTTCGCCACGACGCGTTCGCGCCGTGCTACGGGCTCGCGGAGCTCACGCTCGTCGCGACGTCGAAGCAGATCGGCGCGCCCGTCGTGATCCGGCGCGCGGACTGCGCGGCGCTCGCGGACGGACGCTTCGAGCCGCCGCAAGGCGACGGCCGATCGATCGACGCCGTGTCGGTCGGCGCGCTCGAGCACGCGCATCAAGCGTTTTGCATCGTCGATCCGTCGACGGGCGAGCCGCAGCCGACGGGCGCGATCGGCGAGATCTGCATCGCGAGCGACAGCGTGTGCCACGGTTATTTCGGCCGGCCGGACGCGACCGACGCGACGTTCCGCGCGTACCGCTCCAGCGCGTTTCCGAACGGCATGCTGCGCACGGGCGACCTCGGCTTCATCGACGACGACGGCCATCTGTTCGTCTCCGGGCGAATCAAGGATCTGATCATCCTGAATGGCGTCAACTACTATCCGCAGGACATCGAAGGCGCCGTGCTGAACGTGTCCGACCAGATCCGCGCGAACCGGCTCGCCGCGATCGCGGTCGAGCGCGGCGAGCAGGCGGGCGTCGTCGTCGTGCTCGAGGCGATCGGCCGGTTCGATCTTGCGGCGCTCGCGCCGGAAATCAGCCGCGAAGTATGGGACGCGTGCCAACTGACGCTGAGCGGCGTGATTCGCGTGAAGAAGGGCGAGATACACACGACGTCGAGCGGCAAGATCCAGCGCGCGACCTGCGCGAAGATGCTCGCCGACGGCGCGTTCACGATCGAGGACGCCTATCTGCACGACGCTGCGCAAGCATGGCTCGCACCGGTGGTCGAGCGGTGCGGGAGCGCTCGCCGCGAATCGTCGGGGCAGGCTCGGGCGGTTGCCTGA", "orf_prot_sequence": "MSSIQSALAACRSLTAPPPLAPAANFADVLRFRADTTPDEFAYGYLGFGRTPDRVMRYGDIHRRALAIAREIAAHGRTGNPVLLIFPSAADFIEAFFGCLYAGRMAVPALPPRTEKERRRLISIARDCAPSLAICGDGEMDTVLAELRTAGVVAPPCREVGAIPDCGGGNGGGPSELPAVAPDSIAFLQYTSGSTSDPKGVMVGHDNLLANERLLRRHWGSDRERWLIVSWLPHYHDMGLIGGILQPIYAGRPAVFMSPQDFLQHPARWLHAVSDYGATCSGAPNFGYELCRRRASRMDLTRLDLSTWEQAFNGAEPVRPRTMREFADAFSSTGFRHDAFAPCYGLAELTLVATSKQIGAPVVIRRADCAALADGRFEPPQGDGRSIDAVSVGALEHAHQAFCIVDPSTGEPQPTGAIGEICIASDSVCHGYFGRPDATDATFRAYRSSAFPNGMLRTGDLGFIDDDGHLFVSGRIKDLIILNGVNYYPQDIEGAVLNVSDQIRANRLAAIAVERGEQAGVVVVLEAIGRFDLAALAPEISREVWDACQLTLSGVIRVKKGEIHTTSSGKIQRATCAKMLADGAFTIEDAYLHDAAQAWLAPVVERCGSARRESSGQARAVA", "perc_identity": 31.37}}, "BGC0001102.1|Malleilactone_14 # 34849 # 35748 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=TCG;rbs_spacer=15bp;gc_cont=0.697": {"gnl|BL_ORD_ID|4719|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 34849, "orf_end": 35748, "orf_from": "BGC0001102.1|Malleilactone_14 ", "model_name": "Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "2914", "ARO_accession": "3004480", "ARO_name": "Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin", "ARO_category": {"36349": {"category_aro_accession": "3000210", "category_aro_cvterm_id": "36349", "category_aro_name": "rifamycin-resistant beta-subunit of RNA polymerase (rpoB)", "category_aro_description": "Rifampin resistant RNA polymerases include amino acids substitutions which disrupt the affinity of rifampin for its binding site. These mutations are frequently concentrated in the rif I region of the beta-subunit and most often involve amino acids which make direct interactions with rifampin. However, mutations which also confer resistance can occur outside this region and may involve amino acids which do not directly make contact with rifampin.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}, "35998": {"category_aro_accession": "0001002", "category_aro_cvterm_id": "35998", "category_aro_name": "antibiotic target replacement", "category_aro_description": "Replacement or substitution of antibiotic action target, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.7565, "max_identities": 14, "bit_score": 25.409, "cvterm_id": "42564", "query": "LTPIAMISVGASFSVRHARDAARNFLVGIGFKLLAVPAI", "match": "++P  M+SVGAS       D     L+G   +  AVP I", "sequence_from_db": "VSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLI", "sequence_from_broadstreet": "MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ", "dna_sequence_from_broadstreet": "TTGGCTGAGGCTACGACGAACACCACCACCATCATCGCACGCGCCGACCAGCATGATATTGATCTGCACAAGGCGTCGGACCGTGTGAATTTCGGCTCCATCCGCGAGCCCATTGATGTACCCTACCTGTTGGGTGTACAGACTGACAGCTTTGACTGGCTCATCGGCAACGAGCGCTGGCAGAAGCGAGTCCAGGAGGATCTGGAGAACGGCACCAACACCGTGCCCCACACCTCCGGTCTTGACGAGGTCTTCCAGGAGATCTCCCCGATCGAGAACTTCGCTCAGACCATGAGCCTGACCTTCTCCGATCCGTACTTCGAAGAACCGCGCCACACCGTGCAGGAATGCAAGGAGAAGGATTACACCTACTCCGCGCCGCTGTACGTGAACGCCGAATTCGAGAACGGCGACACCGGCGAAATCAAGTCCCAGACCGTGTTCATGGGCGATTTCCCGCTGCAGACCCCGCACGGCACCTTCATCATCGGTGGTACCGAGCGAGTGATCGTGTCCCAGCTCGTGCGTTCCCCGGGCGTGTACTTCGACCGTTCCCAGGACCGTACCTCCGATAAGGAAGTCTTCGGCGCGAAGATCATCCCGAGCCGTGGCGCATGGCTCGAGTTCGAGATCGACAAGCGCGACGTCCTCGGCGTGCGCGTGGACCGTAAGCGCAAGCAGTCCGCCATCGTGTTCCTCATGGCCATCGGCATGACCAAGGATGAAATTGCCGACGCCTTCAAGGACTACCCGCTGGTCATGGACGCTCTCGCCAAGGAGACCGTGCAGACCCAGGACGAGGCCCTGACCGACCTGTACCGCAAGATCCGTCCGGCCGACACCCCGACTCCGGAAGCCGGCAAGAACCTGCTGGACTCCTTCTACTTCAACACCAAGCGTTACGATCTGGCCCGCGTCGGCCGTTACAAGATCAACCGCAAGCTTGGTCTGGAAAAGGACGTCAACGACCGCAGCCTGTCCCGCGAGGACATCATCGCCACCATCAAGTACTTGGTCACCCTGCATGCGGGCGAGACCAAGTTCCCGGGCAAGCGCGACGGCCAGGACGTTGACCTGCGCGTGGACGTCGACGATATCGACCACTTCGGCAACCGTCGTATCCGCCAGGTCGGCGAGCTGATCCAGAACCAGCTGCGCACCGGTCTGAGCCGTATGGAGCGTGTGGTCCGCGAACGTATGACCACCCAGGATCCCGAGGCCATCACCCCGCAGTCCCTGATCAACATCCGTCCGGTGAACGCCACCATCAAGGAGTTCTTCGGAACCTCCCAGCTGTCCCAGTTCATGGATCAGAACAACCCGCTGGCTGGCGTGACCAACAAGCGTCGTCTGTCCGCTCTGGGCCCCGGTGGCCTGTCCCGCGACCGCGCCTCCATGGAAGTGCGAGACGTGCACCCGTCCCATTTCGGCCGTATGTGCCCGATCGAGTCTCCTGAAGGCCCGAACATCGGTCTGATCGGCTCCCTGGCAACCTTCGGTCGCATCAACCCGTTCGGTTTCATCGAGACCCCGTACCGCAAGGTCGTCAACGGCCACGTCACCGATGAAGTCGAGTACATGACCGCTGACCGCGATGCCGAGCACGTCATCGCCCAGGCCAACCAGGAGCTCGACGAGAACGGCAACTTCGTCAAGAAGCAGGCTCTTGCCCGAGTCGGCGAAGAGGAAGCGGTCGATGTGCCGGTCAGCTCCGTCGATTACATGGACGTCTCCCCGCGTCAGATGGTTTCCGTCGGCGCCTCCCTGATTCCGTTCCTGGAGCACGATGAGGGCCACCGAGCGCTGATGGGCACCAACATGCAGCGTCAGGCCGTGCCGCTGATCGAATCCGAGCGTCCGCTCGTGGGCACCGGCGCCGAATGGCGCGCCGCCGTCGATTCCGGCGACGTCATCCTGGCCGAGAAGCCGGGCGTGGTGACCTACGTGTCCGCCGACATCATCCGTACCATGAACGACGATGGCACCACCAGCTCCTACAAGCTGGCCAAATTCCAGCGTTCCAACCAGACCACCTGCTACAACCAGGTCCCGCTCATCCACGACGGTGAACGCGTGGAAGCCGGCACCGTGCTGGCCGATGGTCCGGCAACCCAGAAGGGCGAGATGGCACTGGGCAAGAACCTGCTCATCGCCTTCATGCCGTGGAACGGCTACAACTACGAGGATGCTGTGATCATCTCCCAGCGCCTTGTGCAGGACGACACCCTGAGCTCCATCCACATCGAGGAGTACGAGATCGATGCCCGTGAAACCAAGCTGGGCGCCGAAGAGATCACCCGCGACCTGCCGAACGTCGGCGAGGACGCGGTGGCCAACCTCGACGAGCGTGGCATCATCCGCATCGGCGCCGAAGTCGAAGCCGGCGACATCCTGGTCGGCAAGGTCACCCCGAAGGGCGAGACCGAGCTGACTCCGGAAGAGCGCCTGCTGCGCGCCATCTTCGGTGAGAAGAGCCGCGAAGTGCGTGACACCTCGCTGCGCGTGCCTCACGGCGAGACCGGCACCGTCATCGCGGTCAAGGAAATCACCCGCGAGGACGCCGAGGAAGACGGCGACGAACTGCCGAACGGCGTGAACCAGATGATTCGCGTCTACATCGCACAGCACCGTAAGATCACCCAGGGCGACAAGCTCTCCGGCCGTCACGGCAACAAGGGCGTCATCTCCCGCATCCTGCCGGAAGAGGACATGCCGTTCCTCGCCGACGGTACTCCGGTGGACATCATGCTGAACCCGCTGGGCGTGCCTTCTCGAATGAACCTTGGCCAGGTGCTGGAACTGCACCTCGGCTGGATCGCGCACGCTGGCTGGGACATCTCCCTGGATCCGGATGCCGAGGCCGCTTGGAAGAAGTACGTGCCGCAGGGCGCCGAAAAGGGCGCTCCGGGCACTCCGGTGGCCACCCCGGTGTTCGACGGCGTCCGTCCGGAAACCATCAAGGGCCTGCTCAGCTGCACCCTTCCGGACCGCGACGGCAACAAGCTCGTCGGCCCCGACGGCAAGGCGACCCTGTTCGACGGCCGTACCGGCGAACCGTTCCCGAAGCCGATCTCCGTGGGCTACATGTACATGCTGAAGCTGCACCACCTGGTCGACGACAAGATCCACGCCCGCTCCACCGGCCCGTACTCCATGATCACCCAGCAGCCGCTGGGCGGCAAGGCTCAGTTCGGTGGCCAGCGCTTCGGCGAGATGGAAGTGTGGGCCCTCGAGGCCTACGGTGCCGCCTACACGCTGCACGAAATGATGACCACCAAGTCCGATGACGTCGACGGCCGCGTGCGCGTCTACGGCGCCATCGTGAAGGGCGAGAACCTGCCGCCGGCAGGCATCCCGGAGTCCTTCAAGGTGCTGCTTAAGGAAATGCAGTCCCTGTCCCTGAATGTCGAAGTGCTCAACGCCGACGGCGTGGCTATCGACATGAAGGAAGAGGACGACGATCCGTCCACATCCTCCGATGATCTGGGCTTCAACATTGGTGCGCGTCCTGACGCTGCCGCCAAGGAAGATCAGGTTGCCGAGGAACCCGAATTCCAGTGA", "partial": "0", "query_start": 35422, "query_end": 35538, "hit_start": 1728, "hit_end": 1845, "orf_dna_sequence": "ATGGCTTCGTTGATTCTCGTTCTCGCCTGCCTCGTCGCGGGCGCCGCGCTCGCGCGCAGCAAGCGCCTGCCGGCCAACTTCCCGGCCAGCCTCAATTACTTCGTAATCCAGATTTCGTTGCCCGCGCTCGTGCTGCAACACCTGCACAAGATCGCGTTCGGCGCCGACATGCTGTGGCTGCTCGCGACGCCCGCGATCGTGTTCGCGGCGACGGCCGTGCTCGCGCTCGCCGCCGGCGCGCTGCTGCGTCTCGACAAGGCGACGGTCGGCTGCCTCACGCTCGTCTGCGGCACGAGCAATACGTCGATTGTCGGCGTGCCGGTCGTGCAGGCGCTGATCGGAAGCGCCGCGGTCGGCCACGCGCTCGTCATCGACCAGGCGAACTTCATCGTGATGTGCACGGCGGGCCTCGTCGCCGCCGATCTGTACGCGGGCAGCGCGACGAGCTGGCGCGGCGTCGCGCGGCAGCTCGCCGGCTACCGGCCGATTCAGGCGATGGCGCTCGCGCTGCTGCTGCGGCCGGTGCCGTTTCCGCCCGCCGTCGAAGACGTGCTGACCGCGCTCGGCGCAACGCTCACGCCAATCGCGATGATCTCGGTGGGCGCGAGCTTCAGCGTGCGCCACGCACGCGACGCCGCGCGCAACTTTCTGGTCGGCATCGGCTTCAAGCTGCTCGCCGTTCCGGCGATCGTGCTCGCGTGCGGGCTCTATGTGTTCTCGCAGCGGGGCGTGCCGCTCACCGTCGCGCTCGTGCAGGCGACGATGCCGCCGATGATCATCGCGGGGCTCATCGCGATCGACAAGAAGCTCGATCCGCCGCTCGCGGGCGCGCTGATGACGCTGGGCGTGCCGGCATCGATCGCCGCCGCATGGCTATGGCGAGGCGTGCTGCCGTATTGA", "orf_prot_sequence": "MASLILVLACLVAGAALARSKRLPANFPASLNYFVIQISLPALVLQHLHKIAFGADMLWLLATPAIVFAATAVLALAAGALLRLDKATVGCLTLVCGTSNTSIVGVPVVQALIGSAAVGHALVIDQANFIVMCTAGLVAADLYAGSATSWRGVARQLAGYRPIQAMALALLLRPVPFPPAVEDVLTALGATLTPIAMISVGASFSVRHARDAARNFLVGIGFKLLAVPAIVLACGLYVFSQRGVPLTVALVQATMPPMIIAGLIAIDKKLDPPLAGALMTLGVPASIAAAWLWRGVLPY", "perc_identity": 35.9}}, "BGC0001102.1|Malleilactone_6 # 13441 # 25587 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=CGA;rbs_spacer=14bp;gc_cont=0.724": {"gnl|BL_ORD_ID|1968|hsp_num:0": {"type_match": "Loose", "snp": {"original": "F", "change": "L", "position": 413}, "query_snp": {"original": "F", "change": "L", "position": 233}, "orf_strand": "+", "orf_start": 13441, "orf_end": 25587, "orf_from": "BGC0001102.1|Malleilactone_6 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.80987e-09, "bit_score": 58.151, "max_identities": 72, "cvterm_id": "39507", "query": "TACSSSLTAIHLALDSLRSGTCDCALAGGVNLIQSPKHLVGLSSLTMLSAGD--------ACRAFGAGADGFVDGEGVGVLVLKPLSRALADGDAIHGIIRGSMINAGGKTHGLTVPNPRAQQAVVAAALARS----GVPARAVGYVEAHGTGTALGDPIELTGLTRAFAEATGDRGFCALGSVKSNIGHCESAAGVAGVTKVLLQMKHRELVPTLHADEPNPDLDFACSPFVLQRALAPWPKPDLDGWPRIAGVSSFGAGGANAHVVLEEF", "match": "+ACSS   AI  A   +  G  D A+ GGV   + P   + +++ +M+ A          A R F    DGFV GE   +++++    A A G     + R  ++ AG  +    +  P A       A+ RS    G+    + +V AHGT T +GD  E   +  A  +        A+ + KS +GH   A G       +L ++   + PTL+ + P+P++D           +A  P+    G  R A  +SFG GG N  +    +", "sequence_from_db": "SACSSGSEAIAHAWRQIVMGDADVAVCGGV---EGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARG--AKPLAR--LLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQ------AAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDV--------VAGEPRY---GDYRYAVNNSFGFGGHNVALAFGRY", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 20287, "query_end": 21066, "hit_start": 504, "hit_end": 1248, "orf_dna_sequence": "ATGACCGCATCCCCTCCTTCCCGCGAACTCGCCACGGCCGTCGAGGCGGCCGTCCTGTCGCTTGCCGGCGACGTCGCCGGCTGCACGTTCGACGCGTCGGCCGCGGAGCGCCCGCTGCACGCGCTCGGCTTCGATTCGGTTCAGTACGTCGAATTGTCCGGATGCCTGAACGAATACTACGGGCTCGATCTCGCGCCGACGCTGTTCTTCGACGTGCATGCGCCGCGCCGAATCGCCGCGCACCTGCTCGCGCGGCATCCGCTGGAGGTCGCGCGCAAGCATGGCGTCGCGTCCGGCGATGAATCGGATGCGCTCGCGCGCGCCGGCGCGGCTTCGGACGGCGGTCGCGAGCGCACCGGCGCGCGCGACGAAACCGCCGCCCACGAACGCGAATCGGCCGGCGACATCGCGATCGTCGGCATGGCCGGCATCTTCCCGCAATCGGCCGATCTCGACGCATTCTGGCGGCATCTCGCCGCGGGCGACGATCTGATCGCCGAAGCGCCGGCCTCGCGCTGGGACTGGCGCGCGGCCGACGGCGAGTCCGCCTCGCGCTGGGGCGGCTTCATTCCGCGAATCGAGTATTTCGACGCCGCGTTCTTCGGCATCTCGCCGCGCGAGGCCGAGCAGATGGACCCGCAGCAGCGCCTGCTGATGCAGACCGCGTGGGCCGCGCTCGAAGACGCGGCGGTCCGCCCGTCCGACCTGATGGGCAGCGACACTGCGGTGTTCGTCGGCGTCAGCACGTCCGACTATCTCGACCTGCTGCCGGGCGCGGACGGCCATCTCGCGGTCGGCAACGCGCACGCGATGCTGCCGAACCGGCTGTCGCACCTGCTCGGCGCGCACGGGCCGAGCGAGGCCGTCGATACCGCGTGCTCGAGTTCGCTCGTCGCGCTGCACCGCGCGGTGTGCGCGCTGCGGCGCGGCGAAAGCGGCGTCGCGATCGTCGGCGGCGTCAACGTGATGCTGACGACGCGGCTGCACCGCGCGCTCGCCGCGGCCGGCATGCTGAGCCCCGACGGGCGTTGCAAGACGTTCGACGCGGCGGCGAACGGCTACGTGCGCGGCGAGGGCATCGCGGCGCTCGTGCTGATGCCGCTCGAGCGCGCGCGCGCGGGCGGGCATCCGGTGCACGCGGTGATCAAGGGCAGCGCGGTCAATCACGGCGGCCGCGCGGCGTTCCTGACCGCGCCGGACATCAATGCGCAAGCCGCGCTGATCGAGGCCGCGTATCGCGACGCGGGCGTCGACCCCGCCACCGTTTCGTACATCGAAGCGCACGGCACCGGCACGTCGCTGGGCGATCCGATCGAAGTGCAGGCGCTGCGCCAGGGCTTCGACGCATGCGCGCGCGCGCGCGGGCATGCCGATGCGCCCGCGCCGGCGCGCTGCGGCCTCGGCTCGGTCAAGACCAATATCGGACATCTCGAAGCGGCGGCGGGCCTCGCGGGCGTCGTCAAGGTCGTGCTCGCGATGAACCGGCGAATGCTGCCGCCGAGCCTGCATTGCCGCGAGCTGAATCCGTATCTGAAGCTCGACGGCAGCCGCTACCACGTCGTCACGGAACCTGTGCCGTGGCCGGGCGATGCAACGCCGACGCCGCTTCGCGCGGGCGTCAGCTCGTTCGGCTTCGGCGGATCGAACGCGCATGTCGTGCTGCAGTCCGCGGACGCTCGGCCGAATGATCGGCCGAGCGCGCCCCGGCCGCCGATCGCGCACGAGCAGGCCGAAGCCGGCGCGGCCGATGCCGCCGGCCCGCTCGCGTGGTTCATCCCGTTGTCGGCGCGCACCGACACCGCGTTGCGGGCGCGCGCCGCGCAGCTCGCGTGCTGGCTCGACGCCGAGCGGGCCGACGACGCGTGGCTGCCCGCGCTCGCCAAAACGCTGTCGATCGGCCGCGAACCGATGGCGTGCCGCTTCGGCGTGACCTGCGCGTCGCTCGACTCGCTGCGCGCGCAACTCGCGGTCGCGCTGAACGGCCCCGCCGCATCGCTCGCGCGCGACGACGCTCGCCTGCAGCCGCATGCGAACGCGCACGCCGCGTGGCTCGCGGGCGGGGCCGATCCGCTGCCCGTCGCCTGGGACGAAGCGACGCCGCGCCTGCGATTGCCCGTCTATCCGTTCGAAGGCGAGCGGCACTGGCCAACCGATGCAGTGCCGCCGGCGCGCTTCACGCTCGCGCCCGAAGGCGACGGCGCGTACCGGATGCACGTCGCGCCCGACGCGCCGCTCGTCGCCGACCATCGGCTCGGCGGCGAGCCCGTGCTCGCGGCCGCCGCGCAGATCGTGATCGCGTGGCGCGCGTTCGAAGCGGACGCGAACGCAGCGGACTCGAGCCGCGCAAGCGAGGCCGGTGAGCCAAGTCAGCCGGATGAACGGAATGAACCGAACGGTTCGAGCCGCGCGATCGGTTCGAAGGGGTCGAATCCTGCCGGCGCTGCGATCGATTCGACCGACGCCGGCGGCTCGCGCGTTTCATCTAATACCGCCGATGCGAACGCCGCGACGCAAATCACGCTGCGCGACATCGAATGGCTTGCGCCGATCGCGATCGGCGCGCCGGCCGATCTGCACGTCACGCTCGCGCGTGAAGAACGCAGCAACGCCAACGAAGACCGCCGCGGCAACGCGCATCGCCGCGAAATCGGCAACGCCGCGCGATTCGCGATCGCCGTCGCCCCGGCCATCGATGCGCCGCTCGGCCGCGGATACGCGGCGCGAATCGCGCGCGCGCCGACGAACGCGCCCGCGCTCGACGTCGATGCGATCCGCGCGCGCTGCACGCAGCCGATCGCGGCCGATGCGTGCTATGACGCGTTCGCCGCGATCGGCATCGGCTACGGCCCGACCTTTCGCCCGCTGCGCGCGATCGCGGTAGGCCGCGACGAAGCGTTCGCCGAATTCGATCCATCGGCGCTCGCGCGCACGACGGGCGACGCACGCATCGTCGCGCTGCTCGACGGCGCATTCCAGGCGATCGCGGGCCTTCAGCTCGCGGACGCAGGGCGTCTGGAAGGCGGCCTGCTGCCCGCGTCGCTCGCCCGCATCGAATTCACGGGACCGCTCGCGGACAGCACCCATGCATGGATTCGCGAGGCGCCGGGCGAGACCGGCCGCCGCACGTTCGACATCGATCTCGTGACCGCGCGCGGCGTGCCGTGCGCGTCGCTGCGCGGCCTCGCGCTCGCGTCCGGACGCGGCGGCGCGTCGCGCGAAGCGCCGCGCGTCGCGACGCCGGGCGACCATCTGCTCGCGCCGCAATGGCTGCCGTGCACGGCGAACGCACCGAGCGCGGCAACGCCGCCGCAGCGCGCCGGCGCGCCGGCCATACTGGGCGGCACGCCGGCCCAGCGCGCCGCGCTCGCGGCGACGCTCGCGACGCCGCCGCGCCTGATCGACGACATCGCTGAACTCAATGCGCATGTCGACCACCTGGTGTGGCTGCCGCCCGCGCCGGCGCATGCGCATGCGCCGCTCGCGCGCTGCGCCGGCCTCGACGGCTTCCGTCTTGTCAAGCGGCTGCTCGCGCTCGGCGCGGGCGAACGCGCCTTCGAGCTGACGGTGCTGACCGTCCGCTCGTGGACGATGCCGGGCGACGCGCCCGCCTTCCCCGCGCATGCGGATCTCGCGGGGCTGTGCGGCTCCCTCGCGAACGAATACCCGCACTGGCGCGTGCGACTCATCGATCTGTCCGACGCCGATGCGCTGCCCGCCGACTGGCGCACGCAAGACACCGAAGGCGGCCATCCGCTGCTGCACCGGCACGGCCAATGGTTCGCGCGCCGGCTCGTGCCGCTCGCCGCGTTGCCGTCGCCCGCGACGCCGCCGTACCGGCCGGGCGGCGTCTATGTCGCGATCGGCGGCGCGGGCGGTCTCGGCCGCGTGTGGACCGGGCACGCGATCCGCGCATGCGGCGCGCAAGTCGTGTGGATCGGACGCCGCCCGCTCGACGCGCAGATCGATGCGCACTGCGACGCGCTGGCCGAGTTCGGCCCGCGCCCGTCGTACCTGAGCGCCGACGCGAGCGACGTCGACAGCCTGCGCGACGCGCGCGACGCGGTGCTCGCGCGTTTCGGCCGGATCGACGGCGTCGTGCACACGGCGATCGTGCTGCAGGACGGCGGCCTCGCGCAGCTCGACGAAGCGCAGTTCAGCGCGGCGCTGAACGCGCAGGTCGCGACGACCGCGAACCTCGCGCGCGTGTTCGGCGGCGATTCTCTCGACTTCATCCTGTTCTTCTCGTCACTGCAAAGCGCGTTCGTCGCGGCGGGCCAGAGCAATTACGCGGCGGGCTGCACGTTCCGCGACGCGTTCGCCGACTGGTTGCGCACGCAGCTCCGATGCGTGGTCAAGGTCGTGAGCTGGGGCTACTGGGGGCAAACGGGGGTCGTCGCATCCGAGCCGTATCGCAAGCGGATGGCCGCGCTCGGCATCGGGTCGATCGAGCCGGCGGCGGCGATGGCTGTCGTCGATGCGCTGCTCGCCGCGCGCGTCGATCAGGTCGGCTATCTGAAGACGACCGCGCGCGCCGCGGTGCCCACGCTCGCGCCCGCGCTCGCCGCGCGCATCGCGCCGCATACGAGCGCGCTCGCCGGCAAGCCGCCGCCGCGCATCGACGAAACGGGCGCGAGCGCGGCATGGAACGACGCGCTCGCGGCGCTCGATCGCGCGATCGCACGCCGGCTGTTCGCGGAGCTCGGCGCGCTGCGCGCATTCGGCGAACGCGACGTAGCGGACGACGGCGCGCTCGGCAGCGTCGCGACCGGAAGCGATGCGCGCGGCAAGCGCTCGTCGGGCGAGCGCACGTTCGAGCCCGCATCGTTCGACATCGACGCCGCGCTGCGCTCGGGCCGCATCGCCCCCGCGTATCGGCGCTGGCTCGCGCATGCGCTGGCGCTGATCGCGCAACACGGCCACCTCGACTGGGACGGCCGCGCGGGCCGCCTCGCCGAAGCGCCGCCGCCGCTGGACGCGGCGCGCGCCGAATGGGCGCATGCGCGCGCGCAGCTCGATCGAACGGCGCTGCTCGACGCGCACCTCGCGCTCGCCGACGCGACGCTCGACGCGCTGCCCGCGATCCTGCAAGGCAGCGTGCCCGCGACGTCGATCCTGTTCCCGGACGGCGACCTGAGCCGCGTCGAAGCCGTCTACCGGCGCAACGAGCAGGCGGACCGCTGCAACCGCGCGCTCGCCGATGCGGTGCTGCATCTCGTCGGCGGCGCGTCGTCCGCGCAACCGGCGGCGCTCGCGGAAATCGGCGCGGGCACGGGCGGCACGACGGTGCCGCTCCTCGCGGCGCTCGACGCGAGCGGCGCGCGGCTTGCCCATTACGACTTCACCGACATCTCGAAGGCGTTCCTGCTGAACGCCGAGCAAACGTTCGGCCGCGGCCGCGACACACTGCGCTACCGGCTGTTCGACGTCGAGCGGCCGGTTGCCGGGCAGGCGCTCGATGCCGGCGGCTACGACATCGTGATCGCGACGAACGTGCTGCACGCGACGCAGGACATCAGCGTGACGCTGCGCAACGCGAAGGCGCTGCTGAAGACGGGCGGCCATCTGATCGTCAACGAGCTGCTCGGCACGCACGGCTTCGCGCACGCGACGTTCGGCCTGCTGCCCGGTTGGTGGCGGCATCGCGACAGCGCGCGCCGGCTGCCCGGCAGCCCGCTGCTGTCGCGCGACGGCTGGATGCGCGCGCTGCGCGAAGCCGGCTTCGCGGTGCCCGACGGCGATTCGGCCGGCGCGGCGGCGGCCGCGGGTCAGGGCGTGATCGTCGCGGTCAGCGACGGCGTGATCGTTCAGCCGGCGATCGCCGATGCCGGCCACGCGGCGCACGCGAACGCCGATGCGCAGGCAAGCGCCGCCCGGCCGGCCTCGTTCGCCGCATCGGCCGCACCCGCGCGCGCCGCTTCGTCGATCGCCGCCGCATCATCCGGCGCCGAGCTGCGCGAGCGCTGCGTGCAATGGCTCGCGCAGCTCGTCGCGCGGACGCTGAAGATGCCCGCCGGCAGGCTCGCGCCCGATCAACCGCTCGGCAGCTACGGCGTCGATTCGATTCTCGTGATCGGCCTCACGAAGACGCTGCGCGAAACGTTCGGCGTCGCGCTGTCGAACGCGACGCTGTTCGAGCACGCGACGCTGAGCGCGCTCGCCGATTTCTTCGTCGCCGAGCATCGCGCCGCGTGCGAGCGCGTGCTCGGCGGCGACGCGGTCGCCGCCTCCGCCGCCTCCTCCGCGTCGGCCGCATCTGCATCGGCGATCCCGAATCAGGCTGCCTCCAACCCGCTCACATCGCACGCGCCGATGCCGATGGCGCTGGCGACGCGAGCGACGCCTCCGGCATCACCCGCATCGCCCGCAACCGCAACCGCCGCCGACACCGCCATCGCCGTCATCGGCATGTCCGGCCGCTACGCGCAGGCGGACAACCTGCGCGAGTTCTGGGCGAATCTCCGCGCGGGCCGCCACTGCATCACCGAAGTGCCCGCCGAGCGATGGGACTGGCGCACGCACTTCGATGCGGAAAAAGGCGCGCCGGGCCGAACGTACAGCCGCTGGGGCGGCTTCCTGAAGCAGATCGACCGCTTCGACGCCGCGTTCTTCCGGATCGCGCCGAGCGACGCGGAGCACATCGATCCGCAAGGCCGCCTGTTCCTCGAGGAAGCGTGGTCCGCGATCGAAGACGCCGGCTACACGCCGGCGACGCTCAGCGCGAACCGCCAGGTCGGCGTGTTCGTCGGCGTGATGAACGGCGACTACCCGACGGGCGCGCAGTTCTGGAGCATCGCGAACCGCGTGTCGCACGCGCTCGATCTGCACGGGCCGAGCCTCGCCGTCGACACCGCGTGCTCGTCGTCGCTGACCGCGATCCATCTCGCGCTCGACAGCCTGCGCAGCGGCACCTGCGACTGCGCGCTCGCGGGCGGCGTCAATCTCATTCAGAGTCCGAAGCATCTGGTCGGGCTGTCGTCGCTGACGATGCTCTCGGCGGGCGACGCGTGCCGCGCGTTCGGCGCGGGTGCGGACGGCTTCGTCGACGGCGAGGGCGTCGGCGTGCTCGTGCTCAAGCCGCTGTCGCGCGCGCTCGCCGACGGCGACGCGATCCACGGCATCATCCGCGGCAGCATGATCAACGCGGGCGGCAAGACGCACGGCCTCACGGTGCCGAACCCGCGCGCGCAGCAGGCGGTCGTCGCCGCGGCGCTCGCGCGAAGCGGCGTGCCCGCGCGCGCGGTCGGCTACGTCGAGGCGCACGGCACCGGCACCGCGCTCGGCGATCCGATCGAGCTCACGGGCCTCACGCGCGCGTTCGCCGAAGCAACCGGCGATCGCGGCTTCTGCGCGCTCGGCTCGGTCAAGTCGAACATCGGCCATTGCGAGAGCGCGGCGGGCGTCGCGGGCGTAACGAAGGTGCTGCTGCAGATGAAGCATCGCGAGCTCGTGCCGACGCTGCATGCGGACGAACCGAATCCCGACCTCGATTTCGCGTGCTCGCCGTTCGTGCTGCAACGCGCGCTCGCGCCGTGGCCGAAACCGGATCTCGACGGATGGCCGCGCATCGCGGGCGTGTCGTCGTTCGGCGCGGGCGGCGCGAACGCGCATGTCGTGCTCGAAGAGTTCGTCGACACGCGCGTCGCCGCCCCCGACGATCGCGCCGGCCCCGCGATCGTCGTGCTGTCCGCCGCGACCGACGACGCACTGCGCCGCCGCGCGCGGCAATTGCACGCCGCGCTCGCCGACGGCGAAATCGACGACGAACGCCTGCACGATCTCGCGTACACGCTGCAGATCGGCCGCGATGCGATGGCTTCGCGCTTCGGCTGCGTCGTGGGGACCGTCGCCGAACTGCAAGCGGCGCTCGCCGCGTTCGTCGAAGGCGACGCATCGCGCGGCTGGCACGCGCACCGGCTCGCCGCCGATCGCCACGGCCTCGCCGAGCTCGACGCCGATCCCGAGCTGCGCGCGTCGCTCGTCGAGCAATGCATCGCGGCCGGCAAGCTCGACAGGCTCGCGGCGCTCTGGTGCCAGGGGCTCGGCGTCGATTGGCCCGCGCTGCATCGCGGCCACGCGCGCCGGCGCGTGCATCTGCCGACCTATCCGTTCGACGGCCCGCGCCATTGGCTGCGCGACGACGCGACGCCCGCCACCGAGCCCGCGCGCGCGCCGGCCGATATCGCGGACAGCCACGCCGCGCCGCCGATGCGCGGCGCAAGCGCCGGCGCGCCGAACGTATCGACGCCCGACGTCGCGGCGCTCGTTCGCCGAACGGTCGCGCAGGTGCTCGGCTATCCGGATGTCGACATGAACGAATCGTTCCTGTCGCTCGGCGGCGATTCGATCCGCGCGGCGCGCGCGCATCGGATGCTGCAACGGTCGCTCGACGTGAAGATTCCGCTCAGCCTGATGCTGGAGGCGAAGACGCTCGCCGAATGCGCGCGCGCGATCGATGCGCTGCCGCCGGCGGAACCGCCGAGCGCGGCCGGCACGCCGGCGGCGGGCGCGCCCCCCGCCGAGCCGCGAGCGCCCCGCGCATCGGCCTTCGCGCCGCGCGACGCCCGCCCGCGCGTGCACACGCTGTCGTCGAACCAGCGGCAGTTCTTTTTCCTCGACCGCCTGAATCCCGCGAATCCGGCGTTCAACCTGCCGGGCGCGCTGCGCGTGCGCGGCGAATGGCATGCCGATGCGCTCGCGGCCGCGTATCAGGCGCTCGTCGATACGCACGACGTGCTGCGCACCCGCTTCGTCGTACGCGGCGGCGAACCGTGCGCGGAAGTCGCGCCGCGCCGCGCGGCCGCGATCCGCCATCACGATCTGTCGGCGCTGCTGCCGAAGCACCAGGCCGCGCGCATCGCCGAATGCCTGACCGGATCGAGCCGCGAAGGCTTCGCGCTGGAACAGGGCGAGCCGAGCCGGCTGACCGTGCTCGAACTGCGCGACGACGACCACGTGATTCTGCTGAACCTGCATCACATCGTCGGCGACGCCGTGTCCGTCGTCGTGCTGCTCGACGTGCTCGCGCGCGCCGCGCTGACAGGCCGCGCGAGCGCGCCGAACCGTGCGCAGCCGCAATACGCGCAATGGGCGGCGGCAGAGCGCGATGCATTGCCGGCGACGGTCGAGCGCGAACTGCCGTACTGGCTCGAGCGCCTGCGCGACGTGCCCCCGCCGCTGCCGCTGCCGTGCGACCGCGCGCGGCCGCCCGTGCCGAGCTATCGCGGGCGCAGCGTGCCGCTCGCGTTCCCGTCCGCGCTCACCGCGCAGCTCGACGCGTACTGCAAGGCGCACGGGCTGTCGCGCTTCGTCGTGATGCTCGCCGCGTTCAAGGTCGCGCTGCGCGTGCTGTCGGGCCGCGACGACATTGTCGTCGGTAGCCCGTACGCGAACCGCGCCGACGACGACACGGCCGACATGATCGGCAGCCTCGCGTACGCGCTCGTGCTGCGCACGCGGCTTGGCGAAGCCGAGACCTTCGCCGACGCGGCCACGCTCGTGAGGCGCACCGTGCATGGCGCGTTCGATCATCTCGGCGTGCCGTATCCCCGGCTCGTCGAGGCGCTGAATCCCGCACGCCACGGCGGCGCGAATCCGCTCTACCAGATCATGTTCAACGTGATCCCGATGCCGGCGCTGCCCGACGGCGTCGAGCCCGTCGAAGTCGATTCCGGCTGGCTCGATTACGATCTGTTCGTGCGGCTGCGCGCCTCGGGCAGCGCGATCGAGGGCGTGCTGCAATTCAGCGCCGACCTCTTCGATCGCTCGACGGCCGAAGCGATCGCCACGTACTACGTCGAGCTGCTGCACACGCTGCTCGCGCATCCGTCGCTGCCGCTCGCGGGCCTCGCGCCGCCGCCCGAGCTCGCGCTCGAACGGACGATCGCCGACGCAATGCCGCCGCTGCGCATCGAAATCGCATCGACGTTCACCGATCGCCCGCTCGCCGGCACGCTGCGCTACTGGGGCGTCGCGACCGGTCAGCCGATCGAGCCCAATTTCGCGCCATACGGGCAGCTGTTCCAGACGCTTTACGATCCGTCGACGCCATTCCATGCGAATCGGCACGGCACGAACGTCGTGCTCGTCAGGCCGCGCGACTGGCTGCGCTTCGGCCAAGCCGATGCGAACGCCGAGACCACCGACACCGCGGCAGACGCGGCGGCCGCGCAAATCGCGCTTCACGCCGAAGAACTCGCCGACGCGCTCGCCGGCGCCGCACCGTCGCTCGCCGTGCCGGTACTCGTGCTGGTGCTGCCGGATGACGCGTCGTCGCTGGCGGCGCACGGCGAACACGGCGGCGAACGGGATGGCGAACCCGCGATCGACTCGTCGCTCGCCCCGTACCGCACGCTCGCCGCCGCGCTCGCGGATCTGCCGTCGGTGACGGTCGCGCACTGGCGCGACGTCGCCGCGATCTATCCGGTCGCCGACGTGTTCGATCCGCACGCGGATGCGGCGGGCCACGTGCCGTTCACGAGCGAGTACTACGCGGCGCTCGCGAGCTACATCGCGCGCACCGCGTTCCAGCACGCGTCGGTGCCGCTAGACGACGCATGGAACCGGCTCGCCGCGCAGATCCGGGACGACGCCGAGCACCTGCTCGCCGCACCCGCCGACGGCGCGCGCGCGCGCCGCGCGCCATACGCGCCGCCGGCCAACGAAGCGCAGGCGACGCTCGCGCCGATCTTCGCGGCCGCGCTGAAGCTCGCCGATCTCGGCATCGACGATAACTTCTTCGACTGCGGCGGCCACTCGATTCTCGCGATCGGCGTCGTCTATCAGATCAACGAAGCATTCGGCACGTCGCTTTCGGTCGCGGACATCTTCATGGCGCCGACCGTGCGCCGGCTCGCCGAGCGGATGCGCGACGCGCCGGACGGCCCCGAGTACGTCGACCTCGCGAGCGCGGCCGTGCTGCCCGACGATATCGCGCCGCTGCCCGGGCCCGTCGCCGGCACGCCGCGCGCGCTGCTGCTGACGGGCGCGACGGGCTTCGTCGGCCGCCACCTGCTGCGCGAGCTGATCGACCGCACCGATGCGACGATCCACTGCCTCGTGCGCGCGCCGGACGCCGCGCAGGGCCTCGCGCGGATTCGCGCGACGCTCGAGCGCTGGTCGCTGTGGCGCGACGGCGACGACGCGCGCGTGATCGCGGTGCCGGGCGATCTCGGCCGCCCGCGGATCGGCCTCTCCGAGCCCGATCGCGCGCGGCTCGTCGCCGAGGTCGACGCGATCTATCACAACGGCACCAGCATGAACCATCTCGAATCGTTCGAGATGGCGCGCGCCGCGAACGTCGGCGGCGTGATCGAGCTGCTGCGGATCGCAACCGAAGGCCGGCCGAAGACATTCAACTACGTGTCGACGCTCGCGGTGTTCAGCATGCGCGAACGCACAGGCACGCACGTATTCGACGAGTCCGCGCCGATCGACGATGAACGGCACCCGTCCGACCAGGGCTACACGACGAGCAAATGGGCCGGCGAACAGTTGACGCATCTGGCCGCCGCGCGCGGCGTGCCGTGCAACGTGTTCCGTCTCGGCCTCGTGACGGGCGACGTGCGGCACGGCCGTTACGACGAACTTCAGGCGTACTACCGGCTGCTGAAGAGCTGCATCCTGATGGGCGCGGCATTCGACGATTTTCGCTACGACCTCGTGATCACGCCCGTCGACTACGTCGCGCGCGCGCTCGCGCATCTCGGCGCGAAGCATCCGCAAGGCGGCCGCGTGTTTCATCTGTCGACGATGCAGGTCACGCCGATGCGCACGGTGTTCGAGATGATGAACGCGCATCTGCCCACGCCGATGCGCATGCTCACTCACCGCGCATGGATCGACGAGCTGCGCGTGCGCTACCGGCGCGGCGACGTGCAATCGATCGTGCCCGTCGTGCAATGGATGATGAACATGAGCGACGCGGAGCTCGTGAAGCTCGCGCGCGAACGCGAGGAAACGACGTTCATCTACGACTGCACGGCGACGCACCGCGAGCTCGAGGAAGCCGGCATCGTCGTGCCCGTGTTCGACGACGCGCTGCTGCAGCGCTATTTGCGCGGCATGTTCGACGAAGACGCGGACCTGCGCGCGCTCGCCGCCCAGCCGGACGGCGGCGAGCGCGCTTCTCCCCTTCACTCCCACATGTGA", "orf_prot_sequence": "MTASPPSRELATAVEAAVLSLAGDVAGCTFDASAAERPLHALGFDSVQYVELSGCLNEYYGLDLAPTLFFDVHAPRRIAAHLLARHPLEVARKHGVASGDESDALARAGAASDGGRERTGARDETAAHERESAGDIAIVGMAGIFPQSADLDAFWRHLAAGDDLIAEAPASRWDWRAADGESASRWGGFIPRIEYFDAAFFGISPREAEQMDPQQRLLMQTAWAALEDAAVRPSDLMGSDTAVFVGVSTSDYLDLLPGADGHLAVGNAHAMLPNRLSHLLGAHGPSEAVDTACSSSLVALHRAVCALRRGESGVAIVGGVNVMLTTRLHRALAAAGMLSPDGRCKTFDAAANGYVRGEGIAALVLMPLERARAGGHPVHAVIKGSAVNHGGRAAFLTAPDINAQAALIEAAYRDAGVDPATVSYIEAHGTGTSLGDPIEVQALRQGFDACARARGHADAPAPARCGLGSVKTNIGHLEAAAGLAGVVKVVLAMNRRMLPPSLHCRELNPYLKLDGSRYHVVTEPVPWPGDATPTPLRAGVSSFGFGGSNAHVVLQSADARPNDRPSAPRPPIAHEQAEAGAADAAGPLAWFIPLSARTDTALRARAAQLACWLDAERADDAWLPALAKTLSIGREPMACRFGVTCASLDSLRAQLAVALNGPAASLARDDARLQPHANAHAAWLAGGADPLPVAWDEATPRLRLPVYPFEGERHWPTDAVPPARFTLAPEGDGAYRMHVAPDAPLVADHRLGGEPVLAAAAQIVIAWRAFEADANAADSSRASEAGEPSQPDERNEPNGSSRAIGSKGSNPAGAAIDSTDAGGSRVSSNTADANAATQITLRDIEWLAPIAIGAPADLHVTLAREERSNANEDRRGNAHRREIGNAARFAIAVAPAIDAPLGRGYAARIARAPTNAPALDVDAIRARCTQPIAADACYDAFAAIGIGYGPTFRPLRAIAVGRDEAFAEFDPSALARTTGDARIVALLDGAFQAIAGLQLADAGRLEGGLLPASLARIEFTGPLADSTHAWIREAPGETGRRTFDIDLVTARGVPCASLRGLALASGRGGASREAPRVATPGDHLLAPQWLPCTANAPSAATPPQRAGAPAILGGTPAQRAALAATLATPPRLIDDIAELNAHVDHLVWLPPAPAHAHAPLARCAGLDGFRLVKRLLALGAGERAFELTVLTVRSWTMPGDAPAFPAHADLAGLCGSLANEYPHWRVRLIDLSDADALPADWRTQDTEGGHPLLHRHGQWFARRLVPLAALPSPATPPYRPGGVYVAIGGAGGLGRVWTGHAIRACGAQVVWIGRRPLDAQIDAHCDALAEFGPRPSYLSADASDVDSLRDARDAVLARFGRIDGVVHTAIVLQDGGLAQLDEAQFSAALNAQVATTANLARVFGGDSLDFILFFSSLQSAFVAAGQSNYAAGCTFRDAFADWLRTQLRCVVKVVSWGYWGQTGVVASEPYRKRMAALGIGSIEPAAAMAVVDALLAARVDQVGYLKTTARAAVPTLAPALAARIAPHTSALAGKPPPRIDETGASAAWNDALAALDRAIARRLFAELGALRAFGERDVADDGALGSVATGSDARGKRSSGERTFEPASFDIDAALRSGRIAPAYRRWLAHALALIAQHGHLDWDGRAGRLAEAPPPLDAARAEWAHARAQLDRTALLDAHLALADATLDALPAILQGSVPATSILFPDGDLSRVEAVYRRNEQADRCNRALADAVLHLVGGASSAQPAALAEIGAGTGGTTVPLLAALDASGARLAHYDFTDISKAFLLNAEQTFGRGRDTLRYRLFDVERPVAGQALDAGGYDIVIATNVLHATQDISVTLRNAKALLKTGGHLIVNELLGTHGFAHATFGLLPGWWRHRDSARRLPGSPLLSRDGWMRALREAGFAVPDGDSAGAAAAAGQGVIVAVSDGVIVQPAIADAGHAAHANADAQASAARPASFAASAAPARAASSIAAASSGAELRERCVQWLAQLVARTLKMPAGRLAPDQPLGSYGVDSILVIGLTKTLRETFGVALSNATLFEHATLSALADFFVAEHRAACERVLGGDAVAASAASSASAASASAIPNQAASNPLTSHAPMPMALATRATPPASPASPATATAADTAIAVIGMSGRYAQADNLREFWANLRAGRHCITEVPAERWDWRTHFDAEKGAPGRTYSRWGGFLKQIDRFDAAFFRIAPSDAEHIDPQGRLFLEEAWSAIEDAGYTPATLSANRQVGVFVGVMNGDYPTGAQFWSIANRVSHALDLHGPSLAVDTACSSSLTAIHLALDSLRSGTCDCALAGGVNLIQSPKHLVGLSSLTMLSAGDACRAFGAGADGFVDGEGVGVLVLKPLSRALADGDAIHGIIRGSMINAGGKTHGLTVPNPRAQQAVVAAALARSGVPARAVGYVEAHGTGTALGDPIELTGLTRAFAEATGDRGFCALGSVKSNIGHCESAAGVAGVTKVLLQMKHRELVPTLHADEPNPDLDFACSPFVLQRALAPWPKPDLDGWPRIAGVSSFGAGGANAHVVLEEFVDTRVAAPDDRAGPAIVVLSAATDDALRRRARQLHAALADGEIDDERLHDLAYTLQIGRDAMASRFGCVVGTVAELQAALAAFVEGDASRGWHAHRLAADRHGLAELDADPELRASLVEQCIAAGKLDRLAALWCQGLGVDWPALHRGHARRRVHLPTYPFDGPRHWLRDDATPATEPARAPADIADSHAAPPMRGASAGAPNVSTPDVAALVRRTVAQVLGYPDVDMNESFLSLGGDSIRAARAHRMLQRSLDVKIPLSLMLEAKTLAECARAIDALPPAEPPSAAGTPAAGAPPAEPRAPRASAFAPRDARPRVHTLSSNQRQFFFLDRLNPANPAFNLPGALRVRGEWHADALAAAYQALVDTHDVLRTRFVVRGGEPCAEVAPRRAAAIRHHDLSALLPKHQAARIAECLTGSSREGFALEQGEPSRLTVLELRDDDHVILLNLHHIVGDAVSVVVLLDVLARAALTGRASAPNRAQPQYAQWAAAERDALPATVERELPYWLERLRDVPPPLPLPCDRARPPVPSYRGRSVPLAFPSALTAQLDAYCKAHGLSRFVVMLAAFKVALRVLSGRDDIVVGSPYANRADDDTADMIGSLAYALVLRTRLGEAETFADAATLVRRTVHGAFDHLGVPYPRLVEALNPARHGGANPLYQIMFNVIPMPALPDGVEPVEVDSGWLDYDLFVRLRASGSAIEGVLQFSADLFDRSTAEAIATYYVELLHTLLAHPSLPLAGLAPPPELALERTIADAMPPLRIEIASTFTDRPLAGTLRYWGVATGQPIEPNFAPYGQLFQTLYDPSTPFHANRHGTNVVLVRPRDWLRFGQADANAETTDTAADAAAAQIALHAEELADALAGAAPSLAVPVLVLVLPDDASSLAAHGEHGGERDGEPAIDSSLAPYRTLAAALADLPSVTVAHWRDVAAIYPVADVFDPHADAAGHVPFTSEYYAALASYIARTAFQHASVPLDDAWNRLAAQIRDDAEHLLAAPADGARARRAPYAPPANEAQATLAPIFAAALKLADLGIDDNFFDCGGHSILAIGVVYQINEAFGTSLSVADIFMAPTVRRLAERMRDAPDGPEYVDLASAAVLPDDIAPLPGPVAGTPRALLLTGATGFVGRHLLRELIDRTDATIHCLVRAPDAAQGLARIRATLERWSLWRDGDDARVIAVPGDLGRPRIGLSEPDRARLVAEVDAIYHNGTSMNHLESFEMARAANVGGVIELLRIATEGRPKTFNYVSTLAVFSMRERTGTHVFDESAPIDDERHPSDQGYTTSKWAGEQLTHLAAARGVPCNVFRLGLVTGDVRHGRYDELQAYYRLLKSCILMGAAFDDFRYDLVITPVDYVARALAHLGAKHPQGGRVFHLSTMQVTPMRTVFEMMNAHLPTPMRMLTHRAWIDELRVRYRRGDVQSIVPVVQWMMNMSDAELVKLAREREETTFIYDCTATHRELEEAGIVVPVFDDALLQRYLRGMFDEDADLRALAAQPDGGERASPLHSHM", "perc_identity": 26.47}}}